
<html lang="en"     class="pb-page"  data-request-id="4765f72b-5d62-4853-826e-08283d1b985a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01884;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-8;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout" /></meta><meta name="dc.Creator" content="Kazuya  Tatani" /></meta><meta name="dc.Creator" content="Masahiro  Hiratochi" /></meta><meta name="dc.Creator" content="Norihiko  Kikuchi" /></meta><meta name="dc.Creator" content="Yu  Kuramochi" /></meta><meta name="dc.Creator" content="Shinjiro  Watanabe" /></meta><meta name="dc.Creator" content="Yuji  Yamauchi" /></meta><meta name="dc.Creator" content="Fumiaki  Itoh" /></meta><meta name="dc.Creator" content="Masayuki  Isaji" /></meta><meta name="dc.Creator" content="Satoshi  Shuto" /></meta><meta name="dc.Description" content="To test the hypothesis that inhibitors of human concentrative nucleoside transporter 2 (hCNT2) suppress increases in serum urate levels derived from dietary purines, we previously identified adenos..." /></meta><meta name="Description" content="To test the hypothesis that inhibitors of human concentrative nucleoside transporter 2 (hCNT2) suppress increases in serum urate levels derived from dietary purines, we previously identified adenos..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 11, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01884" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01884" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01884" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01884" /></link>
        
    
    

<title>Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01884" /></meta><meta property="og:title" content="Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0017.jpeg" /></meta><meta property="og:description" content="To test the hypothesis that inhibitors of human concentrative nucleoside transporter 2 (hCNT2) suppress increases in serum urate levels derived from dietary purines, we previously identified adenosine derivative 1 as a potent hCNT2 inhibitor (IC50 = 0.64 μM), but further study was hampered due to its poor solubility. Here we describe the results of subsequent research to identify more soluble and more potent hCNT2 inhibitors, leading to the discovery of the benzimidazole nucleoside 22, which is the most potent hCNT2 inhibitor (IC50 = 0.062 μM) reported to date. Compound 22 significantly suppressed the increase in plasma uric acid levels after oral administration of purine nucleosides in rats. Because compound 22 was poorly absorbed orally in rats (F = 0.51%), its pharmacologic action was mostly limited to the gastrointestinal tract. These findings suggest that inhibition of hCNT2 in the gastrointestinal tract can be a promising approach for the treatment of hyperuricemia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01884"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01884">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01884&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01884&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01884&amp;href=/doi/10.1021/acs.jmedchem.5b01884" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3719-3731</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01858" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01917" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kazuya++Tatani">Kazuya Tatani</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masahiro++Hiratochi">Masahiro Hiratochi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norihiko++Kikuchi">Norihiko Kikuchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Kuramochi">Yu Kuramochi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shinjiro++Watanabe">Shinjiro Watanabe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuji++Yamauchi">Yuji Yamauchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fumiaki++Itoh">Fumiaki Itoh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masayuki++Isaji">Masayuki Isaji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satoshi++Shuto">Satoshi Shuto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Central Research Laboratories, Kissei Pharmaceutical Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Faculty of Pharmaceutical Sciences, and <sup>§</sup>Center for Research and Education on Drug Discovery, Hokkaido University, Kita-12, Nishi-6, Kita-Ku, Sapporo 060-0812, Japan</span></div><div class="corresp-info"><strong>*</strong>Phone: +81-263-81-8820. Fax: +81-263-82-8827. E-mail: <a href="/cdn-cgi/l/email-protection#781319020d0119270c190c191611380810190a155613110b0b1d11561b17561208"><span class="__cf_email__" data-cfemail="0e656f747b776f517a6f7a6f60674e7e666f7c632065677d7d6b67206d6120647e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01884&amp;href=/doi/10.1021%2Facs.jmedchem.5b01884" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3719–3731</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 23, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 December 2015</li><li><span class="item_label"><b>Published</b> online</span>11 April 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01884" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01884</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3719%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKazuya%2BTatani%252C%2BMasahiro%2BHiratochi%252C%2BNorihiko%2BKikuchi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D8%26contentID%3Dacs.jmedchem.5b01884%26title%3DIdentification%2Bof%2BAdenine%2Band%2BBenzimidazole%2BNucleosides%2Bas%2BPotent%2BHuman%2BConcentrative%2BNucleoside%2BTransporter%2B2%2BInhibitors%253A%2BPotential%2BTreatment%2Bfor%2BHyperuricemia%2Band%2BGout%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3731%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01884"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1541</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01884" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kazuya&quot;,&quot;last_name&quot;:&quot;Tatani&quot;},{&quot;first_name&quot;:&quot;Masahiro&quot;,&quot;last_name&quot;:&quot;Hiratochi&quot;},{&quot;first_name&quot;:&quot;Norihiko&quot;,&quot;last_name&quot;:&quot;Kikuchi&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Kuramochi&quot;},{&quot;first_name&quot;:&quot;Shinjiro&quot;,&quot;last_name&quot;:&quot;Watanabe&quot;},{&quot;first_name&quot;:&quot;Yuji&quot;,&quot;last_name&quot;:&quot;Yamauchi&quot;},{&quot;first_name&quot;:&quot;Fumiaki&quot;,&quot;last_name&quot;:&quot;Itoh&quot;},{&quot;first_name&quot;:&quot;Masayuki&quot;,&quot;last_name&quot;:&quot;Isaji&quot;},{&quot;first_name&quot;:&quot;Satoshi&quot;,&quot;last_name&quot;:&quot;Shuto&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3719-3731&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01884&quot;},&quot;abstract&quot;:&quot;To test the hypothesis that inhibitors of human concentrative nucleoside transporter 2 (hCNT2) suppress increases in serum urate levels derived from dietary purines, we previously identified adenosine derivative 1 as a potent hCNT2 inhibitor (IC50 = 0.64 μM), but further study was hampered due to its poor solubility. Here we describe the results of subsequent research to identify more soluble and more potent hCNT2 inhibitors, leading to the discovery of the benzimidazole nucleoside 22, which is the most potent hCNT2 inhibitor (IC50 = 0.062 μM) reported to date. Compound 22 significantly suppressed the increase in plasma uric acid levels after oral administration of purine nucleosides in rats. Because compound 22 was poorly absorbed orally in rats (F = 0.51%), its pharmacologic action was mostly limited to the gastrointestinal tract. These findings suggest that inhibition of hCNT2 in the gastrointestinal tract can be a promising approach for the treatment of hyperuricemia.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01884&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01884" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01884&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01884" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01884&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01884" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01884&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01884&amp;href=/doi/10.1021/acs.jmedchem.5b01884" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01884" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01884" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (926 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01884%26sid%3Dliteratum%253Aachs%26pmid%3D27007871%26genre%3Darticle%26aulast%3DTatani%26date%3D2016%26atitle%3DIdentification%2Bof%2BAdenine%2Band%2BBenzimidazole%2BNucleosides%2Bas%2BPotent%2BHuman%2BConcentrative%2BNucleoside%2BTransporter%2B2%2BInhibitors%253A%2BPotential%2BTreatment%2Bfor%2BHyperuricemia%2Band%2BGout%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D8%26spage%3D3719%26epage%3D3731%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/jmcmar.2016.59.issue-8/20160428/jmcmar.2016.59.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To test the hypothesis that inhibitors of human concentrative nucleoside transporter 2 (hCNT2) suppress increases in serum urate levels derived from dietary purines, we previously identified adenosine derivative <b>1</b> as a potent hCNT2 inhibitor (IC<sub>50</sub> = 0.64 μM), but further study was hampered due to its poor solubility. Here we describe the results of subsequent research to identify more soluble and more potent hCNT2 inhibitors, leading to the discovery of the benzimidazole nucleoside <b>22</b>, which is the most potent hCNT2 inhibitor (IC<sub>50</sub> = 0.062 μM) reported to date. Compound <b>22</b> significantly suppressed the increase in plasma uric acid levels after oral administration of purine nucleosides in rats. Because compound <b>22</b> was poorly absorbed orally in rats (<i>F</i> = 0.51%), its pharmacologic action was mostly limited to the gastrointestinal tract. These findings suggest that inhibition of hCNT2 in the gastrointestinal tract can be a promising approach for the treatment of hyperuricemia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Uric acid is the end product of purine metabolism in human beings because a gene encoding uricase has undergone mutational silencing during hominoid evolution.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Uricase is an enzyme involved in the degradation of uric acid to the more soluble allantoin and is active in a wide range of organisms, from microorganism to mammals.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8">(4-8)</a> The loss of uricase activity has led to higher uric acid levels in human beings compared with most other mammals.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Uric acid is a weak acid with a p<i>K</i><sub>a</sub> of 5.75 and is present predominantly in the form of urate at a physiologic pH of 7.4.<a onclick="showRef(event, 'ref3 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref3 ref10 ref11">(3, 10, 11)</a> In extracellular fluid, uric acid exists mainly as a solution of monosodium urate, which is a poorly soluble excretion product unlike allantoin and thus has the potential to cause characteristic problems in human beings.<a onclick="showRef(event, 'ref3 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref10">(3, 10)</a></div><div class="NLM_p">Hyperuricemia is a condition in which serum urate levels are abnormally high. The definition of hyperuricemia, though currently arbitrary, is a serum urate concentration in excess of the solubility limit at physiologic temperature and pH (∼6.8 mg/dL).<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16">(11-16)</a> Persistent hyperuricemia is widely accepted as the primary risk factor for urate deposition diseases, such as gouty arthritis, gouty tophi, and renal damage.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> In addition, a number of reports suggest an association between hyperuricemia and pathologic conditions other than urate deposition disease.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17-22)</a> For example, recent epidemiologic studies demonstrated that serum urate levels positively correlate with the frequency of metabolic syndrome<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23-28)</a> and the risk for developing hypertension.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33 ref34 ref35">(29-35)</a> Therefore, treatment of hyperuricemia has become increasingly important.</div><div class="NLM_p">Serum urate levels are controlled through the balance among dietary purines, purine catabolism, and urate excretion.<a onclick="showRef(event, 'ref18 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref22">(18, 22)</a> Therefore, hyperuricemia can result from the excessive intake of purines, the increase in purine catabolism, the decrease in urate excretion, or combinations of them. Currently, two types of therapeutic drugs are available for the treatment of hyperuricemia.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Xanthine oxidase inhibitors and uricosuric agents reduce serum urate levels by blocking the biosynthesis and the tubular reabsorption of urate, respectively. However, no therapeutic drug focused on the third causative factor, dietary purine, has yet been developed. Patients with hyperuricemia are advised to refrain from habitual intake of a purine-rich diet. Hyperuricemia can be evoked in healthy subjects by ingesting yeast nucleic acid for several days.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(36-38)</a> On the other hand, recent epidemiologic studies report that high levels of meat and seafood consumption are associated with high serum urate levels<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(39)</a> and an increased risk of gouty arthritis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(40)</a> In contrast, a low purine diet lowers serum urate levels in patients with hyperuricemia.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(41, 42)</a> Together, these findings suggest that orally ingested purines increase serum urate levels, and thus suppressing their gastrointestinal absorption could be a promising approach for treating hyperuricemia.</div><div class="NLM_p">While dietary purines comprise various forms, such as DNA, RNA, nucleoproteins, oligonucleotides, purine nucleotides, purine nucleosides, and purine bases, most of these forms are unlikely to directly pass through the plasma membranes due to their high molecular weights and/or highly hydrophilic nature. Thus, carrier-mediated transport is probably involved in the gastrointestinal absorption of purines. Nucleoside transporter proteins have been extensively studied as potential carriers.<a onclick="showRef(event, 'ref45 ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48 ref49 ref50">(43-48)</a> Currently, they are roughly classified into two groups in mammals. One group comprises three concentrative nucleoside transporters, CNT1, CNT2, and CNT3 (SLC28A1, SLC28A2, and SLC28A3, respectively), which mediate unidirectional sodium- and/or proton-dependent transport.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(49, 50)</a> Another group comprises four equilibrative nucleoside transporters, ENT1, ENT2, ENT3, and ENT4 (SLC29A1, SLC29A2, SLC29A3, and SLC29A4, respectively), which mediate bidirectional sodium- and proton-independent transport (facilitated diffusion).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(51)</a> In previous reports, we estimated the likelihood that human concentrative nucleoside transporter 2 (hCNT2) plays a central role in the gastrointestinal absorption of purines on the basis of the expression profile and inherent substrate selectivity of the seven transporters in the gastrointestinal tract:<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(52, 53)</a> In human beings, (1) CNT1, CNT2, ENT1, and ENT2 are recognized as the major players in the enterocyte.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(54-56)</a> (2) CNT1 and CNT2 are located on the apical side, while ENT1 and ENT2 are on the basolateral side.<a onclick="showRef(event, 'ref45 ref48 ref50 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref45 ref48 ref50 ref56 ref57 ref58">(43, 46, 48, 54-56)</a> (3) CNT2 is a purine nucleoside-preferring transporter, whereas CNT1 is a practically pyrimidine nucleoside-specific transporter.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(48, 49)</a> Thus, we hypothesized that hCNT2 inhibitors would suppress the elevation of serum urate levels derived from dietary purines.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(52, 53)</a> To test this hypothesis, we searched for potent hCNT2 inhibitors, which led to the discovery of compound <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(53)</a> Further studies using compound <b>1</b> were hampered, however, due to its poor solubility in aqueous medium. For example, the solubility of compound <b>1</b> in the Japanese Pharmacopoeia second fluid for a dissolution test (JP2, pH 6.8)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(57)</a> at 37 °C was 0.003 mg/mL, indicating that <b>1</b> is practically insoluble. Hence, more soluble potent hCNT2 inhibitors are required. In the present paper, we describe structure–activity relationship studies leading to the discovery of potent hCNT2 inhibitors with increased solubility and their suppressive effect on an increase of plasma uric acid levels derived from orally administered purine nucleosides in rats.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. A potent hCNT2 inhibitor discovered in our previous study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Improving Solubility by Manipulating the Biphenyl Conformation</h3><div class="NLM_p">To enhance the solubility of compound <b>1</b>, we focused on its highly hydrophobic biphenyl moiety and synthesized various compounds with modifications in this region. All newly synthesized final products were evaluated primarily for their inhibitory effects on sodium-dependent inosine uptake in COS-7 cells transiently expressing hCNT2 following the previously described procedure.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(52, 53)</a></div><div class="NLM_p">First, the terminal benzene ring was replaced with a pyridine ring (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The pyridin-3-yl analog <b>3</b> exhibited potent hCNT2 inhibitory activity similar to that of compound <b>1</b>, whereas the pyridin-2-yl and pyridin-4-yl analogs (compounds <b>2</b> and <b>4</b>) resulted in somewhat reduced activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Effects of Compounds <b>2</b>–<b>4</b> on hCNT2 and Rat CNT2 (rCNT2) Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">hCNT2</th><th class="colsep0 rowsep0" align="center">rCNT2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.19</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">pyridin-2-yl</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.5</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">>100<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">pyridin-4-yl</td><td class="colsep0 rowsep0" align="left">2.7 ± 0.9</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Concentration of each compound required to inhibit inosine uptake by 50%. Data are expressed as the mean ± standard error of the mean (SEM) of at least three independent experiments unless otherwise stated.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">No inhibition was observed at the maximum concentration of 100 μM.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">11% inhibition was observed at the maximum concentration of 100 μM.</p></div></div></div><div class="NLM_p">We then introduced a polar functional group on the <i>endo</i>-benzene ring (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Among the compounds substituted at the 2-position, the 2-hydroxy derivative <b>5</b> was tolerated without a significant loss of inhibitory activity. While the inhibitory activity of the 2-methoxy derivative <b>6</b> was comparable to that of <b>5</b>, introduction of larger alkoxy groups, including ethoxy, propoxy, and isopropoxy groups, to the 2-position tended to reduce the potency depending on their bulkiness (compounds <b>7</b>–<b>9</b>). The 3-substituted derivatives <b>10</b>–<b>14</b> similarly reduced the potency depending on the bulkiness of the substituent introduced. Thus, irrespective of the substitution position, increased lipophilicity of substituents correlated with decreased activity of the compounds.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Effects of Compounds <b>5</b>–<b>17</b> on hCNT2 and rCNT2 Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0013.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">hCNT2</th><th class="colsep0 rowsep0" align="center">rCNT2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.19</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.6</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.6</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">OPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.2 ± 1.5</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">O-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10.4 ± 1.0</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.1</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">5.4 ± 1.3</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OPr</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">9.3 ± 1.8</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.8</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.5 ± 1.4</td><td class="colsep0 rowsep0" align="left">>100<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">>100<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Concentration of each compound required to inhibit inosine uptake by 50%. Data represent the mean ± SEM of at least three independent experiments unless otherwise stated.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">No inhibition was observed at the maximum concentration of 100 μM.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Less than 5% inhibition was observed at the maximum concentration of 100 μM.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">49% inhibition was observed at the maximum concentration of 100 μM.</p></div></div></div><div class="NLM_p">Although substitution with a small group at both the 2- and 3-positions of the <i>endo</i>-benzene ring did not reduce the activity, we thought that substitution at the 2-position would probably improve the solubility more effectively than substitution at the 3-position because steric repulsion between the 2-substituent and the terminal benzene ring might make the planar conformation of the biphenyl moiety unstable, and thus the biphenyl moiety would become stabilized by assuming a twisted conformation to avoid the steric repulsion. Actually, recent studies suggested that disruption of molecular planarity is a good strategy for improving the aqueous solubility of poorly soluble compounds.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(58, 59)</a> Therefore, we estimated the substituent effects on the conformation of compound <b>1</b>, especially that of the biphenyl moiety, using its 2- and 3-methyl derivatives (<b>A</b> and <b>B</b>, respectively) as model compounds by performing theoretical calculations using the density functional theory B3LYP/6-31G* method in Spartan ’14. When the most stable conformers were compared (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), the biphenyl moiety of 2-methylated <b>A</b> was significantly more twisted (57.4°) than that of 3-methylated <b>B</b> (36.6°) and unmethylated <b>1</b> (37.3°).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Simulation of substituent effects on the biphenyl structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">If the biphenyl moiety of the compound actually assumes a nonplanar twisted conformation, its crystallinity would decrease compared with the planar one to improve the solubility. To test this hypothesis, we measured the solubility of compounds in JP2 at 37 °C using the 2-substituted derivatives <b>6</b> and <b>7</b> and their 3-substituted congeners <b>11</b> and <b>12</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). As expected, each of the 2-substituted compounds <b>6</b> and <b>7</b> had significantly improved solubility compared with the parent compound <b>1</b>. In contrast, despite introduction of the same substituents, the solubility of 3-substituted compounds <b>11</b> and <b>12</b> was unchanged compared to the parent compound <b>1</b>. These results correlated well with the simulation of the biphenyl conformations shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.</div><div class="NLM_p">On the basis of the above encouraging results, other substituents at the 2-position were investigated. Because alkoxy groups introduced at the 2-position tended to decrease hCNT2 inhibitory activity depending on their bulkiness and lipophilicity, we examined alkoxy groups substituted with a polar functional group (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Although the size of the 2-methoxy-2-oxoethoxy and 2-hydroxyethoxy groups was comparable to or greater than the propoxy group, compounds <b>15</b> and <b>17</b> exhibited more potent hCNT2 inhibitory activity than the propoxy derivative <b>8</b> but less potent than the ethoxy derivative <b>7</b>. In contrast, the 2-amino-2-oxoethoxy derivative <b>16</b> resulted in inhibitory activity equal to that of <b>8</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Substituent Effects on the Solubility in JP2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">solubility (mg/mL)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.215</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Solubility in JP2 (pH 6.8) after incubation at 37 °C for 1 h.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Attempt To Improve Inhibitory Activity against Rat CNT2 (rCNT2) in Adenosine Derivatives</h3><div class="NLM_p">We next examined the inhibitory activity of the relatively potent hCNT2 inhibitors <b>3</b>, <b>5</b>, and <b>6</b> against rCNT2.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(52)</a> Unexpectedly, both compounds <b>5</b> and <b>6</b> were inactive against rCNT2 up to the maximum concentration of 100 μM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), whereas <b>3</b> exhibited slight inhibitory activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These findings might be due to differences in the amino acid sequence between hCNT2 and rCNT2: hCNT2 is one amino acid shorter than rCNT2 and 83% identical to rCNT2.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(60, 61)</a> Hence, we also evaluated all other compounds including parent compound <b>1</b> and confirmed that most of these compounds were inactive, and only compounds <b>16</b> and <b>17</b> had weak activity (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Comparison of the 2-ethoxy derivative <b>7</b> with its hydroxylated analog <b>17</b> revealed that the terminal hydroxy group is crucial for exerting rCNT2 inhibitory activity. Therefore, we paid attention to the homologues of compound <b>17</b> and synthesized the 3-hydroxypropoxy, 4-hydroxybutoxy, and 5-hydroxypentyloxy derivatives <b>18</b>–<b>20</b>. As summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, elongation of the ethylene linker in compound <b>17</b> enhanced the inhibitory activity against both hCNT2 and rCNT2. Because the 4-hydroxybutoxy derivative <b>19</b> exhibited the most potent inhibitory activity against both hCNT2 and rCNT2 among the homologues, we selected this compound for further evaluation and measured its solubility in JP2 at 37 °C. As a result, compound <b>19</b> showed much higher solubility (0.190 mg/mL) than the parent compound <b>1</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), suggesting that the 4-hydroxybutoxy group enhanced the twisted structure of the biphenyl moiety to increase solubility, as mentioned above.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Profiles of Compounds <b>17</b>–<b>20</b> and Improved Solubility of <b>19</b> in JP2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0015.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">hCNT2</th><th class="colsep0 rowsep0" align="center">rCNT2</th><th class="colsep0 rowsep0" align="center">solubility (mg/mL)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.19</td><td class="colsep0 rowsep0" align="left">inactive<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">>100<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>OH</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">45.1 ± 2.9</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>4</sub>OH</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.24</td><td class="colsep0 rowsep0" align="left">38 ± 13</td><td class="colsep0 rowsep0" align="left">0.190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>5</sub>OH</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">60 ± 20</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Concentration of each compound required to inhibit inosine uptake by 50%. Data represent the mean ± SEM of at least three independent experiments unless otherwise stated.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">No inhibition was observed at the maximum concentration of 100 μM.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">49% inhibition was observed at the maximum concentration of 100 μM.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Solubility in JP2 (pH 6.8) after incubation at 37 °C for 1 h.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">Subsequently, compound <b>19</b> was evaluated by performing a purine load test in rats. Serum urate levels in rats are quite low (<1 mg/dL),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> in contrast to human beings, due to the existence of uricase activity, and therefore they were pretreated with the uricase inhibitor potassium oxonate (100 mg/kg) to induce serum urate accumulation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(62)</a> Oral administration of a purine mixture (50 mg/kg), an equal mixture of adenosine, inosine, and guanosine, significantly elevated plasma uric acid levels in the rats (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). On the other hand, the purine mixture-induced elevation of plasma uric acid levels was suppressed when compound <b>19</b> was administered simultaneously at a dose of 50 mg/kg. The suppressive ratio was calculated to be 42%, but unfortunately it was not statistically significant. This may be due to insufficient inhibitory activity against rCNT2 (IC<sub>50</sub> = 38 μM).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>19</b> on the elevation of plasma uric acid levels derived from orally administered purine mixture (an equal mixture of adenosine, guanosine, and inosine, 50 mg/kg) in rats. Data are expressed as the mean ± SEM (<i>n</i> = 5): (##) <i>p</i> < 0.01 versus a group treated with only potassium oxonate (100 mg/kg); NS, not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Scaffold Hopping from Adenine to Benzimidazole</h3><div class="NLM_p">On the basis of the above-mentioned in vitro profiles, it was conceivable that the different susceptibility between hCNT2 and rCNT2 observed in this study was a characteristic common to compounds having the 8-(benzylamino)adenosine substructure. Therefore, we designed compounds based on a scaffold hopping strategy to find compounds with enhanced inhibitory activity against rCNT2.</div><div class="NLM_p">Because the sugar moiety has important interactions with CNT2,<a onclick="showRef(event, 'ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67">(63-65)</a> and the substituent at the 8-position of adenosine was highly optimized through our study, we performed adenine moiety-hopping of compound <b>19</b> and designed the hypoxanthine riboside <b>21</b> and the benzimidazole riboside <b>22</b>. As shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, conversion to the inosine congener <b>21</b> not only reduced the inhibitory activity against both hCNT2 and rCNT2 but also increased the susceptibility difference. Replacement of adenine with the benzimidazole forming <b>22</b>, however, considerably enhanced the inhibitory activity against both hCNT2 and rCNT2. Thus, benzimidazole congener <b>22</b> was identified as the most potent hCNT2 inhibitor (IC<sub>50</sub> = 0.062 μM) reported to date, which was also a potent inhibitor against rCNT2 (IC<sub>50</sub> = 1.5 μM).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(66)</a> In addition, the solubility of compound <b>22</b> in JP2 at 37 °C (0.120 mg/mL) was much higher than that of parent compound <b>1</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Profiles and Solubility Data of Compounds <b>19</b>, <b>21</b>, and <b>22</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hCNT2</th><th class="colsep0 rowsep0" align="center">rCNT2</th><th class="colsep0 rowsep0" align="center">solubility (mg/mL)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.94 ± 0.24</td><td class="colsep0 rowsep0" align="left">38 ± 13</td><td class="colsep0 rowsep0" align="left">0.190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">20.1 ± 2.0</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.062 ± 0.017</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.120</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Concentration of each compound required to inhibit inosine uptake by 50%. Data represent the mean ± SEM of at least three independent experiments unless otherwise stated.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">18% inhibition was observed at the maximum concentration of 1000 μM.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Solubility in JP2 (pH 6.8) after incubation at 37 °C for 1 h.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">Although the issue of the susceptibility difference remained, compound <b>22</b> had more than 25-fold more potent inhibitory activity than <b>19</b> against rCNT2 and therefore was evaluated by purine load test in the same manner as described above (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Compound <b>22</b> significantly suppressed the increase in plasma uric acid levels derived from the purine mixture at a lower dose of 1.0 mg/kg, which was probably due to enhanced in vitro activity. A higher dose of compound <b>22</b> (10 mg/kg), however, resulted in little enhancement of the suppressive effect. These results suggested that rCNT2 played a central role in the absorption of purine nucleosides through the gastrointestinal tract, while pathways other than via rCNT2 might be involved in the uptake of orally ingested purine nucleosides, including their breakdown products, in rats.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>22</b> on the elevation of plasma uric acid levels derived from orally administered purine mixture (50 mg/kg) in rats. Data are expressed as the mean ± SEM (<i>n</i> = 5–11): (###) <i>p</i> < 0.001 versus a group treated with only potassium oxonate (100 mg/kg); (∗∗∗) <i>p</i> < 0.001 versus a group treated with potassium oxonate and purine mixture.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, the oral absorption properties of compound <b>22</b> were investigated in rats (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). The maximum plasma concentration value (<i>C</i><sub>max</sub>) of compound <b>22</b> (0.11 μM) after oral administration (10 mg/kg) was below one-tenth of the IC<sub>50</sub> value of <b>22</b> (1.5 μM), and the oral bioavailability (<i>F</i>) was calculated to be 0.51%. These results suggested that compound <b>22</b> was poorly absorbed orally and that its action was mostly limited to the gastrointestinal tract. Therefore, the pharmacologic effects of compound <b>22</b> in the purine load test were probably due to the uptake inhibition of purine nucleosides via rCNT2 through the gastrointestinal tract.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters of Compound <b>22</b> in Rats after Intravenous (iv) and Oral (po) Administrations<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">iv<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">po<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">394</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub> (mL/kg)</td><td class="colsep0 rowsep0" align="left">117</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> (μM·h)</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–<i>x</i></sub> (μM·h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Data are expressed as the mean (<i>n</i> = 3).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Compound <b>22</b> was dissolved in 50% (v/v) <i>N</i>,<i>N</i>-dimethylacetamide in 5% glucose solution and administered intravenously at a dose of 1.0 mg/kg.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Compound <b>22</b> was suspended in sodium carboxymethylcellulose and administered orally at a dose of 10 mg/kg.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The adenosine derivatives <b>2</b>–<b>4</b> were synthesized by nucleophilic aromatic substitution of commercially available 8-bromoadenosine with the amines <b>24</b>, <b>28</b>, and <b>30</b>, which were prepared from commercially available starting materials (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The amine <b>24</b> was prepared by reducing 4-(pyridin-2-yl)benzonitrile <b>23</b> with LiAlH<sub>4</sub>. Suzuki–Miyaura coupling of 4-cyanophenylboronic acid <b>25</b> with 3-bromopyridine and subsequent treatment with LiAlH<sub>4</sub> gave 4-(pyridin-3-yl)benzylamine, which was purified after conversion to corresponding trifluoroacetamide <b>27</b>. Alkaline hydrolysis of compound <b>27</b> afforded amine <b>28</b>. In a similar fashion, amine <b>30</b> could be synthesized starting from compound <b>25</b> without the additional protection–deprotection step for purification.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiAlH<sub>4</sub>, THF, 60 °C; (b) 8-bromoadenosine, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (c) 3-bromopyridine or 4-bromopyridine hydrochloride, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2.0 M aq Na<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C; (d) CF<sub>3</sub>CO<sub>2</sub>Et, EtOH, rt; (e) 2.0 M aq NaOH, EtOH, 60 °C.</p></p></figure><div class="NLM_p">Adenosine derivatives <b>5</b>–<b>9</b> and <b>15</b>–<b>20</b> were synthesized starting from commercially available 4-hydroxy-3-methoxybenzonitrile <b>31</b> (<a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compound <b>31</b> was converted to its triflate, followed by Suzuki–Miyaura coupling with phenylboronic acid to give the biphenyl <b>32</b>. Reduction of compound <b>32</b> with LiAlH<sub>4</sub> and subsequent nucleophilic aromatic substitution with 8-bromoadenosine furnished <b>6</b>. In addition, methyl ether <b>32</b> was converted to the corresponding benzyl ether <b>35</b> by stepwise treatment with BBr<sub>3</sub> and BnBr before reduction with LiAlH<sub>4</sub> to afford amine <b>36</b>. Condensation of compound <b>36</b> with 8-bromo-2′,3′,5′-tris-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)adenosine, which was prepared according to the method described in the literature<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(67)</a> with some modifications, and subsequent catalytic hydrogenation provided the common intermediate <b>38</b>. Treatment of compound <b>38</b> with NH<sub>4</sub>F yielded <b>5</b>. On the other hand, the hydroxyl group of compound <b>38</b> was alkylated with the appropriate alkyl halide followed by treatment with NH<sub>4</sub>F to give <b>7</b>–<b>9</b> and <b>15</b>. Reactions of the ester <b>15</b> with NH<sub>3</sub> and NaBH<sub>4</sub> afforded the amide <b>16</b> and alcohol <b>17</b>, respectively. Alkylation of compound <b>34</b> with the appropriate alkyl bromide and subsequent reduction with LiAlH<sub>4</sub> provided amines <b>46</b>–<b>48</b>, which were then subjected to nucleophilic aromatic substitution with 8-bromoadenosine before removal of the benzyl groups by catalytic hydrogenation to furnish <b>18</b>-<b>20</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tf<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (b) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DMF, 80 °C; (c) LiAlH<sub>4</sub>, THF, 60 °C; (d) 8-bromoadenosine, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube.</p></p></figure><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>5</b>, <b>7</b>–<b>9</b>, and <b>15</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BBr<sub>3</sub> (1.0 M in DCM), DCM, 30 °C; (b) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (c) LiAlH<sub>4</sub>, THF, 60 °C; (d) 8-bromo-2′,3′,5′-tris-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)adenosine,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(67)</a><i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (e) H<sub>2</sub>, 10% Pd–C, AcOEt, rt; (f) NH<sub>4</sub>F, MeOH, reflux; (g) R<sub>6</sub>I or R<sub>6</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 35–50 °C; (h) NH<sub>3</sub> (2.0 M in MeOH), rt; (i) NaBH<sub>4</sub>, EtOH, rt.</p></p></figure><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>18</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>7</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C; (b) LiAlH<sub>4</sub>, THF, 60 °C; (c) 8-bromoadenosine, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (d) H<sub>2</sub>, 10% Pd–C, MeOH, 50 °C.</p></p></figure><div class="NLM_p">The adenosine derivatives <b>10</b>–<b>14</b> were synthesized starting from commercially available 4-bromo-2-hydroxybenzonitrile <b>52</b> following a methodology similar to that described above (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Suzuki–Miyaura coupling with phenylboronic acid after benzylation of compound <b>52</b> and subsequent reduction with LiAlH<sub>4</sub> provided the amine <b>54</b>. Condensation of compound <b>54</b> with 8-bromo-2′,3′,5′-tris-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)adenosine<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(67)</a> followed by catalytic hydrogenation yielded the common intermediate <b>56</b>. The silyl ethers of compound <b>56</b> were cleaved by treatment with NH<sub>4</sub>F to give <b>10</b>. On the other hand, the hydroxy group of compound <b>56</b> was alkylated with the appropriate alkyl iodide before treatment with NH<sub>4</sub>F to afford <b>11</b>–<b>14</b>.</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>10</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (b) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DMF, 80 °C; (c) LiAlH<sub>4</sub>, THF, 60 °C; (d) 8-bromo-2′,3′,5′-tris-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)adenosine,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(67)</a><i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (e) H<sub>2</sub>, 10% Pd–C, AcOEt, rt; (f) NH<sub>4</sub>F, MeOH, reflux; (g) R<sub>9</sub>I, K<sub>2</sub>CO<sub>3</sub>, DMF, rt to 50 °C.</p></p></figure><div class="NLM_p">The inosine derivative <b>21</b> was synthesized by treating the adenosine derivatives <b>50</b> with NaNO<sub>2</sub> in aqueous acetic acid followed by catalytic hydrogenation to remove the benzyl group (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaNO<sub>2</sub>, 75% (v/v) aq AcOH, rt; (b) H<sub>2</sub>, 10% Pd–C, MeOH, 50 °C.</p></p></figure><div class="NLM_p">The benzimidazole nucleoside <b>22</b> was synthesized starting from commercially available 2-chloro-1<i>H</i>-benzimidazole <b>62</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Compound <b>62</b> was silylated with <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide, followed by glycosidation with 1,2,3,5-tetra-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-ribofuranose in the presence of TMSOTf to give <b>63</b>. Treatment of compound <b>63</b> with NaOMe provided <b>64</b>, which was then subjected to a nucleophilic aromatic substitution with <b>47</b> followed by catalytic hydrogenation to furnish <b>22</b>.</div><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide, MeCN, 80 °C, then TMSOTf, 1,2,3,4-tetra-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-ribofuranose, rt; (b) <i>t</i>-BuOK, MeOH, rt; (c) <b>47</b>, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (d) H<sub>2</sub>, 10% Pd–C, MeOH, 50 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We searched for potent hCNT2 inhibitors with increased solubility starting from compound <b>1</b>, a potent but poorly soluble inhibitor that we reported previously. Substituents at the 2-position of the biphenyl-4-yl substructure in compound <b>1</b> effectively ameliorated the solubility in JP2 at 37 °C. Introduction of terminally hydroxylated alkoxy groups was crucial for acquisition of the rCNT2 inhibitory activity, which led to the discovery of compound <b>19</b>. Subsequent scaffold hopping of compound <b>19</b> by adenine replacement yielded the benzimidazole nucleoside <b>22</b> as the most potent hCNT2 inhibitor reported to date. Compound <b>22</b> exhibited potent inhibitory activity against rCNT2 and significantly suppressed increases in plasma urate levels in a purine load test using rats. Compound <b>22</b> had a poorly absorbable nature after oral administration in rats, and thus its pharmacologic action is likely limited to the gastrointestinal tract. These findings suggest that inhibition of hCNT2 in the gastrointestinal tract can be a promising approach for the treatment of hyperuricemia.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Methods</h3><div class="NLM_p last">Reagents and solvents were purchased from commercial sources and used without further purification. All moisture and air sensitive reactions were carried out in an oven-dried flask under an argon atmosphere. Reaction conditions and yields were not optimized. All melting points were determined on a Yanaco micro melting point apparatus (MP-J3) and are uncorrected. Reactions were monitored by thin layer chromatography (TLC) using Merck Kieselgel 60 F<sub>254</sub> plates or Fuji Silysia Chemical Ltd. Chromatorex NH-TLC plates. Flash column chromatography was performed on Biotage prepacked columns or Yamazen Hi-Flash columns using an automated flash chromatography systems Biotage Isolera One (Biotage AB, Uppsala, Sweden) or W-prep 2XY (Yamazen Corporation, Osaka, Japan). <sup>1</sup>H NMR spectra were recorded on a Bruker AV400M spectrometer at 400.1 MHz. Chemical shifts (δ) are reported in parts per million (ppm) units using tetramethylsilane as an internal standard. Data are presented as follows; chemical shift, multiplicity (s, singlet; d, doublet; dd, double doublet; t, triplet; q, quartet; m, multiplet; br, broad; br s, broad singlet), coupling constant, and integration. <sup>13</sup>C NMR spectra were recorded on a Bruker AV400M spectrometer at 100.6 MHz with complete proton decoupling. Chemical shifts (δ) are reported in parts per million (ppm) with the solvent as the internal reference (δ 77.16 in CDCl<sub>3</sub> or δ 39.52 in DMSO-<i>d</i><sub>6</sub>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(68)</a> High resolution mass spectra (HRMS) were recorded on an Agilent Technologies 6520 Accurate-Mass Q-TOF instrument using electrospray ionization (ESI, positive or negative ion mode). The purity of all tested compounds was determined to be ≥95% by HPLC–UV analysis, which was performed on a Shimadzu LC-VP series instrument (Shimadzu Corporation, Kyoto, Japan) with the following parameters: analytical column, Inertsil ODS-3, 4.6 mm × 250 mm, 5 μm (GL Sciences Inc., Tokyo, Japan); mobile phase, linear gradient of 10–90% MeOH in 0.1% (v/v) aq HCO<sub>2</sub>H for 45 min with flow rate of 1.0 mL/min; column temperature, 40 °C; injection volume, 10 μL; compound concentration, 2 mM in DMSO; detection wavelength, 260 nm.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 8-[4-(Pyridin-2-yl)benzylamino]adenosine (<b>2</b>)</h3><div class="NLM_p last">A mixture of <b>24</b> (343 mg, 1.86 mmol), 8-bromoadenosine (215 mg, 0.621 mmol), and <i>i</i>-Pr<sub>2</sub>NEt (482 mg, 3.73 mmol) in EtOH (5.18 mL) was heated in a screw tube at 120 °C with stirring for 90 h. The reaction mixture was allowed to cool to room temperature and then concentrated under reduced pressure. The residue was purified by flash column chromatography on NH silica gel (gradient; 8–15% MeOH in DCM) followed by flash column chromatography on silica gel (gradient; 10–20% MeOH in DCM) to give <b>2</b> (235 mg, 84%) as a yellow foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.53–3.73 (m, 2H), 3.96–4.05 (m, 1H), 4.09–4.17 (m, 1H), 4.55–4.81 (m, 3H), 5.18 (d, <i>J</i> = 4.0 Hz, 1H), 5.32 (d, <i>J</i> = 6.8 Hz, 1H), 5.92 (dd, <i>J</i> = 4.0, 6.3 Hz, 1H), 5.96 (d, <i>J</i> = 7.5 Hz, 1H), 6.54 (br s, 2H), 7.28–7.37 (m, 1H), 7.43–7.53 (m, 2H), 7.55–7.67 (m, 1H), 7.80–7.97 (m, 3H), 7.99–8.10 (m, 2H), 8.60–8.69 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.1, 61.8, 71.0, 71.2, 85.9, 86.6, 117.1, 120.1, 122.5, 126.5, 127.5, 137.3 (2C), 140.9, 148.7, 149.6, 149.9, 151.4, 152.5, 156.0. HRMS calcd for C<sub>22</sub>H<sub>24</sub>N<sub>7</sub>O<sub>4</sub> (M + H)<sup>+</sup> 450.1884, found 450.1886.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 8-[4-(Pyridin-3-yl)benzylamino]adenosine (<b>3</b>)</h3><div class="NLM_p last">The title compound was synthesized from <b>28</b> (160 mg, 0.867 mmol) and 8-bromoadenosine (100 mg, 0.289 mmol) according to the procedure described for <b>2</b>. The crude product was purified by flash column chromatography on NH silica gel (gradient; 8–15% MeOH in DCM) followed by flash column chromatography on silica gel (gradient; 10–24% MeOH in DCM) to afford <b>3</b> (99.9 mg, 77%) as a beige amorphous solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.55–3.74 (m, 2H), 3.96–4.06 (m, 1H), 4.10–4.20 (m, 1H), 4.54–4.82 (m, 3H), 5.16 (d, <i>J</i> = 4.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.8 Hz, 1H), 5.85–6.00 (m, 2H), 6.53 (br s, 2H), 7.44–7.55 (m, 3H), 7.61 (t, <i>J</i> = 6.0 Hz, 1H), 7.64–7.73(m, 2H), 7.90 (s, 1H), 8.02–8.10 (m, 1H), 8.55 (dd, <i>J</i> = 1.8, 4.8 Hz, 1H), 8.84–8.91 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.0, 61.8, 71.0, 71.1, 85.9, 86.6, 117.0, 123.9, 126.8, 127.9, 134.0, 135.5 (2C), 140.0, 147.6, 148.3, 148.5, 149.9, 151.4, 152.4. HRMS calcd for C<sub>22</sub>H<sub>24</sub>N<sub>7</sub>O<sub>4</sub> (M + H)<sup>+</sup> 450.1884, found 450.1879.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 8-[4-(Pyridin-4-yl)benzylamino]adenosine (<b>4</b>)</h3><div class="NLM_p last">A mixture of <b>30</b> (227 mg, 1.23 mmol), 8-bromoadenosine (142 mg, 0.410 mmol), and <i>i</i>-Pr<sub>2</sub>NEt (318 mg, 2.46 mmol) in EtOH (4.10 mL) was heated in a screw tube at 120 °C with stirring for 96 h. The reaction mixture was allowed to cool to room temperature and then concentrated under reduced pressure. To the suspension of the residue in DCM (20.0 mL) was added <i>i</i>-Pr<sub>2</sub>NEt (159 mg, 1.23 mmol), and the resulting mixture was stirred at room temperature for 20 h. The precipitate was collected by filtration, washed with DCM, air-dried, and dried under reduced pressure to give an orange brown solid (256 mg). The solid (252 mg) was suspended in EtOH (30.0 mL) and heated under reflux with stirring for 1 h before being allowed to cool to room temperature. The precipitate was collected by filtration, washed with EtOH, air-dried, and dried under reduced pressure to give <b>4</b> (93.0 mg, 50%) as a pale brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.54–3.71 (m, 2H), 3.96–4.06 (m, 1H), 4.10–4.20 (m, 1H), 4.52–4.84 (m, 3H), 5.16 (d, <i>J</i> = 4.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.8 Hz, 1H), 5.90 (dd, <i>J</i> = 4.0, 6.0 Hz, 1H), 5.95 (d, <i>J</i> = 7.5 Hz, 1H), 6.52 (br s, 2H), 7.48–7.59 (m, 2H), 7.62 (t, <i>J</i> = 6.2 Hz, 1H), 7.66–7.86 (m, 4H), 7.90 (s, 1H), 8.58–8.69 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.0, 61.8, 71.0, 71.1, 85.8, 86.5, 117.0, 121.1, 126.7, 127.9, 135.6, 141.3, 146.8, 148.6, 149.9, 150.2, 151.3, 152.5. HRMS calcd for C<sub>22</sub>H<sub>24</sub>N<sub>7</sub>O<sub>4</sub> (M + H)<sup>+</sup> 450.1884, found 450.1884.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 8-(2-Hydroxybiphenyl-4-ylmethylamino)adenosine (<b>5</b>)</h3><div class="NLM_p last">To a solution of <b>38</b> (367 mg, 0.455 mmol) in MeOH (9.09 mL) was added NH<sub>4</sub>F (1.01 g, 27.3 mmol), and the resulting mixture was heated under reflux with stirring for 24 h. The reaction mixture was allowed to cool to room temperature, diluted with H<sub>2</sub>O (9.09 mL), and then stirred for 1 h. The precipitate was collected by filtration, washed with MeOH/H<sub>2</sub>O (1/1), air-dried, and then recrystallized from EtOH to give <b>5</b> (75.0 mg, 36%) as an off-white solid. Mp 240–242 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.56–3.75 (m, 2H), 3.96–4.08 (m, 1H), 4.10–4.19 (m, 1H), 4.46–4.63 (m, 2H), 4.72–4.82 (m, 1H), 5.17 (d, <i>J</i> = 4.3 Hz, 1H), 5.24 (d, <i>J</i> = 6.8 Hz, 1H), 5.85–5.93 (m, 1H), 5.95 (d, <i>J</i> = 7.3 Hz, 1H), 6.51 (br s, 2H), 6.84–6.91 (m, 1H), 6.92–6.99 (m, 1H), 7.19 (d, <i>J</i> = 7.8 Hz, 1H), 7.23–7.31 (m, 1H), 7.33–7.43 (m, 2H), 7.47–7.62 (m, 3H), 7.90 (s, 1H), 9.46 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.0, 61.8, 71.1, 85.8, 86.6, 114.7, 117.1, 118.2, 126.2, 126.4, 127.9, 129.0, 130.1, 138.6, 140.5, 148.5, 149.8, 151.5, 152.5, 154.2. HRMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 465.1881, found 465.1873.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 8-(2-Methoxybiphenyl-4-ylmethylamino)adenosine (<b>6</b>)</h3><div class="NLM_p last">The title compound was synthesized from <b>33</b> (370 mg, 1.73 mmol) and 8-bromoadenosine (200 mg, 0.578 mmol) according to the procedure described for <b>2</b>. The crude product was purified by flash column chromatography on NH silica gel (gradient; 8–15% MeOH in DCM) followed by flash column chromatography on silica gel (gradient; 10–17% MeOH in DCM) to afford <b>6</b> (257 mg, 93%) as a yellow solid. Mp 137–139 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.57–3.72 (m, 2H), 3.75 (s, 3H), 3.97–4.05 (m, 1H), 4.08–4.21 (m, 1H), 4.51–4.82 (m, 3H), 5.17 (d, <i>J</i> = 4.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.8 Hz, 1H), 5.87–6.03 (m, 2H), 6.53 (br s, 2H), 6.98–7.08 (m, 1H), 7.13–7.51 (m, 7H), 7.52–7.64 (m, 1H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.3, 55.5, 61.8, 71.0, 71.1, 85.9, 86.5, 110.7, 117.1, 119.5, 126.7, 128.0, 128.2, 129.2, 130.2, 138.1, 141.0, 148.6, 149.9, 151.3, 152.5, 156.0. HRMS calcd for C<sub>24</sub>H<sub>27</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 479.2037, found 479.2036.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 8-(2-Ethoxybiphenyl-4-ylmethylamino)adenosine (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>39</b> (350 mg, 0.419 mmol) in MeOH (8.38 mL) was added NH<sub>4</sub>F (931 mg, 25.1 mmol), and the resulting mixture was heated under reflux with stirring for 24 h. The reaction mixture was allowed to cool to room temperature, diluted with DCM (34.0 mL), stirred for 1 h, and then filtered through a pad of Hyflo Super-Cel. The filtrate was concentrated under reduced pressure and the residue was purified by flash column chromatography on silica gel (gradient; 10–17% MeOH in DCM) to give <b>7</b> (146 mg, 71%) as a pale yellow solid. Mp 128–130 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (t, <i>J</i> = 6.9 Hz, 3H), 3.56–3.73 (m, 2H), 3.94–4.21 (m, 4H), 4.61 (d, <i>J</i> = 6.0 Hz, 2H), 4.70–4.81 (m, 1H), 5.18 (d, <i>J</i> = 4.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.8 Hz, 1H), 5.90–6.04 (m, 2H), 6.54 (br s, 2H), 6.98–7.06 (m, 1H), 7.11–7.55 (m, 7H), 7.58 (t, <i>J</i> = 6.0 Hz, 1H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 14.6, 45.2, 61.8, 63.5, 71.0, 71.2, 85.9, 86.5, 111.8, 117.1, 119.5, 126.7, 128.0, 128.3, 129.2, 130.3, 138.2, 140.9, 148.6, 149.9, 151.3, 152.5, 155.3. HRMS calcd for C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 493.2194, found 493.2199.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 8-(2-Propoxybiphenyl-4-ylmethylamino)adenosine (<b>8</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>40</b> (414 mg, 0.487 mmol) following the procedure described for <b>7</b>. The crude product was purified by flash column chromatography on silica gel (gradient; 10–17% MeOH in DCM) to afford <b>8</b> (236 mg, 96%) as a pale yellow foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.89 (t, <i>J</i> = 7.4 Hz, 3H), 1.56–1.71 (m, 2H), 3.57–3.72 (m, 2H), 3.92 (t, <i>J</i> = 6.4 Hz, 2H), 3.97–4.05 (m, 1H), 4.10–4.18 (m, 1H), 4.61 (d, <i>J</i> = 6.0 Hz, 2H), 4.70–4.81 (m, 1H), 5.19 (d, <i>J</i> = 4.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.8 Hz, 1H), 5.89–6.01 (m, 2H), 6.54 (br s, 2H), 6.98–7.07 (m, 1H), 7.11–7.18 (m, 1H), 7.23 (d, <i>J</i> = 7.8 Hz, 1H), 7.25–7.33 (m, 1H), 7.33–7.64 (m, 5H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.6, 22.1, 45.2, 61.8, 69.3, 71.0, 71.1, 85.9, 86.5, 111.6, 117.1, 119.4, 126.7, 127.9, 128.3, 129.2, 130.2, 138.2, 140.9, 148.6, 149.9, 151.3, 152.5, 155.4. HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 507.2350, found 507.2350.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 8-(2-Isopropoxybiphenyl-4-ylmethylamino)adenosine (<b>9</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41</b> (310 mg, 0.365 mmol) following the procedure described for <b>7</b>. The crude product was purified by flash column chromatography on silica gel (gradient; 10–17% MeOH in DCM) to afford <b>9</b> (180 mg, 97%) as an ivory-colored foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.11–1.24 (m, 6H), 3.55–3.74 (m, 2H), 3.95–4.05 (m, 1H), 4.09–4.18 (m, 1H), 4.48–4.81 (m, 4H), 5.18 (d, <i>J</i> = 4.0 Hz, 1H), 5.29 (d, <i>J</i> = 6.8 Hz, 1H), 5.88–6.03 (m, 2H), 6.53 (br s, 2H), 6.96–7.05 (m, 1H), 7.10–7.18 (m, 1H), 7.19–7.52 (m, 6H), 7.59 (t, <i>J</i> = 6.0 Hz, 1H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 21.8 (2C), 45.2, 61.8, 69.8, 71.0, 71.1, 85.9, 86.5, 113.5, 117.1, 119.6, 126.6, 127.9, 129.1, 129.2, 130.5, 138.4, 140.8, 148.6, 149.9, 151.3, 152.5, 154.1. HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 507.2350, found 507.2345.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 8-(3-Hydroxybiphenyl-4-ylmethylamino)adenosine (<b>10</b>)</h3><div class="NLM_p last">To a solution of <b>56</b> (517 mg, 0.640 mmol) in MeOH (12.8 mL) was added NH<sub>4</sub>F (1.42 g, 38.4 mmol), and the resulting mixture was heated under reflux with stirring for 24 h. The reaction mixture was allowed to cool to room temperature, diluted with DCM (40.0 mL), stirred for 1 h, and then filtered through a pad of Hyflo Super-Cel. The filtrate was concentrated under reduced pressure and the residue was purified by flash column chromatography on silica gel (gradient; 10–20% MeOH in DCM) to give <b>10</b> (291 mg, 98%) as a yellow solid. Mp 161–163 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.53–3.74 (m, 2H), 3.96–4.05 (m, 1H), 4.09–4.19 (m, 1H), 4.46–4.64 (m, 2H), 4.68–4.84 (m, 1H), 5.18 (d, <i>J</i> = 4.0 Hz, 1H), 5.34 (d, <i>J</i> = 6.8 Hz, 1H), 5.86–6.04 (m, 2H), 6.55 (br s, 2H), 7.01–7.13 (m, 2H), 7.22–7.72 (m, 7H), 7.92 (s, 1H), 10.19 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 41.0, 61.8, 70.9, 71.2, 85.9, 86.6, 113.7, 116.6, 117.5, 125.3, 126.5, 127.3, 128.9 (2C), 140.2, 140.3, 148.8, 149.9, 151.7, 152.4, 155.4. HRMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 465.1881, found 465.1884.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 8-(3-Methoxybiphenyl-4-ylmethylamino)adenosine (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>57</b> (384 mg, 0.468 mmol) in MeOH (9.35 mL) was added NH<sub>4</sub>F (1.04 g, 28.1 mmol), and the resulting mixture was heated under reflux with stirring for 26 h. The reaction mixture was allowed to cool to room temperature, diluted with H<sub>2</sub>O (40.0 mL), and then stirred for 1 h. The precipitate was collected by filtration, washed with H<sub>2</sub>O, air-dried, and then recrystallized from EtOH to give <b>11</b> (167 mg, 75%) as a pale yellow solid. Mp 236–238 °C (dec). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.57–3.72 (m, 2H), 3.93 (s, 3H), 3.98–4.05 (m, 1H), 4.10–4.19 (m, 1H), 4.51–4.68 (m, 2H), 4.73–4.83 (m, 1H), 5.17 (d, <i>J</i> = 4.0 Hz, 1H), 5.33 (d, <i>J</i> = 6.8 Hz, 1H), 5.86 (dd, <i>J</i> = 4.0, 6.0 Hz, 1H), 5.99 (d, <i>J</i> = 7.3 Hz, 1H), 6.51 (br s, 2H), 7.14–7.26 (m, 2H), 7.28–7.52 (m, 5H), 7.63–7.73 (m, 2H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 40.6, 55.4, 61.8, 70.9, 71.2, 85.9, 86.5, 108.8, 117.1, 118.5, 126.6, 126.8, 127.3, 127.4, 128.9, 140.1, 140.4, 148.6, 149.9, 151.4, 152.5, 157.0. HRMS calcd for C<sub>24</sub>H<sub>27</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 479.2037, found 479.2046.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 8-(3-Ethoxybiphenyl-4-ylmethylamino)adenosine (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>58</b> (322 mg, 0.386 mmol) in MeOH (7.71 mL) was added NH<sub>4</sub>F (857 mg, 23.1 mmol), and the resulting mixture was heated under reflux with stirring for 24 h. The reaction mixture was allowed to cool to room temperature, diluted with DCM (24.0 mL), stirred for 1 h, and then filtered through a pad of Hyflo Super-Cel. The filtrate was concentrated under reduced pressure, and the residue was triturated in DCM. The precipitate was collected by filtration, washed with DCM, air-dried, and then recrystallized from EtOH to give <b>12</b> (120 mg, 63%) as a pale yellow solid. Mp 219–221 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.40 (t, <i>J</i> = 6.9 Hz, 3H), 3.56–3.71 (m, 2H), 3.97–4.06 (m, 1H), 4.10–4.27 (m, 3H), 4.52–4.69 (m, 2H), 4.73–4.84 (m, 1H), 5.17 (d, <i>J</i> = 4.0 Hz, 1H), 5.34 (d, <i>J</i> = 6.8 Hz, 1H), 5.85 (dd, <i>J</i> = 4.0, 6.0 Hz, 1H), 6.00 (d, <i>J</i> = 7.5 Hz, 1H), 6.50 (br s, 2H), 7.12–7.52 (m, 7H), 7.61–7.74 (m, 2H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 14.8, 40.6, 61.8, 63.3, 70.9, 71.2, 85.9, 86.5, 109.5, 117.1, 118.4, 126.7, 126.8, 127.2, 127.3, 128.9, 140.0, 140.4, 148.6, 149.9, 151.5, 152.5, 156.3. HRMS calcd for C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 493.2194, found 493.2191.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 8-(3-Propoxybiphenyl-4-ylmethylamino)adenosine (<b>13</b>)</h3><div class="NLM_p last">To a solution of <b>59</b> (378 mg, 0.445 mmol) in MeOH (8.90 mL) was added NH<sub>4</sub>F (989 mg, 26.7 mmol), and the resulting mixture was heated under reflux with stirring for 24 h. The reaction mixture was allowed to cool to room temperature, diluted with H<sub>2</sub>O (17.8 mL), and then stirred for 1.5 h. The precipitate was collected by filtration, washed with MeOH/H<sub>2</sub>O (1/2), air-dried, and then recrystallized from EtOH to give <b>13</b> (121 mg, 54%) as a pale yellow solid. Mp 211–213 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.05 (t, <i>J</i> = 7.4 Hz, 3H), 1.71–1.90 (m, 2H), 3.55–3.72 (m, 2H), 3.97–4.21 (m, 4H), 4.53–4.69 (m, 2H), 4.74–4.83 (m, 1H), 5.19 (d, <i>J</i> = 4.0 Hz, 1H), 5.35 (d, <i>J</i> = 6.8 Hz, 1H), 5.87 (dd, <i>J</i> = 4.1, 5.9 Hz, 1H), 6.00 (d, <i>J</i> = 7.5 Hz, 1H), 6.51 (br s, 2H), 7.11–7.23 (m, 2H), 7.28 (d, <i>J</i> = 7.8 Hz, 1H), 7.31–7.50 (m, 4H), 7.61–7.72 (m, 2H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.6, 22.2, 40.6, 61.8, 69.0, 71.0, 71.2, 85.9, 86.5, 109.5, 117.1, 118.4, 126.8 (2C), 127.0, 127.3, 128.9, 140.0, 140.4, 148.6, 149.9, 151.5, 152.5, 156.4. HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 507.2350, found 507.2344.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 8-(3-Isopropoxybiphenyl-4-ylmethylamino)adenosine (<b>14</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>60</b> (283 mg, 0.333 mmol) following the procedure described for <b>10</b>. The crude product was purified by flash column chromatography on silica gel (gradient; 10–17% MeOH in DCM) to afford <b>14</b> (159 mg, 94%) as a pale yellow solid. Mp 198–201 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.31–1.41 (m, 6H), 3.54–3.73 (m, 2H), 3.97–4.07 (m, 1H), 4.10–4.20 (m, 1H), 4.47–4.68 (m, 2H), 4.72–4.89 (m, 2H), 5.17 (d, <i>J</i> = 4.0 Hz, 1H), 5.33 (d, <i>J</i> = 6.8 Hz, 1H), 5.86 (dd, <i>J</i> = 4.0, 6.0 Hz, 1H), 5.99 (d, <i>J</i> = 7.3 Hz, 1H), 6.49 (br s, 2H), 7.13 (dd, <i>J</i> = 1.5, 7.8 Hz, 1H), 7.20 (d, <i>J</i> = 1.5 Hz, 1H), 7.27–7.50 (m, 5H), 7.61–7.71 (m, 2H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 22.1, 40.7, 61.8, 69.6, 71.0, 71.1, 85.9, 86.5, 111.0, 117.1, 118.4, 126.8, 127.3, 127.5, 127.6, 128.9, 140.0, 140.4, 148.6, 149.9, 151.5, 152.4, 155.3. HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> 507.2350, found 507.2349.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 8-[2-(2-Methoxy-2-oxoethoxy)biphenyl-4-ylmethylamino]adenosine (<b>15</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>42</b> (335 mg, 0.381 mmol) following the procedure described for <b>10</b>. The crude product was purified by flash column chromatography on silica gel (gradient; 9–16% MeOH in DCM) to afford <b>15</b> (184 mg, 90%) as a pale brown solid. Mp 121–123 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.56–3.79 (m, 5H), 3.96–4.07 (m, 1H), 4.10–4.23 (m, 1H), 4.59 (d, <i>J</i> = 6.0 Hz, 2H), 4.69–4.78 (m, 1H), 4.80 (s, 2H), 5.19 (d, <i>J</i> = 4.0 Hz, 1H), 5.29 (d, <i>J</i> = 7.0 Hz, 1H), 5.88–6.07 (m, 2H), 6.55 (br s, 2H), 7.00–7.16 (m, 2H), 7.22–7.71 (m, 7H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.1, 51.8, 61.8, 64.5, 71.0, 71.1, 85.8, 86.5, 111.2, 117.1, 120.1, 126.8, 128.0, 128.4, 129.3, 130.5, 137.9, 140.9, 148.6, 149.8, 151.3, 152.5, 154.3, 169.3. HRMS calcd for C<sub>26</sub>H<sub>29</sub>N<sub>6</sub>O<sub>7</sub> (M + H)<sup>+</sup> 537.2092, found 537.2092.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 8-[2-(2-Amino-2-oxoethoxy)biphenyl-4-ylmethylamino]adenosine (<b>16</b>)</h3><div class="NLM_p last">To <b>15</b> (195 mg, 0.363 mmol) was added a 2.0 M solution of NH<sub>3</sub> in MeOH (14.5 mL), and the resulting mixture was stirred at room temperature for 72 h. The reaction mixture was diluted with MeOH (15 mL) and CHCl<sub>3</sub> (20 mL). The resulting suspension was heated under reflux until a clear solution was formed. The solution was allowed to cool to room temperature while stirring. The precipitate was collected by filtration, washed with MeOH/CHCl<sub>3</sub> (6/4), air-dried, and dried at 60 °C under reduced pressure to give <b>16</b> (145 mg, 77%) as a white solid. Mp 166–169 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.56–3.72 (m, 2H), 3.97–4.03 (m, 1H), 4.10–4.18 (m, 1H), 4.43 (s, 2H), 4.52–4.64 (m, 2H), 4.70–4.80 (m, 1H), 5.16 (d, <i>J</i> = 4.0 Hz, 1H), 5.29 (d, <i>J</i> = 6.8 Hz, 1H), 5.91 (dd, <i>J</i> = 4.0, 6.0 Hz, 1H), 5.95 (d, <i>J</i> = 7.5 Hz, 1H), 6.53 (br s, 2H), 7.01–7.13 (m, 3H), 7.23–7.45 (m, 5H), 7.51–7.62 (m, 3H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.2, 61.8, 67.4, 71.0, 71.1, 85.9, 86.5, 112.2, 117.1, 120.3, 126.9, 128.1, 128.7, 129.3, 130.4, 138.0, 140.9, 148.6, 149.9, 151.3, 152.5, 154.6, 170.1. HRMS calcd for C<sub>25</sub>H<sub>28</sub>N<sub>7</sub>O<sub>6</sub> (M + H)<sup>+</sup> 522.2096, found 522.2092.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 8-[2-(2-Hydroxyethoxy)biphenyl-4-ylmethylamino]adenosine (<b>17</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>15</b> (194 mg, 0.362 mmol) in EtOH (3.62 mL) was added NaBH<sub>4</sub> (68.4 mg, 1.81 mmol) in small portions, and the resulting mixture was stirred at room temperature for 25 h. The reaction mixture was quenched by addition of AcOH (434 mg, 7.23 mmol) and then concentrated under reduced pressure. To the residue was added DCM/MeOH (6/1), and the insoluble material was filtered out. The filtrate was concentrated under reduced pressure and the residue was purified by flash column chromatography on NH silica gel (gradient; 7–15% MeOH in DCM) to give <b>17</b> (165 mg, 90%) as a pale yellow solid. Mp 143–146 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.52–3.79 (m, 4H), 3.92–4.22 (m, 4H), 4.61 (d, <i>J</i> = 6.3 Hz, 2H), 4.70–4.82 (m, 2H), 5.18 (d, <i>J</i> = 4.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.8 Hz, 1H), 5.90–6.04 (m, 2H), 6.54 (br s, 2H), 6.98–7.07 (m, 1H), 7.13–7.20 (m, 1H), 7.21–7.43 (m, 4H), 7.51–7.68 (m, 3H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 45.2, 59.5, 61.8, 69.9, 71.0, 71.1, 85.9, 86.5, 111.9, 117.1, 119.6, 126.6, 128.0, 128.3, 129.3, 130.3, 138.1, 140.9, 148.6, 149.9, 151.3, 152.5, 155.4. HRMS calcd for C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O<sub>6</sub> (M + H)<sup>+</sup> 509.2143, found 509.2142.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 8-[2-(3-Hydroxypropoxy)biphenyl-4-ylmethylamino]adenosine (<b>18</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>49</b> (278 mg, 0.454 mmol) following the procedure described for <b>19</b>. The crude product was purified by flash column chromatography on NH silica gel (isocratic; 15% MeOH in DCM) to afford <b>18</b> (214 mg, 90%) as an off-white foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.71–1.88 (m, 2H), 3.42–3.55 (m, 2H), 3.57–3.73 (m, 2H), 3.96–4.18 (m, 4H), 4.45–4.52 (m, 1H), 4.61 (d, <i>J</i> = 6.1 Hz, 2H), 4.70–4.81 (m, 1H), 5.17 (d, <i>J</i> = 4.0 Hz, 1H), 5.29 (d, <i>J</i> = 6.8 Hz, 1H), 5.88–6.01 (m, 2H), 6.52 (br s, 2H), 6.97–7.07 (m, 1H), 7.12–7.53 (m, 7H), 7.58 (t, <i>J</i> = 6.1 Hz, 1H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 32.1, 45.3, 57.4, 61.8, 64.8, 71.0, 71.1, 85.9, 86.5, 111.6, 117.1, 119.4, 126.7, 127.9, 128.2, 129.2, 130.2, 138.2, 140.9, 148.6, 149.8, 151.3, 152.5, 155.4. HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>6</sub>O<sub>6</sub> (M + H)<sup>+</sup> 523.2300, found 523.2292.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 8-[2-(4-Hydroxybutoxy)biphenyl-4-ylmethylamino]adenosine (<b>19</b>)</h3><div class="NLM_p last">A mixture of <b>50</b> (354 mg, 0.565 mmol) and 10% Pd–C (51.7 wt % H<sub>2</sub>O, 220 mg) in MeOH (11.3 mL) was heated at 50 °C with stirring for 50 h under H<sub>2</sub> atmosphere. The reaction mixture was allowed to cool to room temperature and then filtered through a pad of Hyflo Super-Cel. The filtrate was concentrated under reduced pressure and the residue was purified by flash column chromatography on NH silica gel (gradient; 3–15% MeOH in DCM) to give <b>19</b> (245 mg, 81%) as a pale yellow foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.42–1.55 (m, 2H), 1.59–1.75 (m, 2H), 3.29–3.44 (m, 2H), 3.56–3.74 (m, 2H), 3.90–4.08 (m, 3H), 4.08–4.20 (m, 1H), 4.42 (t, <i>J</i> = 5.1 Hz, 1H), 4.61 (d, <i>J</i> = 6.0 Hz, 2H), 4.70–4.82 (m, 1H), 5.19 (d, <i>J</i> = 4.0 Hz, 1H), 5.31 (d, <i>J</i> = 7.0 Hz, 1H), 5.90–6.03 (m, 2H), 6.55 (br s, 2H), 6.97–7.07 (m, 1H), 7.11–7.19 (m, 1H), 7.23 (d, <i>J</i> = 7.8 Hz, 1H), 7.25–7.33 (m, 1H), 7.34–7.43 (m, 2H), 7.43–7.53 (m, 2H), 7.58 (t, <i>J</i> = 6.0 Hz, 1H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 25.5, 29.0, 45.2, 60.4, 61.8, 67.8, 71.0, 71.2, 85.9, 86.5, 111.6, 117.1, 119.4, 126.7, 127.9, 128.3, 129.2, 130.3, 138.2, 140.9, 148.6, 149.9, 151.3, 152.5, 155.4. HRMS calcd for C<sub>27</sub>H<sub>33</sub>N<sub>6</sub>O<sub>6</sub> (M + H)<sup>+</sup> 537.2456, found 537.2458.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 8-[2-(5-Hydroxypentyloxy)biphenyl-4-ylmethylamino]adenosine (<b>20</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>51</b> (314 mg, 0.490 mmol) following the procedure described for <b>19</b>. The crude product was purified by flash column chromatography on NH silica gel (gradient; 3–10% MeOH in DCM) to afford <b>20</b> (204 mg, 76%) as an off-white foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.28–1.45 (m, 4H), 1.55–1.70 (m, 2H), 3.28–3.43 (m, 2H), 3.56–3.75 (m, 2H), 3.90–4.06 (m, 3H), 4.09–4.21 (m, 1H), 4.30–4.38 (m, 1H), 4.61 (d, <i>J</i> = 6.1 Hz, 2H), 4.71–4.81 (m, 1H), 5.17 (d, <i>J</i> = 4.0 Hz, 1H), 5.28 (d, <i>J</i> = 6.8 Hz, 1H), 5.89–6.03 (m, 2H), 6.52 (br s, 2H), 6.98–7.06 (m, 1H), 7.11–7.52 (m, 7H), 7.57 (t, <i>J</i> = 6.1 Hz, 1H), 7.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 22.0, 28.4, 32.0, 45.2, 60.6, 61.8, 67.7, 70.9, 71.1, 85.8, 86.5, 111.6, 117.0, 119.3, 126.6, 127.8, 128.2, 129.2, 130.2, 138.1, 140.8, 148.6, 149.8, 151.2, 152.4, 155.4. HRMS calcd for C<sub>28</sub>H<sub>35</sub>N<sub>6</sub>O<sub>6</sub> (M + H)<sup>+</sup> 551.2613, found 551.2607.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 8-[2-(4-Hydroxybutoxy)biphenyl-4-ylmethylamino]inosine (<b>21</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>61</b> (111 mg, 0.177 mmol) following the procedure described for <b>19</b>. The crude product was purified by flash column chromatography on silica gel (gradient; 13–20% MeOH in DCM) to afford <b>21</b> (75.2 mg, 79%) as a pale yellow amorphous solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.41–1.57 (m, 2H), 1.60–1.79 (m, 2H), 3.29–3.47 (m, 2H), 3.60–3.76 (m, 2H), 3.91–4.08 (m, 3H), 4.09–4.21 (m, 1H), 4.41 (t, <i>J</i> = 5.3 Hz, 1H), 4.54 (d, <i>J</i> = 6.0 Hz, 2H), 4.61–4.74 (m, 1H), 5.20 (d, <i>J</i> = 4.3 Hz, 1H), 5.38 (d, <i>J</i> = 6.8 Hz, 1H), 5.77 (t, <i>J</i> = 4.5 Hz, 1H), 5.94 (d, <i>J</i> = 7.5 Hz, 1H), 6.94–7.03 (m, 1H), 7.06–7.14 (m, 1H), 7.22 (d, <i>J</i> = 7.8 Hz, 1H), 7.24–7.63 (m, 6H), 7.83 (s, 1H), 12.11 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 25.5, 29.0, 45.1, 60.4, 61.5, 67.7, 70.7, 71.0, 85.8, 86.6, 111.4, 119.2, 121.7, 126.6, 127.9, 128.2, 129.2, 130.2, 138.2, 141.1, 142.4, 147.7, 150.5, 155.4 (2C). HRMS calcd for C<sub>27</sub>H<sub>32</sub>N<sub>5</sub>O<sub>7</sub> (M + H)<sup>+</sup> 538.2296, found 538.2287.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-[2-(4-Hydroxybutoxy)biphenyl-4-ylmethylamino]-1-(β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl)-1<i>H</i>-benzimidazole (<b>22</b>)</h3><div class="NLM_p last">A mixture of <b>65</b> (192 mg, 0.315 mmol) and 10% Pd–C (56.5 wt % H<sub>2</sub>O, 133 mg) in MeOH (6.30 mL) was heated at 50 °C with stirring for 24 h under H<sub>2</sub> atmosphere. The reaction mixture was allowed to cool to room temperature and then filtered through a pad of Hyflo Super-Cel. The filtrate was concentrated under reduced pressure and the residue was purified by flash column chromatography on silica gel (gradient; 8–15% MeOH in DCM) to give <b>22</b> (144 mg, 88%) as an off-white amorphous solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.42–1.54 (m, 2H), 1.61–1.73 (m, 2H), 3.28–3.43 (m, 2H), 3.64–3.78 (m, 2H), 3.90–4.05 (m, 3H), 4.08–4.16 (m, 1H), 4.37–4.50 (m, 2H), 4.59 (d, <i>J</i> = 6.0 Hz, 2H), 5.23 (d, <i>J</i> = 4.5 Hz, 1H), 5.31 (d, <i>J</i> = 7.3 Hz, 1H), 5.62–5.70 (m, 1H), 5.83 (d, <i>J</i> = 7.5 Hz, 1H), 6.84–7.06 (m, 3H), 7.10–7.60 (m, 10H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 25.5, 29.0, 45.5, 60.3, 61.2, 67.7, 70.4, 71.3, 85.4, 87.6, 108.7, 111.4, 115.2, 118.6, 119.3, 120.7, 126.6, 127.9, 128.1, 129.2, 130.2, 134.1, 138.2, 141.3, 142.5, 154.0, 155.4. HRMS calcd for C<sub>29</sub>H<sub>34</sub>O<sub>3</sub>N<sub>6</sub> (M + H)<sup>+</sup> 520.2442, found 520.2441.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Inosine Uptake Inhibition Assay</h3><div class="NLM_p">The cDNA encoding hCNT2 or rCNT2 was subcloned into the pCI-neo mammalian expression vector (Promega, Madison, WI). COS-7 cells (RIKEN, Japan) were then transfected with a given expression vector by using Lipofectamine 2000 (Thermo Fischer Scientific, MA, USA). Briefly, COS-7 cells were seeded at 5 × 10<sup>4</sup> cells into each well of collagen type I coated 96-well plates containing DMEM (Thermo Fischer Scientific, MA, USA) with 10% fetal calf serum and cultured for 2 h. Then, for use in each well, 0.3 μg of plasmid DNA was diluted in 25 μL of OPTI-MEM (Thermo Fischer Scientific, MA, USA). 0.5 μL of Lipofectamine 2000 was also diluted in 25 μL of OPTI-MEM and incubated at room temperature for 5 min. After the incubation, the diluted plasmid DNA was mixed with the diluted Lipofectamine 2000, and the mixture was incubated at room temperature for 25 min. Finally, the incubated mixture was added to each well, and the cells were cultured for 2 days, after which the inhibition assay was performed.</div><div class="NLM_p last">Transport assays were performed with a modification of the method described by Schaner et al.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(69)</a> Transport activities in COS-7 cells transiently expressing hCNT2 or rCNT2 were examined with [<sup>14</sup>C]-inosine. The transfected cells were incubated with pretreatment buffer (2 mM KCl, 1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 10 mM HEPES, 5 mM Tris, and 140 mM choline chloride; pH 7.4) at 37 °C twice for 10 min each time. Following aspiration of the pretreatment buffer, uptake buffer containing 10 μM inosine prepared with <sup>14</sup>C-labeled and unlabeled inosine was added to the cells, which were then incubated at 37 °C for 30 min. All uptake studies were carried out in the presence of 10 μM nitrobenzylthioinosine (NBMPR), which is an ENT inhibitor but not effective against CNTs. Uptake was measured in the presence of Na<sup>+</sup> (140 mM NaCl, 2 mM KCl, 1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 10 mM HEPES, 5 mM Tris, 5 mM glucose; pH 7.4) or absence of Na<sup>+</sup>, in which case the Na<sup>+</sup> was replaced by choline chloride (140 mM). The transport was stopped by aspiration of the reaction mixture, and the cells were washed twice with ice-cold Na<sup>+</sup>-free buffer including 10 μM unlabeled inosine. Then, they were solubilized with 0.2 M sodium hydroxide. Radioactivity of the cell lysates was measured by means of a liquid scintillation counter. 100% transport was set as the difference between the uptake in the presence and the absence of Na<sup>+</sup>, and the percentage of inosine uptake at each compound concentration was calculated. The half maximal inhibitory concentration (IC<sub>50</sub> value) was calculated by nonlinear regression analysis of inosine uptake assays (at least three independent experiments) using GraphPad Prism (GraphPad Software, CA, USA).</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Animals</h3><div class="NLM_p last">Male Sprague–Dawley (SD) rats were purchased from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). Throughout the study, the rodents were housed in a constant-temperature room with a 12-h/12-h lighting cycle (lights on 8:00 a.m. to 8:00 p.m.) and allowed access to laboratory chow diet (CE-2 pellets; CLEA Japan, Inc.) and water ad libitum. All studies using rats were performed in accordance with guidelines approved by the laboratory animal committee of Kissei Pharmaceutical Co., Ltd.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Purine Load Test in Rats</h3><div class="NLM_p">Male SD rats (5 weeks old) were fasted overnight and subcutaneously treated with potassium oxonate (Sigma-Aldrich, MO, USA; 100 mg/kg), and after 1 h, purine mixture (adenosine/inosine/guanosine = 1:1:1, 50 mg/kg) and compound <b>19</b> (50 mg/kg) or <b>22</b> (0.1, 1.0, or 10 mg/kg) were orally administered simultaneously. A control group was treated with potassium oxonate and purine mixture, and a group treated with only potassium oxonate represented endogenous plasma uric acid level. After 1 h, blood was collected from the abdominal aorta under anesthesia, and uric acid levels in plasma were measured by phosphotungstic acid method.</div><div class="NLM_p last">Data were presented as mean values ± SEM for each group. Statistical analysis was performed by using SAS System, version 9.3 (SAS Institute Inc., NC, USA). The statistical significance of the results was analyzed by the Student’s <i>t</i> test or the Dunnett’s test.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Pharmacokinetic Study of Compound <b>22</b> in Rats</h3><div class="NLM_p last">Pharmacokinetics was investigated in male SD rats (6 weeks old, fasted for 16 h) after intravenous and oral administration. Compound <b>22</b> was dissolved in a mixture of dimethylacetamide and 5% glucose solution (1:1 v/v) for intravenous bolus injections at a dose of 1.0 mg mL<sup>–1</sup> kg<sup>–1</sup>. The intravenous dose was administered via tail vein. Compound <b>22</b> was suspended in 0.5% sodium carboxymethylcellulose solution for oral administration at a dose of [10 mg/(5 mL)]/kg. Blood samples (about 200 μL) were collected from the jugular vein by use of heparinized syringe at 2 min, 0.25, 1, 2, 4, 6, 8, and 24 h after intravenous administration and at 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h after oral administration. Plasma was prepared by centrifugation at 2280<i>g</i> for 10 min at 4 °C. The collected plasma samples were stored at −20 °C until analysis. Aliquots of the plasma (50 μL) were deproteined with 150 μL of acetonitrile, and 50 μL of internal standard (100 nmol/L warfarin) was added. The samples were then centrifuged at 2280<i>g</i> for 20 min at 4 °C. The supernatant (5 μL) was injected into LC/MS. Samples were analyzed using a LC system coupled to a Q Exactive orbitrap mass spectrometer (Thermo Fisher scientific, MA, USA). For MS detection, the heated ESI source was operated in positive ion mode. Ions monitored in the SIM mode were <i>m</i>/<i>z</i> 520.2442 for compound <b>22</b>. LC separation was performed using an Ultimate 3000 system (Thermo Fisher scientific, MA, USA) with a gradient elution from a Cadenza CD-C18 HT column (3 μm, 50 mm × 2.0 mm i.d.; Imtakt, Kyoto, Japan). The flow rate and column temperature were set at 0.4 mL/min and 50 °C, respectively. The mobile phase consisted of solvent A, 10 mM ammonium acetate aqueous solution, and solvent B, acetonitrile containing 0.1% formic acid and 20% 2-propanol. The gradient program is shown as follows: 10% B at 0–0.1 min; 90% at 0.1–0.5 min; 90% at 0.5–1.7 min; 10% at 1.7–1.8 min. The flow rate at 1.7–1.8 min was set at 1.4 mL/min for reequilibration. The standard curve was prepared in a concentration range from 1 to 5000 ng/mL for compound <b>22</b>. Pharmacokinetic calculation was performed by noncompartmental analysis using WinNonlin, version 6 (Pharsight Corporation, CA, USA) to obtain the maximal plasma concentration (<i>C</i><sub>max</sub>) and the area under the curve (AUC). Bioavailability (<i>F</i>) was calculated as <i>F</i> = (AUC (po)/AUC (iv)) × (dose (iv)/dose (po)) × 100. The plasma total clearance (CL<sub>tot</sub>), the volume of distribution (<i>V</i><sub>dss</sub>), and the elimination half-life (<i>t</i><sub>1/2</sub>) were calculated after intravenous administration.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01884">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01884" class="ext-link">10.1021/acs.jmedchem.5b01884</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_003.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Synthetic procedures and characterization data for all intermediates, HPLC analysis data for all tested compounds, experimental procedures for conformational analysis, and determination of solubility in JP2 (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_002.pdf">jm5b01884_si_002.pdf (200.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_003.xlsx">jm5b01884_si_003.xlsx (10.17 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01884" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuya Tatani</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#600b011a1519013f140114010e0920100801120d4e0b09131305094e030f4e0a10"><span class="__cf_email__" data-cfemail="f2999388878b93ad869386939c9bb2829a93809fdc999b8181979bdc919ddc9882">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masahiro Hiratochi</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norihiko Kikuchi</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Kuramochi</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinjiro Watanabe</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuji Yamauchi</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fumiaki Itoh</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masayuki Isaji</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoshi Shuto</span> - <span class="hlFld-Affiliation affiliation">Central
Research Laboratories, Kissei Pharmaceutical
Co., Ltd., 4365-1, Hotakakashiwabara, Azumino, Nagano 399-8304, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">‡Faculty
of Pharmaceutical Sciences, and §Center for Research and Education
on Drug Discovery, Hokkaido University, Kita-12, Nishi-6, Kita-Ku, Sapporo 060-0812, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d198e4239-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank all of our colleagues at Kissei Pharmaceutical Co., Ltd. who were involved in the work reported in this article.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i53" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i53"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> Abbreviations Used</h2><tr><td class="NLM_term">CNT</td><td class="NLM_def"><p class="first last">concentrative nucleoside transporter</p></td></tr><tr><td class="NLM_term">ENT</td><td class="NLM_def"><p class="first last">equilibrative nucleoside transporter</p></td></tr><tr><td class="NLM_term">JP2</td><td class="NLM_def"><p class="first last">Japanese Pharmacopoeia second fluid</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 69 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span> </span><span class="NLM_article-title">Urate oxidase: Primary structure and evolutionary implications</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9412</span><span class="NLM_x">–</span> <span class="NLM_lpage">9416</span><span class="refDoi"> DOI: 10.1073/pnas.86.23.9412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1073%2Fpnas.86.23.9412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9412-9416&author=X.+Wuauthor=C.+C.+Leeauthor=D.+M.+Muznyauthor=C.+T.+Caskey&title=Urate+oxidase%3A+Primary+structure+and+evolutionary+implications&doi=10.1073%2Fpnas.86.23.9412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.86.23.9412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.86.23.9412%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26atitle%3DUrate%2520oxidase%253A%2520Primary%2520structure%2520and%2520evolutionary%2520implications%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1989%26volume%3D86%26spage%3D9412%26epage%3D9416%26doi%3D10.1073%2Fpnas.86.23.9412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span> </span><span class="NLM_article-title">Two independent mutational events in the loss of urate oxidase during hominoid evolution</span> <span class="citation_source-journal">J. Mol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1007/BF00163854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2FBF00163854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1992&pages=78-84&author=X.+Wuauthor=D.+M.+Muznyauthor=C.+C.+Leeauthor=C.+T.+Caskey&title=Two+independent+mutational+events+in+the+loss+of+urate+oxidase+during+hominoid+evolution&doi=10.1007%2FBF00163854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF00163854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00163854%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26atitle%3DTwo%2520independent%2520mutational%2520events%2520in%2520the%2520loss%2520of%2520urate%2520oxidase%2520during%2520hominoid%2520evolution%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D1992%26volume%3D34%26spage%3D78%26epage%3D84%26doi%3D10.1007%2FBF00163854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Richette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardin, T.</span><span> </span><span class="NLM_article-title">Gout</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/S0140-6736(09)60883-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2FS0140-6736%2809%2960883-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=19692116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=318-328&author=P.+Richetteauthor=T.+Bardin&title=Gout&doi=10.1016%2FS0140-6736%2809%2960883-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Gout</span></div><div class="casAuthors">Richette, Pascal; Bardin, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">9711</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Gout is a common arthritis caused by deposition of monosodium urate crystals within joints after chronic hyperuricemia.  It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men.  Epidemiol. data are consistent with a rise in prevalence of gout.  Diet and genetic polymorphisms of renal transporters of urate seem to be the main causal factors of primary gout.  Gout and hyperuricemia are assocd. with hypertension, diabetes mellitus, metabolic syndrome, and renal and cardiovascular diseases.  Non-steroidal anti-inflammatory drugs and colchicine remain the most widely recommended drugs to treat acute attacks.  Oral corticosteroids could be an alternative to these drugs.  Interleukin 1β is a pivotal mediator of acute gout and could become a therapeutic target.  When serum uric acid concns. are lowered below monosodium urate satn. point, the crystals dissolve and gout can be cured.  Patient education, appropriate lifestyle advice, and treatment of comorbidities are an important part of management of patients with gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoauG4iOInjKLVg90H21EOLACvtfcHk0ljVuWFGeadXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSktg%253D%253D&md5=61694a6c4492214f16781a881c2a67bc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2960883-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252960883-7%26sid%3Dliteratum%253Aachs%26aulast%3DRichette%26aufirst%3DP.%26aulast%3DBardin%26aufirst%3DT.%26atitle%3DGout%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D318%26epage%3D328%26doi%3D10.1016%2FS0140-6736%2809%2960883-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lehejčková, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demnerová, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Králová, B.</span><span> </span><span class="NLM_article-title">Screening of microorganisms with uricase activity</span> <span class="citation_source-journal">Biotechnol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1007/BF01040862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2FBF01040862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1986&pages=341-342&author=R.+Lehej%C4%8Dkov%C3%A1author=K.+Demnerov%C3%A1author=B.+Kr%C3%A1lov%C3%A1&title=Screening+of+microorganisms+with+uricase+activity&doi=10.1007%2FBF01040862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF01040862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01040862%26sid%3Dliteratum%253Aachs%26aulast%3DLehej%25C4%258Dkov%25C3%25A1%26aufirst%3DR.%26aulast%3DDemnerov%25C3%25A1%26aufirst%3DK.%26aulast%3DKr%25C3%25A1lov%25C3%25A1%26aufirst%3DB.%26atitle%3DScreening%2520of%2520microorganisms%2520with%2520uricase%2520activity%26jtitle%3DBiotechnol.%2520Lett.%26date%3D1986%26volume%3D8%26spage%3D341%26epage%3D342%26doi%3D10.1007%2FBF01040862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Shaaban, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelmegeed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, Y. M.</span><span> </span><span class="NLM_article-title">Cloning, expression, and purification of recombinant uricase enzyme from <i>Pseudomonas aeruginosa</i> Ps43 using <i>Escherichia coli</i></span> <span class="citation_source-journal">J. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span><span class="refDoi"> DOI: 10.4014/jmb.1410.10041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.4014%2Fjmb.1410.10041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=25588559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CmtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=887-892&author=M.+I.+Shaabanauthor=E.+Abdelmegeedauthor=Y.+M.+Ali&title=Cloning%2C+expression%2C+and+purification+of+recombinant+uricase+enzyme+from+Pseudomonas+aeruginosa+Ps43+using+Escherichia+coli&doi=10.4014%2Fjmb.1410.10041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression, and purification of recombinant uricase enzyme from Pseudomonas aeruginosa Ps43 using Escherichia coli</span></div><div class="casAuthors">Shaaban, Mona I.; Abdelmegeed, Eman; Ali, Youssif M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-892</span>CODEN:
                <span class="NLM_cas:coden">JOMBES</span>;
        ISSN:<span class="NLM_cas:issn">1017-7825</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Microbiology and Biotechnology</span>)
        </div><div class="casAbstract">Uricase is an important microbial enzyme that can be used in the clin. treatment of gout, hyperuricemia, and tumor lysis syndrome.  A total of 127 clin. isolates of Pseudomonas aeruginosa were tested for uricase prodn.  A Pseudomonas strain named Ps43 showed the highest level of native uricase enzyme expression.  The open reading frame of the uricase enzyme was amplified from Ps43 and cloned into the expression vector pRSET-B.  Uricase was expressed using E. coli BL21 (DE3).  The ORF was sequenced and assigned GenBank Accession No. KJ718888.  The nucleotide sequence anal. was identical to the coding sequence of uricase gene puuD of P. aeruginosa PAO1.  The authors report the successful expression of P. aeruginosa uricase in Escherichia coli.  E. coli showed an induced protein with a mol. mass of ∼58 kDa that was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting.  The authors also established efficient protein purifn. using the Ni-Sepharose column with activity of the purified enzyme of 2.16 1U and a 2-fold increase in the specific activity of the pure enzyme compared with the crude enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPnOQJuE-AC7Vg90H21EOLACvtfcHk0ljVuWFGeadXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CmtLjP&md5=6e5bb815c5fc93caa7432452cab7bf89</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4014%2Fjmb.1410.10041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4014%252Fjmb.1410.10041%26sid%3Dliteratum%253Aachs%26aulast%3DShaaban%26aufirst%3DM.%2BI.%26aulast%3DAbdelmegeed%26aufirst%3DE.%26aulast%3DAli%26aufirst%3DY.%2BM.%26atitle%3DCloning%252C%2520expression%252C%2520and%2520purification%2520of%2520recombinant%2520uricase%2520enzyme%2520from%2520Pseudomonas%2520aeruginosa%2520Ps43%2520using%2520Escherichia%2520coli%26jtitle%3DJ.%2520Microbiol.%2520Biotechnol.%26date%3D2015%26volume%3D25%26spage%3D887%26epage%3D892%26doi%3D10.4014%2Fjmb.1410.10041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nanda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeesh Babu, P. E.</span><span> </span><span class="NLM_article-title">Isolation, screening and production studies of uricase producing bacteria from poultry sources</span> <span class="citation_source-journal">Prep. Biochem. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1080/10826068.2013.867875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1080%2F10826068.2013.867875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24279683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=811-821&author=P.+Nandaauthor=P.+E.+Jagadeesh+Babu&title=Isolation%2C+screening+and+production+studies+of+uricase+producing+bacteria+from+poultry+sources&doi=10.1080%2F10826068.2013.867875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">ISOLATION, SCREENING AND PRODUCTION STUDIES OF URICASE PRODUCING BACTERIA FROM POULTRY SOURCES</span></div><div class="casAuthors">Nanda, Pooja; Jagadeesh Babu, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Preparative Biochemistry & Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">811-821</span>CODEN:
                <span class="NLM_cas:coden">PBBIF4</span>;
        ISSN:<span class="NLM_cas:issn">1082-6068</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Uricase (urate oxidase EC 1.7.3.3) is a therapeutic enzyme that is widely used to catalyze the enzymic oxidn. of uric acid in the treatment of hyperuricemia and gout diseases.  In this study, three bacterial species capable of producing extracellular uricase were isolated from a poultry source and screened based on the size of the clear zone using a uric acid agar plate.  The bacterial species capable of producing uricase with the highest uricolytic activity was identified as Bacillus cereus strain DL3 using a 16SrRNA gene sequencing approach.  The time-course study of uricase prodn. was performed and the medium was optimized.  CM-cellulose and asparagine were the best carbon and nitrogen sources.  Maximum uricolytic activity was obsd. at pH 7.0 with an inducer concn. of 2.0 g/L.  Inoculum size of 5% gave max. uricolytic activity.  The max. uricolytic activity of 15.43 U/mL was achieved at optimized conditions, which is 1.61 times more than the initial activity.  Further, enzymic stability was detd. at different pH and temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFU-9UlEvlfLVg90H21EOLACvtfcHk0lhsIvSiesuAhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgsbrM&md5=1b00e42726be4b5f887b2de6e6fb5b2c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F10826068.2013.867875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10826068.2013.867875%26sid%3Dliteratum%253Aachs%26aulast%3DNanda%26aufirst%3DP.%26aulast%3DJagadeesh%2BBabu%26aufirst%3DP.%2BE.%26atitle%3DIsolation%252C%2520screening%2520and%2520production%2520studies%2520of%2520uricase%2520producing%2520bacteria%2520from%2520poultry%2520sources%26jtitle%3DPrep.%2520Biochem.%2520Biotechnol.%26date%3D2014%26volume%3D44%26spage%3D811%26epage%3D821%26doi%3D10.1080%2F10826068.2013.867875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chang, B. S. W.</span><span> </span><span class="NLM_article-title">Ancient insights into uric acid metabolism in primates</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">3657</span><span class="NLM_x">–</span> <span class="NLM_lpage">3658</span><span class="refDoi"> DOI: 10.1073/pnas.1401037111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1073%2Fpnas.1401037111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=3657-3658&author=B.+S.+W.+Chang&title=Ancient+insights+into+uric+acid+metabolism+in+primates&doi=10.1073%2Fpnas.1401037111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1401037111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1401037111%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DB.%2BS.%2BW.%26atitle%3DAncient%2520insights%2520into%2520uric%2520acid%2520metabolism%2520in%2520primates%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D3657%26epage%3D3658%26doi%3D10.1073%2Fpnas.1401037111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Álvarez-Lario, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macarrón-Vicente, J.</span><span> </span><span class="NLM_article-title">Uric acid and evolution</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2010</span><span class="NLM_x">–</span> <span class="NLM_lpage">2015</span><span class="refDoi"> DOI: 10.1093/rheumatology/keq204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1093%2Frheumatology%2Fkeq204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=2010-2015&author=B.+%C3%81lvarez-Larioauthor=J.+Macarr%C3%B3n-Vicente&title=Uric+acid+and+evolution&doi=10.1093%2Frheumatology%2Fkeq204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeq204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeq204%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2581lvarez-Lario%26aufirst%3DB.%26aulast%3DMacarr%25C3%25B3n-Vicente%26aufirst%3DJ.%26atitle%3DUric%2520acid%2520and%2520evolution%26jtitle%3DRheumatology%26date%3D2010%26volume%3D49%26spage%3D2010%26epage%3D2015%26doi%3D10.1093%2Frheumatology%2Fkeq204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mount, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reginato, A. M.</span><span> </span><span class="NLM_article-title">Pathogenesis of gout</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.7326/0003-4819-143-7-200510040-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.7326%2F0003-4819-143-7-200510040-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16204163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2005&pages=499-516&author=H.+K.+Choiauthor=D.+B.+Mountauthor=A.+M.+Reginato&title=Pathogenesis+of+gout&doi=10.7326%2F0003-4819-143-7-200510040-00009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of gout</span></div><div class="casAuthors">Choi, Hyon K.; Mount, David B.; Reginato, Anthony M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-516</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians</span>)
        </div><div class="casAbstract">A review.  Gout is a type of inflammatory arthritis that is triggered by the crystn. of uric acid within the joints and is often assocd. with hyperuricemia.  Researchers have recently made great advances in defining the pathogenesis of gout, including elucidating its risk factors and tracing the mol. mechanisms of renal urate transport and crystal-induced inflammation.  Key aspects of the pathogenesis of gout are reviewed with a focus on the recent advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKRcGVzwvIjrVg90H21EOLACvtfcHk0lhsIvSiesuAhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrrN&md5=fe9ddad02c650ee8ebd76029c56bc793</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-143-7-200510040-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-143-7-200510040-00009%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DMount%26aufirst%3DD.%2BB.%26aulast%3DReginato%26aufirst%3DA.%2BM.%26atitle%3DPathogenesis%2520of%2520gout%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2005%26volume%3D143%26spage%3D499%26epage%3D516%26doi%3D10.7326%2F0003-4819-143-7-200510040-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Liebman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushinsky, D. A.</span><span> </span><span class="NLM_article-title">Uric acid nephrolithiasis</span> <span class="citation_source-journal">Curr. Rheumatol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1007/s11926-007-0040-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11926-007-0040-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17531180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVentbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=251-257&author=S.+E.+Liebmanauthor=J.+G.+Taylorauthor=D.+A.+Bushinsky&title=Uric+acid+nephrolithiasis&doi=10.1007%2Fs11926-007-0040-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Uric acid nephrolithiasis</span></div><div class="casAuthors">Liebman, Scott E.; Taylor, Jeremy G.; Bushinsky, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Rheumatology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-257</span>CODEN:
                <span class="NLM_cas:coden">CRRUCI</span>;
        ISSN:<span class="NLM_cas:issn">1523-3774</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Uric acid nephrolithiasis is typically found in individuals with a low urine pH and a normal concn. of urinary uric acid.  Patients with a history of gout are at greater risk of forming uric acid stones, as are patients with obesity, diabetes, or the complete metabolic syndrome.  The unifying renal tubular abnormality of these disorders appears to be the excretion of abnormally acidic urine.  This article focuses on the relationship of these disorders to the development of uric acid stones.  The diagnosis of uric acid stones can be elusive, because pure uric acid stones are radiolucent on plain radiographs.  Ultrasound, or preferably noncontrast helical CT scanning, is required for their detection.  The treatment of uric acid stones should focus on alkalinization of the urine with citrate or bicarbonate salts.  Addnl. interventions such as increase in fluid intake and decrease in animal protein ingestion are often beneficial.  Patients with documented hyperuricemia often require specific therapy to lower serum uric acid concn. and subsequent excretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk4IAECj4IV7Vg90H21EOLACvtfcHk0lhTk_ibd4o-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVentbnK&md5=f00bc0f4e3bffd0e92a1d2f8dac23c4a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs11926-007-0040-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-007-0040-z%26sid%3Dliteratum%253Aachs%26aulast%3DLiebman%26aufirst%3DS.%2BE.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DBushinsky%26aufirst%3DD.%2BA.%26atitle%3DUric%2520acid%2520nephrolithiasis%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D251%26epage%3D257%26doi%3D10.1007%2Fs11926-007-0040-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Jalal, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chonchol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targher, G.</span><span> </span><span class="NLM_article-title">Uric acid as a target of therapy in CKD</span> <span class="citation_source-journal">Am. J. Kidney Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1053/j.ajkd.2012.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1053%2Fj.ajkd.2012.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=23058478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2jsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=134-146&author=D.+I.+Jalalauthor=M.+Choncholauthor=W.+Chenauthor=G.+Targher&title=Uric+acid+as+a+target+of+therapy+in+CKD&doi=10.1053%2Fj.ajkd.2012.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Uric Acid as a Target of Therapy in CKD</span></div><div class="casAuthors">Jalal, Diana I.; Chonchol, Michel; Chen, Wei; Targher, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The prevalence of chronic kidney disease (CKD) has increased and will continue to increase in the United States and worldwide.  This is alarming considering that CKD is an irreversible condition and patients who progress to chronic kidney failure have reduced quality of life and high mortality rates.  As such, it is imperative to identify modifiable risk factors to develop strategies to slow CKD progression.  One such factor is hyperuricemia.  Recent observational studies have assocd. hyperuricemia with kidney disease.  In addn., hyperuricemia is largely prevalent in patients with CKD.  Data from exptl. studies have shown several potential mechanisms by which hyperuricemia may contribute to the development and progression of CKD.  In this article, we offer a crit. review of the exptl. evidence linking hyperuricemia to CKD, highlight gaps in our knowledge on the topic as it stands today, and review the observational and interventional studies that have examd. the potential nephroprotective effect of decreasing uric acid levels in patients with CKD.  Although uric acid also may be linked to cardiovascular disease and mortality in patients with CKD, this review focuses only on uric acid as a potential therapeutic target to prevent kidney disease onset and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9kaNI0pfO97Vg90H21EOLACvtfcHk0lhTk_ibd4o-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2jsrrO&md5=f7317150c29fef9df0463df30b42afd0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2012.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2012.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DJalal%26aufirst%3DD.%2BI.%26aulast%3DChonchol%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DTargher%26aufirst%3DG.%26atitle%3DUric%2520acid%2520as%2520a%2520target%2520of%2520therapy%2520in%2520CKD%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2013%26volume%3D61%26spage%3D134%26epage%3D146%26doi%3D10.1053%2Fj.ajkd.2012.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">De Angelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Renzo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianci, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naticchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giarrizzo, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splendiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lorenzo, A.</span><span> </span><span class="NLM_article-title">Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study</span> <span class="citation_source-journal">Eur. Rev. Med. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=179-184&author=S.+De+Angelisauthor=A.+Noceauthor=L.+Di+Renzoauthor=R.+Cianciauthor=A.+Naticchiaauthor=G.+F.+Giarrizzoauthor=F.+Giordanoauthor=C.+Tozzoauthor=G.+Splendianiauthor=A.+De+Lorenzo&title=Is+rasburicase+an+effective+alternative+to+allopurinol+for+management+of+hyperuricemia+in+renal+failure+patients%3F+A+double+blind-randomized+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BAngelis%26aufirst%3DS.%26aulast%3DNoce%26aufirst%3DA.%26aulast%3DDi%2BRenzo%26aufirst%3DL.%26aulast%3DCianci%26aufirst%3DR.%26aulast%3DNaticchia%26aufirst%3DA.%26aulast%3DGiarrizzo%26aufirst%3DG.%2BF.%26aulast%3DGiordano%26aufirst%3DF.%26aulast%3DTozzo%26aufirst%3DC.%26aulast%3DSplendiani%26aufirst%3DG.%26aulast%3DDe%2BLorenzo%26aufirst%3DA.%26atitle%3DIs%2520rasburicase%2520an%2520effective%2520alternative%2520to%2520allopurinol%2520for%2520management%2520of%2520hyperuricemia%2520in%2520renal%2520failure%2520patients%253F%2520A%2520double%2520blind-randomized%2520study%26jtitle%3DEur.%2520Rev.%2520Med.%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D11%26spage%3D179%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Schlesinger, N.</span><span> </span><span class="NLM_article-title">Dietary factors and hyperuricaemia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4133</span><span class="NLM_x">–</span> <span class="NLM_lpage">4138</span><span class="refDoi"> DOI: 10.2174/138161205774913273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F138161205774913273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16375734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KgtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=4133-4138&author=N.+Schlesinger&title=Dietary+factors+and+hyperuricaemia&doi=10.2174%2F138161205774913273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary factors and hyperuricaemia</span></div><div class="casAuthors">Schlesinger, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4133-4138</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The connection of gout and hyperuricemia with gluttony, overindulgence in food and alc. and obesity dates from ancient times.  Studies from different parts of the world suggest that the incidence and severity of hyperuricemia and gout may be increasing.  Uric acid (urate) is the end product of purine degrdn.  Although most uric acid is derived from the metab. of endogenous purine, eating foods rich in purines contributes to the total pool of uric acid.  Sustained hyperuricemia is a risk factor for acute gouty arthritis, chronic tophaceous gout, renal stones and possibly cardiovascular events and mortality.  Before starting lifelong urate-lowering drug therapy, it is important to identify and treat underlying disorders that may be contributing to hyperuricemia.  It is relevant to recognize the strong assocn. of the insulin resistance syndrome (IRS) (abdominal obesity, dyslipidemia, hypertension, raised serum insulin levels and glucose intolerance) with hyperuricemia.  Consumption of meat, seafood and alc. beverages in moderation and attention to food portion size is important.  Moderation in the consumption of not only beer but also other forms of alc. is essential.  In the obese, controlled wt. management has the potential to lower serum urate in a quant. similar way to relatively unpalatable "low purine" diets.  Non-fat milk and low-fat yogurt have a variety of health benefits and dairy products may have clin. meaningful antihyperuricemic effects.  In addn., fruits, such as cherries and high intakes of vegetable protein diet may reduce serum urate levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKyaMRIGepm7Vg90H21EOLACvtfcHk0lg9xT5vxLCZJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KgtrnL&md5=af6032e1228fd26d6e3bb06ec0af53ef</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138161205774913273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161205774913273%26sid%3Dliteratum%253Aachs%26aulast%3DSchlesinger%26aufirst%3DN.%26atitle%3DDietary%2520factors%2520and%2520hyperuricaemia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D4133%26epage%3D4138%26doi%3D10.2174%2F138161205774913273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Riegersperger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, D.</span><span> </span><span class="NLM_article-title">Allopurinol, uric acid, and oxidative stress in cardiorenal disease</span> <span class="citation_source-journal">Int. Urol. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1007/s11255-011-9929-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11255-011-9929-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=21547469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=441-449&author=M.+Riegerspergerauthor=A.+Covicauthor=D.+Goldsmith&title=Allopurinol%2C+uric+acid%2C+and+oxidative+stress+in+cardiorenal+disease&doi=10.1007%2Fs11255-011-9929-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Allopurinol, uric acid, and oxidative stress in cardiorenal disease</span></div><div class="casAuthors">Riegersperger, Markus; Covic, Adrian; Goldsmith, David</div><div class="citationInfo"><span class="NLM_cas:title">International Urology and Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">IURNAE</span>;
        ISSN:<span class="NLM_cas:issn">0301-1623</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In humans, the hepatic end product of purine metab. is uric acid.  Serum uric acid levels physiol. and gradually rise during human lifetime.  Hyperuricemia also arises from excess dietary purine or ethanol intake, decreased renal excretion of uric acid, tumor lysis in lymphoma, leukemia or solid tumors, and sometimes pharmacotherapy.  The definition of hyperuricemia is currently arbitrary.  Hyperuricemia is assocd. with chronic kidney disease, arterial hypertension, coronary artery and heart disease, cerebrovascular disease and diabetes mellitus.  Xanthine oxidase, a hepatic enzyme, catalyzes the prodn. of uric acid, nitric oxide, and reactive oxygen species, which potentially damage DNA, RNA and proteins, inactivate enzymes, oxidize amino acids and convert poly-unsatd. fatty acids to lipids.  This is believed to contribute to atherosclerosis, endothelial dysfunction, renovascular hypertension, and cardiovascular disease.  Xanthine oxidase inhibition efficiently blocks uric acid generation, and this improves glomerular filtration rates, systemic blood pressure, and cerebro-cardiovascular outcomes.  Here, data from animal, in vivo, retro- and prospective, and interventional studies are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp72ZpwULCfvbVg90H21EOLACvtfcHk0lg9xT5vxLCZJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVylsL8%253D&md5=528a2cb6911886687cb92135061a2da8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs11255-011-9929-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11255-011-9929-6%26sid%3Dliteratum%253Aachs%26aulast%3DRiegersperger%26aufirst%3DM.%26aulast%3DCovic%26aufirst%3DA.%26aulast%3DGoldsmith%26aufirst%3DD.%26atitle%3DAllopurinol%252C%2520uric%2520acid%252C%2520and%2520oxidative%2520stress%2520in%2520cardiorenal%2520disease%26jtitle%3DInt.%2520Urol.%2520Nephrol.%26date%3D2011%26volume%3D43%26spage%3D441%26epage%3D449%26doi%3D10.1007%2Fs11255-011-9929-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yamanaka, H.</span><span> </span><span class="NLM_article-title">Japanese guideline for the management of hyperuricemia and gout: Second edition</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.1080/15257770.2011.596496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1080%2F15257770.2011.596496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=22132951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKjurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=1018-1029&author=H.+Yamanaka&title=Japanese+guideline+for+the+management+of+hyperuricemia+and+gout%3A+Second+edition&doi=10.1080%2F15257770.2011.596496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition</span></div><div class="casAuthors">Yamanaka, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1018-1029</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Gout is a urate deposition disease caused by persistent hyperuricemia.  Because gout patients present with a variety of clin. symptoms, it is necessary to have a guideline for the std. management and care of gout and hyperuricemia.  The Japanese Society of Gout and Nucleic Acid Metab., a scientific society committed to study nucleic acid metab. and related diseases, established the 1st edition of the "Guideline for the Management of Hyperuricemia and Gout" in 2002, and published the revised version in Jan. 2010.  This second edition is not only evidence based on a search of systemic literature, but also includes consensus levels by a Delphi exercise to det. the strength of the recommendations.  A draft version of this guideline was reviewed by internal and external reviewers as well as a patient.  In this guideline, key messages from each chapter are listed as statements together with the evidence level, consensus level, and strength of the recommendation.  In this proceeding, several selected chapters on the clin. management of gout and hyperuricemia are described.  We hope this guideline is appropriately used for the std. management and care of patients with hyperuricemia and gout in daily practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Vj8Yy2vAwLVg90H21EOLACvtfcHk0lic_J4_fXs89g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKjurbI&md5=fa13d1fbafbc6745eb6a4e8e61bea031</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F15257770.2011.596496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770.2011.596496%26sid%3Dliteratum%253Aachs%26aulast%3DYamanaka%26aufirst%3DH.%26atitle%3DJapanese%2520guideline%2520for%2520the%2520management%2520of%2520hyperuricemia%2520and%2520gout%253A%2520Second%2520edition%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2011%26volume%3D30%26spage%3D1018%26epage%3D1029%26doi%3D10.1080%2F15257770.2011.596496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Edwards, N. L.</span><span> </span><span class="NLM_article-title">The role of hyperuricemia and gout in kidney and cardiovascular disease</span> <span class="citation_source-journal">Cleveland Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">S13</span><span class="NLM_x">–</span> <span class="NLM_lpage">S16</span><span class="refDoi"> DOI: 10.3949/ccjm.75.Suppl_5.S13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.3949%2Fccjm.75.Suppl_5.S13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=S13-S16&issue=Suppl.+5&author=N.+L.+Edwards&title=The+role+of+hyperuricemia+and+gout+in+kidney+and+cardiovascular+disease&doi=10.3949%2Fccjm.75.Suppl_5.S13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3949%2Fccjm.75.Suppl_5.S13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.75.Suppl_5.S13%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DN.%2BL.%26atitle%3DThe%2520role%2520of%2520hyperuricemia%2520and%2520gout%2520in%2520kidney%2520and%2520cardiovascular%2520disease%26jtitle%3DCleveland%2520Clin.%2520J.%2520Med.%26date%3D2008%26volume%3D75%26issue%3DSuppl.%25205%26spage%3DS13%26epage%3DS16%26doi%3D10.3949%2Fccjm.75.Suppl_5.S13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zoccali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamaci, F.</span><span> </span><span class="NLM_article-title">Uric acid, hypertension, and cardiovascular and renal complications</span> <span class="citation_source-journal">Curr. Hypertens. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1007/s11906-013-0391-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11906-013-0391-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24072559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGmsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=531-537&author=C.+Zoccaliauthor=F.+Mallamaci&title=Uric+acid%2C+hypertension%2C+and+cardiovascular+and+renal+complications&doi=10.1007%2Fs11906-013-0391-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Uric Acid, Hypertension, and Cardiovascular and Renal Complications</span></div><div class="casAuthors">Zoccali, Carmine; Mallamaci, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Current Hypertension Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-537</span>CODEN:
                <span class="NLM_cas:coden">CHRUCG</span>;
        ISSN:<span class="NLM_cas:issn">1522-6417</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Over the last decade, the biol. interference of uric acid with the cardiovascular (CV) system and the kidney has been intensively investigated, and several exptl. studies in animal models and in vitro documented that hyperuricemia may trigger hypertension and incite endothelial dysfunction, vascular damage and renal disease.  A substantial proportion of epidemiol. studies are compatible with the hypothesis that hyperuricemia may be noxious to the CV system and the kidney as well.  However, there are still no well-powered trials testing whether uric acid-lowering interventions may reduce BP or attenuate the risk for adverse CV and renal outcomes.  Evidence still remains largely insufficient to recommend changes in the current policy of not prescribing uric acid-lowering drugs to individuals with asymptomatic hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTNZy1lobiWbVg90H21EOLACvtfcHk0lic_J4_fXs89g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGmsLvF&md5=4683311b4d2ddd3ce020b0378a772c2f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs11906-013-0391-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-013-0391-y%26sid%3Dliteratum%253Aachs%26aulast%3DZoccali%26aufirst%3DC.%26aulast%3DMallamaci%26aufirst%3DF.%26atitle%3DUric%2520acid%252C%2520hypertension%252C%2520and%2520cardiovascular%2520and%2520renal%2520complications%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2013%26volume%3D15%26spage%3D531%26epage%3D537%26doi%3D10.1007%2Fs11906-013-0391-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fenech, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajzbaum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazighi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacher, J.</span><span> </span><span class="NLM_article-title">Serum uric acid and cardiovascular risk: State of the art and perspectives</span> <span class="citation_source-journal">Jt., Bone, Spine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/j.jbspin.2014.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.jbspin.2014.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24565888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivF2ms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=392-397&author=G.+Fenechauthor=G.+Rajzbaumauthor=M.+Mazighiauthor=J.+Blacher&title=Serum+uric+acid+and+cardiovascular+risk%3A+State+of+the+art+and+perspectives&doi=10.1016%2Fj.jbspin.2014.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid and cardiovascular risk: State of the art and perspectives</span></div><div class="casAuthors">Fenech, Goel; Rajzbaum, Gerald; Mazighi, Mikael; Blacher, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Joint, Bone, Spine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-397</span>CODEN:
                <span class="NLM_cas:coden">JBSPFA</span>;
        ISSN:<span class="NLM_cas:issn">1297-319X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Hyperuricemia is commonly found in subjects with cardiovascular disease, but its role as risk factor is very controversial.  Although several studies reported serum uric acid as a marker of an underlying pathophysiol. process, other studies hypothesis a potential causal link between serum uric acid and cardiovascular diseases.  Some studies suggest that uric acid is biol. active and may have an atherogenesis role in development of cardiovascular diseases, although the mechanisms are not fully understood.  Other studies have shown that uric acid can independently predict the development of some cardiovascular risk factors such as hypertension and metabolic syndrome, as well as myocardial infarction and stroke.  The relations between serum uric acid and established cardiovascular risk factors are complex, and these latter could be considered as confounding factors.  In this report, we review the inextricably link of serum uric acid to known cardiovascular risk factors, and we describe the possible mechanisms and potential causative role between serum uric acid and cardiovascular events in the general population, in subjects with cardiovascular risk factors and in those with pre-existing cardiovascular diseases.  Limited information however is available concerning the impact of urate-lowering treatments on cardiovascular events, whereas only a pos. therapeutic trial could give definite answers to the difficult problem of causality of uric acid in relation to cardiovascular risk.  Thus, it is time to propose the design of a therapeutic trial, integrating cardiologists and rheumatologists, in order to further decrease cardiovascular risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kXyDRE7fPrVg90H21EOLACvtfcHk0lilyKaBvgbpew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivF2ms7Y%253D&md5=b011f05697bec01b2bb670e7bee161a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jbspin.2014.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbspin.2014.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DFenech%26aufirst%3DG.%26aulast%3DRajzbaum%26aufirst%3DG.%26aulast%3DMazighi%26aufirst%3DM.%26aulast%3DBlacher%26aufirst%3DJ.%26atitle%3DSerum%2520uric%2520acid%2520and%2520cardiovascular%2520risk%253A%2520State%2520of%2520the%2520art%2520and%2520perspectives%26jtitle%3DJt.%252C%2520Bone%252C%2520Spine%26date%3D2014%26volume%3D81%26spage%3D392%26epage%3D397%26doi%3D10.1016%2Fj.jbspin.2014.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Gosling, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matisoo-Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merriman, T. R.</span><span> </span><span class="NLM_article-title">Hyperuricaemia in the Pacific: why the elevated serum urate levels?</span> <span class="citation_source-journal">Rheumatol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.1007/s00296-013-2922-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs00296-013-2922-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24378761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVaitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=743-757&author=A.+L.+Goslingauthor=E.+Matisoo-Smithauthor=T.+R.+Merriman&title=Hyperuricaemia+in+the+Pacific%3A+why+the+elevated+serum+urate+levels%3F&doi=10.1007%2Fs00296-013-2922-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperuricaemia in the Pacific: why the elevated serum urate levels?</span></div><div class="casAuthors">Gosling, Anna L.; Matisoo-Smith, Elizabeth; Merriman, Tony R.</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Pacific Island populations, particularly those of Polynesian descent, have a high prevalence of hyperuricemia and gout.  This is due to an inherently higher urate level among these populations with a demonstrated genetic predisposition.  While an excess of urate can cause pathol., urate is also important for human health.  It has been implicated as an antioxidant, has a neuroprotective role and is involved in innate immune responses.  This paper provides a brief review of urate levels worldwide, with a particular focus on island Southeast Asia and the Pacific.  We then present possible evolutionary explanations for the elevated serum urate levels among Pacific populations in the context of the physiol. importance of urate and of the settlement history of the region.  Finally, we propose that ancestry may play a significant role in hyperuricemia in these populations and that exposure to malaria prior to population expansion into the wider Pacific may have driven genetic selection for variants contributing to high serum urate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowXhePv-Men7Vg90H21EOLACvtfcHk0lilyKaBvgbpew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVaitA%253D%253D&md5=b0b6800f9efeca2ec92bfe04e352f045</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00296-013-2922-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-013-2922-x%26sid%3Dliteratum%253Aachs%26aulast%3DGosling%26aufirst%3DA.%2BL.%26aulast%3DMatisoo-Smith%26aufirst%3DE.%26aulast%3DMerriman%26aufirst%3DT.%2BR.%26atitle%3DHyperuricaemia%2520in%2520the%2520Pacific%253A%2520why%2520the%2520elevated%2520serum%2520urate%2520levels%253F%26jtitle%3DRheumatol.%2520Int.%26date%3D2014%26volume%3D34%26spage%3D743%26epage%3D757%26doi%3D10.1007%2Fs00296-013-2922-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Blond, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudable, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laville, M.</span><span> </span><span class="NLM_article-title">Nonalcoholic fatty liver disease and hyperuricemia: A close relation with hepatic insulin resistance after nicotinic acid treatment?</span> <span class="citation_source-journal">Horm. Metab. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1055/s-0034-1390463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1055%2Fs-0034-1390463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=25350520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVersrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=546-547&author=E.+Blondauthor=J.+Goudableauthor=M.+Laville&title=Nonalcoholic+fatty+liver+disease+and+hyperuricemia%3A+A+close+relation+with+hepatic+insulin+resistance+after+nicotinic+acid+treatment%3F&doi=10.1055%2Fs-0034-1390463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nonalcoholic Fatty Liver Disease and Hyperuricemia: A Close Relation with Hepatic Insulin Resistance after Nicotinic Acid Treatment?</span></div><div class="casAuthors">Blond, E.; Goudable, J.; Laville, M.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">546-547</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">This review highlights on nonalcoholic fatty liver disease and hyperuricemia and its close relation with hepatic insulin resistance after nicotinic acid (NA) treatment.  NA is known to generate insulin resistance state and get an improvement of lipid profile, but mol. mechanisms explaining discrepancy between its beneficial effects on lipids metab. and deleterious effects on glucose metab. remain to be defined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn7A17DyQYLLVg90H21EOLACvtfcHk0lilyKaBvgbpew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVersrrJ&md5=f7dac4793885ef1a3e4d882d375328c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1055%2Fs-0034-1390463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0034-1390463%26sid%3Dliteratum%253Aachs%26aulast%3DBlond%26aufirst%3DE.%26aulast%3DGoudable%26aufirst%3DJ.%26aulast%3DLaville%26aufirst%3DM.%26atitle%3DNonalcoholic%2520fatty%2520liver%2520disease%2520and%2520hyperuricemia%253A%2520A%2520close%2520relation%2520with%2520hepatic%2520insulin%2520resistance%2520after%2520nicotinic%2520acid%2520treatment%253F%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2015%26volume%3D47%26spage%3D546%26epage%3D547%26doi%3D10.1055%2Fs-0034-1390463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Abeles, A. M.</span><span> </span><span class="NLM_article-title">Hyperuricemia, gout, and cardiovascular disease: An update</span> <span class="citation_source-journal">Curr. Rheumatol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="refDoi"> DOI: 10.1007/s11926-015-0495-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11926-015-0495-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=25740704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhsVelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=13&author=A.+M.+Abeles&title=Hyperuricemia%2C+gout%2C+and+cardiovascular+disease%3A+An+update&doi=10.1007%2Fs11926-015-0495-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperuricemia, gout, and cardiovascular disease: an update</span></div><div class="casAuthors">Abeles Aryeh M</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Across the globe, both gout and hyperuricemia have become increasingly common over the last few decades.  The burden of gouty disease is made heavier by its association with several comorbid conditions, including hypertension, cardiovascular disease, and chronic kidney disease.  Accruing evidence from prospective studies suggests that gout is an independent risk factor for developing cardiovascular disease and for higher cardiovascular mortality.  While asymptomatic hyperuricemia does not seem to be an independent risk factor for cardiovascular disease, increasing data implicates hyperuricemia as a risk factor for developing incidental hypertension.  Important questions that remain unanswered include whether addressing asymptomatic hyperuricemia forestalls the onset of hypertension, and whether treating gout with urate-lowering agents improves cardiovascular outcomes.  This article reviews the most recent data regarding the relationship between hyperuricemia, gout, hypertension, and cardiovascular disease, as well as emerging evidence as to whether treatment of hyperuricemia and gout improves cardiovascular outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_Ry_IfB6dF4NpW7w2tapOfW6udTcc2ebI-Zino3yRqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhsVelug%253D%253D&md5=66bb36218795936c207a9bfed5265f11</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs11926-015-0495-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-015-0495-2%26sid%3Dliteratum%253Aachs%26aulast%3DAbeles%26aufirst%3DA.%2BM.%26atitle%3DHyperuricemia%252C%2520gout%252C%2520and%2520cardiovascular%2520disease%253A%2520An%2520update%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2015%26volume%3D17%26spage%3D13%26doi%3D10.1007%2Fs11926-015-0495-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lima, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins-Santos, M. E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, V. E.</span><span> </span><span class="NLM_article-title">Uric acid as a modulator of glucose and lipid metabolism</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1016/j.biochi.2015.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.biochi.2015.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=17-23&author=W.+G.+Limaauthor=M.+E.+S.+Martins-Santosauthor=V.+E.+Chaves&title=Uric+acid+as+a+modulator+of+glucose+and+lipid+metabolism&doi=10.1016%2Fj.biochi.2015.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2015.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2015.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DW.%2BG.%26aulast%3DMartins-Santos%26aufirst%3DM.%2BE.%2BS.%26aulast%3DChaves%26aufirst%3DV.%2BE.%26atitle%3DUric%2520acid%2520as%2520a%2520modulator%2520of%2520glucose%2520and%2520lipid%2520metabolism%26jtitle%3DBiochimie%26date%3D2015%26volume%3D116%26spage%3D17%26epage%3D23%26doi%3D10.1016%2Fj.biochi.2015.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ishizaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakado, M.</span><span> </span><span class="NLM_article-title">Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1161/01.ATV.0000161274.87407.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.ATV.0000161274.87407.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15746438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1038-1044&author=N.+Ishizakaauthor=Y.+Ishizakaauthor=E.+Todaauthor=R.+Nagaiauthor=M.+Yamakado&title=Association+between+serum+uric+acid%2C+metabolic+syndrome%2C+and+carotid+atherosclerosis+in+Japanese+individuals&doi=10.1161%2F01.ATV.0000161274.87407.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals</span></div><div class="casAuthors">Ishizaka, Nobukazu; Ishizaka, Yuko; Toda, Ei-Ichi; Nagai, Ryozo; Yamakado, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1038-1044</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">There are few data available on possible independent assocn. between uric acid and carotid atherosclerosis.  Here the authors first sought to investigate assocn. between uric acid levels and metabolic syndrome in Japanese; second, the authors assessed whether there is an independent assocn. of uric acid with prevalence of carotid atherosclerosis in individuals subdivided according to gender and metabolic syndrome status.  Cross-sectional data from 8144 individuals who underwent general health screening were analyzed.  After adjusting for age, total cholesterol, and smoking status, the odds ratios (95% CI) of sex-specific quartiles of serum uric acid for metabolic syndrome were 1.0, 1.06 (0.60 to 1.87), 2.18 (1.30 to 3.64), and 4.17 (2.56 to 6.79) in women, and 1.0, 0.92 (0.74 to 1.14), 1.52 (1.25 to 1.65), and 1.97 (1.61 to 2.40) in men.  After adjusting for age, serum levels, total cholesterol, and smoking status, prevalence of carotid plaque was higher in subjects in the second, third, and fourth quartiles of uric acid level with odds ratios (95% CI) of 1.24 (1.01 to 1.52), 1.37 (1.11 to 1.68), and 1.31 (1.05 to 1.63), resp., in men without metabolic syndrome but not in men with metabolic syndrome or in women with or without metabolic syndrome.  The prevalence of metabolic syndrome showed a graded increase according to serum uric acid values in both genders.  In men who did not have metabolic syndrome, uric acid was found to be an independent risk factor for incidence of carotid plaque.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzv9qnjWbkLVg90H21EOLACvtfcHk0lgyPoACui3tSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVCjtLo%253D&md5=052f038b22573d54f1ee252ae90a7299</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000161274.87407.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000161274.87407.26%26sid%3Dliteratum%253Aachs%26aulast%3DIshizaka%26aufirst%3DN.%26aulast%3DIshizaka%26aufirst%3DY.%26aulast%3DToda%26aufirst%3DE.%26aulast%3DNagai%26aufirst%3DR.%26aulast%3DYamakado%26aufirst%3DM.%26atitle%3DAssociation%2520between%2520serum%2520uric%2520acid%252C%2520metabolic%2520syndrome%252C%2520and%2520carotid%2520atherosclerosis%2520in%2520Japanese%2520individuals%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D1038%26epage%3D1044%26doi%3D10.1161%2F01.ATV.0000161274.87407.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lohsoonthorn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanamun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. A.</span><span> </span><span class="NLM_article-title">Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span><span class="refDoi"> DOI: 10.1016/j.arcmed.2006.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.arcmed.2006.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16971230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=883-889&author=V.+Lohsoonthornauthor=B.+Dhanamunauthor=M.+A.+Williams&title=Prevalence+of+hyperuricemia+and+its+relationship+with+metabolic+syndrome+in+Thai+adults+receiving+annual+health+exams&doi=10.1016%2Fj.arcmed.2006.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams</span></div><div class="casAuthors">Lohsoonthorn, Vitool; Dhanamun, Bodi; Williams, Michelle A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-889</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Assocns. between hyperuricemia, metabolic syndrome, cardiovascular disease and diabetes have been reported.  Limited information, however, is available concerning the prevalence and correlates of hyperuricemia among Thai men and women.  We sought to est. the prevalence of hyperuricemia among a population of patients receiving annual health exams and to evaluate its relationship with metabolic syndrome (MetS).  We conducted a cross-sectional study of 1381 patients (376 men and 1005 women) who first participated in annual health examns. at the Preventive Medicine Clinic of the King Chulalongkorn Memorial Hospital in Bangkok, Thailand during the period July 1999 through Feb. 2000.  Hyperuricemia was defined as >7.0 mg/dL in men and >6.0 mg/dL in women.  MetS was defined using the modified ATP III criteria.  Results: The overall prevalence of the hyperuricemia was 10.6%.  The condition was more common in men than in women (18.4 vs. 7.8%).  Among women, serum uric acid was statistically significantly correlated with body mass index (BMI), systolic and diastolic blood pressure, high-d. lipoprotein-cholesterol, triglyceride and fasting plasma glucose (all p < 0.05).  Men with serum uric acid concns. >6.7 mg/dL (upper quartile) had a 3.91-fold increased in risk of MetS (95% CI:1.36-11.23), as compared with those who had concns. <5.1 mg/dL (lowest quartile).  Among women, the risk of MetS increased at least 2-fold for concn. of serum uric acid concns. >4.0 mg/dL (p for trend <0.001).  Hyperuricemia is prevalent among Thai men and women receiving routine health exams.  Addnl., serum uric acid is pos. assocd. with MetS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJXY4GU-YcrVg90H21EOLACvtfcHk0lgyPoACui3tSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWmu7o%253D&md5=3a539bf2ec33a7ab5231239a70df525e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2006.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2006.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DLohsoonthorn%26aufirst%3DV.%26aulast%3DDhanamun%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DM.%2BA.%26atitle%3DPrevalence%2520of%2520hyperuricemia%2520and%2520its%2520relationship%2520with%2520metabolic%2520syndrome%2520in%2520Thai%2520adults%2520receiving%2520annual%2520health%2520exams%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2006%26volume%3D37%26spage%3D883%26epage%3D889%26doi%3D10.1016%2Fj.arcmed.2006.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Onat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyarel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenç, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karabulut, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albayrak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sari, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keleş, I.</span><span> </span><span class="NLM_article-title">Serum uric acid is a determinant of metabolic syndrome in a population-based study</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1016/j.amjhyper.2006.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.amjhyper.2006.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17027827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=1055-1062&author=A.+Onatauthor=H.+Uyarelauthor=G.+Hergen%C3%A7author=A.+Karabulutauthor=S.+Albayrakauthor=I.+Sariauthor=M.+Yaziciauthor=I.+Kele%C5%9F&title=Serum+uric+acid+is+a+determinant+of+metabolic+syndrome+in+a+population-based+study&doi=10.1016%2Fj.amjhyper.2006.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid is a determinant of metabolic syndrome in a population-based study</span></div><div class="casAuthors">Onat, Altan; Uyarel, Hueseyin; Hergenc, Guelay; Karabulut, Ahmet; Albayrak, Sinan; Sari, Ibrahim; Yazici, Mehmet; Keles, Ibrahim</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1055-1062</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Detn. of serum uric acid concns. and role in risk of metabolic syndrome (MS) were investigated in 1877 participants in a cross-sectional population-based study including a brief follow-up.  The MS was identified by modified criteria of the Adult Treatment Panel III, and coronary heart disease (CHD) by clin. findings and Minnesota coding of resting electrocardiograms.  Uric acid concns. were measured by the uricase method.  Metabolic syndrome was present in 39.1% of the cohort.  Linear regression anal. of uric acid levels in a model comprising 13 variables identified gender, waist girth, total cholesterol (TC), alc. usage, triglycerides, log C-reactive protein (CRP), and log γ-glutamyl transferase (GGT), and in women diuretic use and elevated blood pressure (BP), as significant independent covariates whereby the largest contribution (1.6 mg/dL) was generated by waist girth.  Logistic regression anal. of serum uric acid for MS disclosed for the top vs. the bottom tertile an odds ratio (OR) of 1.89 (95% confidence interval [CI]: 1.45-2.46) in men and women combined, after adjustment for sex, age, TC, log CRP, log GGT, alc., and diuretic drug use, presence of diabetes/impaired fasting glucose, elevated BP, and smoking status.  This corresponded to an increase by 35% in MS likelihood for each 1 SD uric acid increment.  This rate declined to a significant 15% by inclusion of waist girth into the model.  The OR of uric acid concns. for prevalent and incident CHD, adjusted for age, MS, smoking, and diuretic use, was not significant among women and only tended toward significance in men.  Abdominal obesity is the main determinant of uric acid variance.  An increment of 1 SD in serum uric acid levels are assocd. in both sexes with a 35% higher MS likelihood, independent of 10 risk factors related to MS.  After adjustment for waist girth, a more modest but significant likelihood persists, which suggests that serum uric acid is a determinant of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfdxVd9I0zobVg90H21EOLACvtfcHk0lic6KeInUgAhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrtb7M&md5=f2a7f963738efe3196717219c42a75dc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2006.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2006.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DOnat%26aufirst%3DA.%26aulast%3DUyarel%26aufirst%3DH.%26aulast%3DHergen%25C3%25A7%26aufirst%3DG.%26aulast%3DKarabulut%26aufirst%3DA.%26aulast%3DAlbayrak%26aufirst%3DS.%26aulast%3DSari%26aufirst%3DI.%26aulast%3DYazici%26aufirst%3DM.%26aulast%3DKele%25C5%259F%26aufirst%3DI.%26atitle%3DSerum%2520uric%2520acid%2520is%2520a%2520determinant%2520of%2520metabolic%2520syndrome%2520in%2520a%2520population-based%2520study%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2006%26volume%3D19%26spage%3D1055%26epage%3D1062%26doi%3D10.1016%2Fj.amjhyper.2006.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, E. S.</span><span> </span><span class="NLM_article-title">Prevalence of the metabolic syndrome in individuals with hyperuricemia</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1016/j.amjmed.2006.06.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.amjmed.2006.06.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17466656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A280%3ADC%252BD2s3lvVCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=442-447&author=H.+K.+Choiauthor=E.+S.+Ford&title=Prevalence+of+the+metabolic+syndrome+in+individuals+with+hyperuricemia&doi=10.1016%2Fj.amjmed.2006.06.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of the metabolic syndrome in individuals with hyperuricemia</span></div><div class="casAuthors">Choi Hyon K; Ford Earl S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">442-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The link between hyperuricemia and insulin resistance has been noted, but the prevalence of the metabolic syndrome by recent definitions among individuals with hyperuricemia remains unclear.  Our objective was to determine the prevalence of the metabolic syndrome according to serum uric acid levels in a nationally representative sample of US adults.  METHODS:  By using data from 8669 participants aged 20 years and more in The Third National Health and Nutrition Examination Survey (1988-1994), we determined the prevalence of the metabolic syndrome at different serum uric acid levels.  We used both the revised and original National Cholesterol Education Program Adult Treatment Panel (NCEP/ATP) III criteria to define the metabolic syndrome.  RESULTS:  The prevalences of the metabolic syndrome according to the revised NCEP/ATP III criteria were 18.9% (95% confidence interval [CI], 16.8-21.0) for uric acid levels less than 6 mg/dL, 36.0% (95% CI, 32.5-39.6) for uric acid levels from 6 to 6.9 mg/dL, 40.8% (95% CI, 35.3-46.4) for uric acid levels from 7 to 7.9 mg/dL, 59.7% (95% CI, 53.0-66.4) for uric acid levels from 8 to 8.9 mg/dL, 62.0% (95% CI, 53.0-66.4) for uric acid levels from 9 to 9.9 mg/dL, and 70.7% for uric acid levels of 10 mg/dL or greater.  The increasing trends persisted in subgroups stratified by sex, age group, alcohol intake, body mass index, hypertension, and diabetes.  For example, among individuals with normal body mass index (<25 kg/m2), the prevalence increased from 5.9% (95% CI, 4.8-7.0), for a uric acid level of less than 6 mg/dL, to 59.0%, (95% CI, 20.1-97.9) for a uric acid level of 10 mg/dL or greater.  With the original NCEP/ATP criteria, the corresponding prevalences were slightly lower.  CONCLUSIONS:  These findings from a nationally representative sample of US adults indicate that the prevalence of the metabolic syndrome increases substantially with increasing levels of serum uric acid.  Physicians should recognize the metabolic syndrome as a frequent comorbidity of hyperuricemia and treat it to prevent serious complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdLt9pbzpipdFxYDaSSP8XfW6udTcc2ebIho5EoFW5Y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3lvVCntg%253D%253D&md5=81c7df9a5fc05a91dd16ca4e23283d25</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2006.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2006.06.040%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DFord%26aufirst%3DE.%2BS.%26atitle%3DPrevalence%2520of%2520the%2520metabolic%2520syndrome%2520in%2520individuals%2520with%2520hyperuricemia%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2007%26volume%3D120%26spage%3D442%26epage%3D447%26doi%3D10.1016%2Fj.amjmed.2006.06.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Numata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyatake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, H.</span><span> </span><span class="NLM_article-title">Comparison of serum uric acid levels between Japanese with and without metabolic syndrome</span> <span class="citation_source-journal">Diabetes Res. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e5</span><span class="refDoi"> DOI: 10.1016/j.diabres.2007.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.diabres.2007.10.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=e1-e5&author=T.+Numataauthor=N.+Miyatakeauthor=J.+Wadaauthor=H.+Makino&title=Comparison+of+serum+uric+acid+levels+between+Japanese+with+and+without+metabolic+syndrome&doi=10.1016%2Fj.diabres.2007.10.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.diabres.2007.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabres.2007.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DNumata%26aufirst%3DT.%26aulast%3DMiyatake%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DJ.%26aulast%3DMakino%26aufirst%3DH.%26atitle%3DComparison%2520of%2520serum%2520uric%2520acid%2520levels%2520between%2520Japanese%2520with%2520and%2520without%2520metabolic%2520syndrome%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2008%26volume%3D80%26spage%3De1%26epage%3De5%26doi%3D10.1016%2Fj.diabres.2007.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meriwether, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, S. N.</span><span> </span><span class="NLM_article-title">Uric acid and the development of metabolic syndrome in women and men</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1016/j.metabol.2008.01.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.metabol.2008.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=18502269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVaqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=845-852&author=X.+Suiauthor=T.+S.+Churchauthor=R.+A.+Meriwetherauthor=F.+Lobeloauthor=S.+N.+Blair&title=Uric+acid+and+the+development+of+metabolic+syndrome+in+women+and+men&doi=10.1016%2Fj.metabol.2008.01.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Uric acid and the development of metabolic syndrome in women and men</span></div><div class="casAuthors">Sui, Xuemei; Church, Timothy S.; Meriwether, Rebecca A.; Lobelo, Felipe; Blair, Steven N.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Assocns. between serum uric acid (UA) levels and metabolic syndrome (MetS) have been reported in cross-sectional studies.  Limited information, however, is available concerning the prospective assocn. of UA and the risk of developing MetS.  The authors evaluated UA as a risk factor for incident MetS in a prospective study of 8429 men and 1260 women (aged 20-82 years) who were free of MetS and for whom measures of waist girth, resting blood pressure, fasting lipids, and glucose were taken during baseline and follow-up examns. between 1977 and 2003.  Hyperuricemia was defined as >7.0 mg/dL in men and >6.0 mg/dL in women.  Metabolic syndrome was defined with the National Cholesterol Education Program Adult Treatment Panel III criteria.  The overall prevalence of hyperuricemia was 17%.  During a mean follow-up of 5.7 years, 1120 men and 44 women developed MetS.  Men with serum UA concns. ≥6.5 mg/dL (upper third) had a 1.60-fold increase in risk of MetS (95% confidence interval, 1.34-1.91) as compared with those who had concns. <5.5 mg/dL (lowest third).  Among women, the risk of MetS was at least 2-fold higher for serum UA concns. ≥4.6 mg/dL (P for trend =.02).  Higher serum UA is a strong and independent predictor of incident MetS in men and women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUyJlDaEmdX7Vg90H21EOLACvtfcHk0ljvovGAjeAZlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVaqtL8%253D&md5=e1cf9191e58c0016b49034df5976e3da</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2008.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2008.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DX.%26aulast%3DChurch%26aufirst%3DT.%2BS.%26aulast%3DMeriwether%26aufirst%3DR.%2BA.%26aulast%3DLobelo%26aufirst%3DF.%26aulast%3DBlair%26aufirst%3DS.%2BN.%26atitle%3DUric%2520acid%2520and%2520the%2520development%2520of%2520metabolic%2520syndrome%2520in%2520women%2520and%2520men%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2008%26volume%3D57%26spage%3D845%26epage%3D852%26doi%3D10.1016%2Fj.metabol.2008.01.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Taniguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span> </span><span class="NLM_article-title">Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1215</span><span class="refDoi"> DOI: 10.1097/00004872-200107000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1097%2F00004872-200107000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=11446710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVGktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=1209-1215&author=Y.+Taniguchiauthor=T.+Hayashiauthor=K.+Tsumuraauthor=G.+Endoauthor=S.+Fujiiauthor=K.+Okada&title=Serum+uric+acid+and+the+risk+for+hypertension+and+Type+2+diabetes+in+Japanese+men%3A+The+Osaka+Health+Survey&doi=10.1097%2F00004872-200107000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka health survey</span></div><div class="casAuthors">Taniguchi, Yuki; Hayashi, Tomoshige; Tsumura, Kei; Endo, Ginji; Fujii, Satoru; Okada, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1209-1215</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective To investigate the assocn. of serum uric acid level with the risk for hypertension and Type 2 diabetes.  Design Prospective cohort study.  Setting Work site in Osaka, Japan.  Participants A total of 6356 Japanese men, aged 35-60 yr with systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg, normal glucose intolerance, and no history of hypertension or diabetes at baseline.  Main outcome measures Blood pressure was measured by std. techniques, using 160/95 mmHg for diagnosis of hypertension.  Type 2 diabetes was defined as a fasting plasma glucose level ≥ 126 mg/dL or a 2 h post-loaded plasma glucose level ≥ 200 mg/dL.  Results During the 61 716 person-years follow-up period, we confirmed 639 cases of hypertension and 454 cases of Type 2 diabetes.  Serum uric acid level was assocd. with an increased risk for hypertension but not for Type 2 diabetes.  After adjustment for known risk factors, including daily alc. consumption, the serum uric acid level was assocd. with an increased risk for hypertension; the relative risks for hypertension were 1.00 for quintile 1 of the serum uric acid level, 1.24 [95% confidence interval (Cl), 0.94-1.65] for quintile 2, 1.34 (Cl, 1.03-1.76) for quintile 3, 1.76 (Cl, 1.35-2.29) for quintile 4, and 2.01 (Cl, 1.56-2.60) for quintile 5 (P for trend < 0.001).  Even among both non-drinkers and lean subjects, serum uric acid level was assocd. with an increased risk for hypertension.  Conclusions Serum uric acid level was assocd. with an increased risk for hypertension but not for Type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt8vegcP9eA7Vg90H21EOLACvtfcHk0ljvovGAjeAZlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVGktr8%253D&md5=812aea7a891adfa6d10ae9c5b0796c8c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F00004872-200107000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200107000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DG.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DSerum%2520uric%2520acid%2520and%2520the%2520risk%2520for%2520hypertension%2520and%2520Type%25202%2520diabetes%2520in%2520Japanese%2520men%253A%2520The%2520Osaka%2520Health%2520Survey%26jtitle%3DJ.%2520Hypertens.%26date%3D2001%26volume%3D19%26spage%3D1209%26epage%3D1215%26doi%3D10.1097%2F00004872-200107000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Nakanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatara, K.</span><span> </span><span class="NLM_article-title">Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers</span> <span class="citation_source-journal">Eur. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1023/A:1024600905574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1023%2FA%3A1024600905574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=12908717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVemsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=523-530&author=N.+Nakanishiauthor=M.+Okamotoauthor=H.+Yoshidaauthor=Y.+Matsuoauthor=K.+Suzukiauthor=K.+Tatara&title=Serum+uric+acid+and+risk+for+development+of+hypertension+and+impaired+fasting+glucose+or+Type+II+diabetes+in+Japanese+male+office+workers&doi=10.1023%2FA%3A1024600905574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers</span></div><div class="casAuthors">Nakanishi, N.; Okamoto, M.; Yoshida, H.; Matsuo, Y.; Suzuki, K.; Tatara, K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Epidemiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-530</span>CODEN:
                <span class="NLM_cas:coden">EJEPE8</span>;
        ISSN:<span class="NLM_cas:issn">0393-2990</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We examd. the assocn. of serum uric acid (SUA) with development of hypertension (blood pressure ≥ 140/90 mmHg and/or medication for hypertension) and impaired fasting glucose (IFG) (a fasting plasma glucose level 6.1-6.9 mmol/l) or Type II (non-insulin-dependent) diabetes (a fasting plasma glucose level ≥ 7.0 mmol/l and/or medication for diabetes) over a 6-yr follow-up among 2310 Japanese male office workers aged 35-59 yr who did not have hypertension, IFG, Type II diabetes, or past history of cardiovascular disease at study entry.  After controlling for potential predictors of hypertension and diabetes, the relative risk for hypertension compared with quintile 1 of SUA level was 1.27 [95% confidence interval (CI): 1.00-1.62] for quintile 2, 1.34 (95% CI: 1.08-1.74) for quintile 3, 1.48 (95% CI: 1.18-1.89) for quintile 4, and 1.58 (95% CI: 1.26-1.99) for quintile 5 (p for trend <0.001).  The resp. multivariate-adjusted relative risks for IFG or Type II diabetes compared with quintile 1 of SUA level were 1.55 (95% CI: 0.95-2.63), 1.62 (95% CI: 0.98-2.67), 1.61 (95% CI: 1.01-2.58), and 1.78 (95% CI: 1.11-2.85) (p for trend = 0.030).  The assocn. between SUA level and risk for hypertension and IFG or Type II diabetes was stronger among men with a body mass index (BMI) <24.2 kg/m2 than among men with a BMI ≥ 24.2 kg/m2, although the abs. risk was greater in more obese men.  These results indicate that SUA level is closely assocd. with an increased risk for hypertension and IFG or Type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cnCE46OuC7Vg90H21EOLACvtfcHk0lgxDrk9oFHxVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVemsrc%253D&md5=e45bb450308dd110e14f8bc793e3237e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1023%2FA%3A1024600905574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1024600905574%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DN.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DTatara%26aufirst%3DK.%26atitle%3DSerum%2520uric%2520acid%2520and%2520risk%2520for%2520development%2520of%2520hypertension%2520and%2520impaired%2520fasting%2520glucose%2520or%2520Type%2520II%2520diabetes%2520in%2520Japanese%2520male%2520office%2520workers%26jtitle%3DEur.%2520J.%2520Epidemiol.%26date%3D2003%26volume%3D18%26spage%3D523%26epage%3D530%26doi%3D10.1023%2FA%3A1024600905574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sundström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agostino, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kannel, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasan, R. S.</span><span> </span><span class="NLM_article-title">Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000150784.92944.9a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000150784.92944.9a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=28-33&author=J.+Sundstr%C3%B6mauthor=L.+Sullivanauthor=R.+B.+D%E2%80%99Agostinoauthor=D.+Levyauthor=W.+B.+Kannelauthor=R.+S.+Vasan&title=Relations+of+serum+uric+acid+to+longitudinal+blood+pressure+tracking+and+hypertension+incidence&doi=10.1161%2F01.HYP.0000150784.92944.9a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000150784.92944.9a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000150784.92944.9a%26sid%3Dliteratum%253Aachs%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSullivan%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%2BB.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DKannel%26aufirst%3DW.%2BB.%26aulast%3DVasan%26aufirst%3DR.%2BS.%26atitle%3DRelations%2520of%2520serum%2520uric%2520acid%2520to%2520longitudinal%2520blood%2520pressure%2520tracking%2520and%2520hypertension%2520incidence%26jtitle%3DHypertension%26date%3D2005%26volume%3D45%26spage%3D28%26epage%3D33%26doi%3D10.1161%2F01.HYP.0000150784.92944.9a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Alper, A. B.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, L. L.</span><span> </span><span class="NLM_article-title">Childhood uric acid predicts adult blood pressure. The Bogalusa Heart Study</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000150783.79172.bb</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000150783.79172.bb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=34-38&author=A.+B.+Alperauthor=W.+Chenauthor=L.+Yauauthor=S.+R.+Srinivasanauthor=G.+S.+Berensonauthor=L.+L.+Hamm&title=Childhood+uric+acid+predicts+adult+blood+pressure.+The+Bogalusa+Heart+Study&doi=10.1161%2F01.HYP.0000150783.79172.bb"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000150783.79172.bb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000150783.79172.bb%26sid%3Dliteratum%253Aachs%26aulast%3DAlper%26aufirst%3DA.%2BB.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DYau%26aufirst%3DL.%26aulast%3DSrinivasan%26aufirst%3DS.%2BR.%26aulast%3DBerenson%26aufirst%3DG.%2BS.%26aulast%3DHamm%26aufirst%3DL.%2BL.%26atitle%3DChildhood%2520uric%2520acid%2520predicts%2520adult%2520blood%2520pressure.%2520The%2520Bogalusa%2520Heart%2520Study%26jtitle%3DHypertension%26date%3D2005%26volume%3D45%26spage%3D34%26epage%3D38%26doi%3D10.1161%2F01.HYP.0000150783.79172.bb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Shankar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, B. E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. J.</span><span> </span><span class="NLM_article-title">The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study</span> <span class="citation_source-journal">J. Hum. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1038/sj.jhh.1002095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1038%2Fsj.jhh.1002095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17024135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1akurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=937-945&author=A.+Shankarauthor=R.+Kleinauthor=B.+E.+K.+Kleinauthor=F.+J.+Nieto&title=The+association+between+serum+uric+acid+level+and+long-term+incidence+of+hypertension%3A+population-based+cohort+study&doi=10.1038%2Fsj.jhh.1002095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study</span></div><div class="casAuthors">Shankar, A.; Klein, R.; Klein, B. E. K.; Nieto, F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Human Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">937-945</span>CODEN:
                <span class="NLM_cas:coden">JHHYEN</span>;
        ISSN:<span class="NLM_cas:issn">0950-9240</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increasing exptl. evidence, including recently developed animal models support a causal role for uric acid in the development of hypertension.  However, it is not clear whether serum uric acid levels are independently assocd. with the long-term incidence of hypertension.  We examd. the assocn. between serum uric acid levels and 10-yr incidence of hypertension in a population-based cohort study based in Beaver Dam city and township, Wisconsin, US.  We studied 2520 hypertension-free individuals (56.3% women, age: 43-84 years, 98% Caucasian) at the baseline examn. (1988-1990).  The main outcome of interest was hypertension (systolic blood pressure (BP) of 140 mm Hg or higher, diastolic BP 90 mm Hg or higher, or combination of self-reported high BP diagnosis and use of antihypertensive medications) incidence over 10 years among baseline normotensive individuals.  Nine hundred and fifty-six individuals developed hypertension over a 10-yr follow-up period.  The relative risk (RR) (95% confidence intervals (CI)) of incident hypertension increased in a dose-dependent manner (P-trend<0.05 in all models) with increasing uric acid quartiles.  Multivariable RR (95% CI) comparing the highest quartile of serum uric acid (≥390 μmol/l) to the lowest quartile (≤260 μmol/l) was 1.65 (1.41-1.93).  This assocn. persisted in subgroup analyses by categories of smoking, alc. intake, body mass index, baseline blood pressure and estd. glomerular filtration rate (GFR).  In conclusion, increasing quartiles of serum uric acid was assocd. with 10-yr incidence of hypertension independent of smoking, alc. intake and baseline kidney function suggesting an independent pos. assocn. between serum uric acid levels and hypertension development among community-dwelling older adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZTwJtaXZ-LVg90H21EOLACvtfcHk0lgxDrk9oFHxVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1akurjF&md5=87ad1385c9c8f2a7dff1007fea892887</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fsj.jhh.1002095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jhh.1002095%26sid%3Dliteratum%253Aachs%26aulast%3DShankar%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKlein%26aufirst%3DB.%2BE.%2BK.%26aulast%3DNieto%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520association%2520between%2520serum%2520uric%2520acid%2520level%2520and%2520long-term%2520incidence%2520of%2520hypertension%253A%2520population-based%2520cohort%2520study%26jtitle%3DJ.%2520Hum.%2520Hypertens.%26date%3D2006%26volume%3D20%26spage%3D937%26epage%3D945%26doi%3D10.1038%2Fsj.jhh.1002095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Mellen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleyer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlinger, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenknecht, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wofford, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrington, D. M.</span><span> </span><span class="NLM_article-title">Serum uric acid predicts incident hypertension in a biethnic cohort. The atherosclerosis risk in communities study</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000249768.26560.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000249768.26560.66" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=1037-1042&author=P.+B.+Mellenauthor=A.+J.+Bleyerauthor=T.+P.+Erlingerauthor=G.+W.+Evansauthor=F.+J.+Nietoauthor=L.+E.+Wagenknechtauthor=M.+R.+Woffordauthor=D.+M.+Herrington&title=Serum+uric+acid+predicts+incident+hypertension+in+a+biethnic+cohort.+The+atherosclerosis+risk+in+communities+study&doi=10.1161%2F01.HYP.0000249768.26560.66"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000249768.26560.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000249768.26560.66%26sid%3Dliteratum%253Aachs%26aulast%3DMellen%26aufirst%3DP.%2BB.%26aulast%3DBleyer%26aufirst%3DA.%2BJ.%26aulast%3DErlinger%26aufirst%3DT.%2BP.%26aulast%3DEvans%26aufirst%3DG.%2BW.%26aulast%3DNieto%26aufirst%3DF.%2BJ.%26aulast%3DWagenknecht%26aufirst%3DL.%2BE.%26aulast%3DWofford%26aufirst%3DM.%2BR.%26aulast%3DHerrington%26aufirst%3DD.%2BM.%26atitle%3DSerum%2520uric%2520acid%2520predicts%2520incident%2520hypertension%2520in%2520a%2520biethnic%2520cohort.%2520The%2520atherosclerosis%2520risk%2520in%2520communities%2520study%26jtitle%3DHypertension%26date%3D2006%26volume%3D48%26spage%3D1037%26epage%3D1042%26doi%3D10.1161%2F01.HYP.0000249768.26560.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Krishnan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwoh, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuller, L.</span><span> </span><span class="NLM_article-title">Hyperuricemia and incidence of hypertension among men without metabolic syndrome</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000254480.64564.b6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000254480.64564.b6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17190877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivFKrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=298-303&author=E.+Krishnanauthor=C.+K.+Kwohauthor=H.+R.+Schumacherauthor=L.+Kuller&title=Hyperuricemia+and+incidence+of+hypertension+among+men+without+metabolic+syndrome&doi=10.1161%2F01.HYP.0000254480.64564.b6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome</span></div><div class="casAuthors">Krishnan, Eswar; Kwoh, C. Kent; Schumacher, H. Ralph; Kuller, Lewis</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-303</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The aim of this project was to study the risk of developing hypertension over a 6-yr follow-up in normotensive men with baseline hyperuricemia (serum uric acid >7.0 mg/dL) but without diabetes/glucose intolerance or metabolic syndrome.  We analyzed the data on men without metabolic syndrome or hypertension at baseline from the Multiple Risk Factor Intervention Trial.  These men (n=3073; age: 35 to 57 years) were followed for an av. of 6 years by annual examns.  Follow-up blood pressure among those with baseline was consistently higher than among those with normal serum uric acid concn.  We used Cox regression models for adjustment for the effects of serum creatinine, body mass index, age, blood pressure, proteinuria, serum cholesterol and triglycerides, alc. and tobacco use, risk factor interventions, and use of diuretics.  In these models, normotensive men with baseline hyperuricemia had an 80% excess risk for incident hypertension (hazard ratio: 1.81; 95% CI: 1.59 to 2.07) compared with those who did not.  Each unit increase in serum uric acid was assocd. with a 9% increase in the risk for incident hypertension (hazard ratio: 1.09; 95% CI: 1.02 to 1.17).  We conclude that the hyperuricemia-hypertension risk relationship is present among normotensive middle-aged men without diabetes/glucose intolerance or metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsHbjKakq3LVg90H21EOLACvtfcHk0linFM9H9zSdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivFKrtw%253D%253D&md5=2989f4340bb7396463f0d0ca8dbd7f6b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000254480.64564.b6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000254480.64564.b6%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DE.%26aulast%3DKwoh%26aufirst%3DC.%2BK.%26aulast%3DSchumacher%26aufirst%3DH.%2BR.%26aulast%3DKuller%26aufirst%3DL.%26atitle%3DHyperuricemia%2520and%2520incidence%2520of%2520hypertension%2520among%2520men%2520without%2520metabolic%2520syndrome%26jtitle%3DHypertension%26date%3D2007%26volume%3D49%26spage%3D298%26epage%3D303%26doi%3D10.1161%2F01.HYP.0000254480.64564.b6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Edozien, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udo, U. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrimshaw, N. S.</span><span> </span><span class="NLM_article-title">Effects of high levels of yeast feeding on uric acid metabolism of young men</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="refDoi"> DOI: 10.1038/228180a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1038%2F228180a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=5460023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaE3MXhtV2hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1970&pages=180&author=J.+C.+Edozienauthor=U.+U.+Udoauthor=V.+R.+Youngauthor=N.+S.+Scrimshaw&title=Effects+of+high+levels+of+yeast+feeding+on+uric+acid+metabolism+of+young+men&doi=10.1038%2F228180a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of high levels of yeast feeding on uric acid metabolism of young men</span></div><div class="casAuthors">Edozien, J. C.; Udo, Udo U.; Young, Vernon Robert; Scrimshaw, Nevin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">5267</span>),
    <span class="NLM_cas:pages">180</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The daily feeding of 45 g of yeast contg. 2.9 g of nucleic acid increased the serum uric acid level of a subject to approx. 7 mg/100 ml which is the dividing line between normal persons and those with gout or gallstones.  For 16 days, 4 subjects were fed a controlled, low-purine diet.  Then, for 9-day periods, they received different levels of food yeast (Torula utilis [Torulopsis utilis]).  Total protein intake was maintained at 100 g/day.  Ingestion of more than 2.9 g of nucleic acid/day increased the uric acid excretion to >1000 mg/ day.  Doubling the nucleic acid ingestion to 5.8 g/day likewise doubled the uric acid excretion.  It was suggested that for normal individuals, a dietary level of 2 g of a single-cell protein/ individual/day would seem to involve the least risk of stone formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNEiMFkXXoCrVg90H21EOLACvtfcHk0linFM9H9zSdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtV2hsg%253D%253D&md5=be49ba424d5e134dd6bf1b195c0596cc</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2F228180a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F228180a0%26sid%3Dliteratum%253Aachs%26aulast%3DEdozien%26aufirst%3DJ.%2BC.%26aulast%3DUdo%26aufirst%3DU.%2BU.%26aulast%3DYoung%26aufirst%3DV.%2BR.%26aulast%3DScrimshaw%26aufirst%3DN.%2BS.%26atitle%3DEffects%2520of%2520high%2520levels%2520of%2520yeast%2520feeding%2520on%2520uric%2520acid%2520metabolism%2520of%2520young%2520men%26jtitle%3DNature%26date%3D1970%26volume%3D228%26spage%3D180%26doi%3D10.1038%2F228180a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Yü, T.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, L.</span><span> </span><span class="NLM_article-title">Impaired renal function in gout; Its association with hypertensive vascular disease and intrinsic renal disease</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/0002-9343(82)90593-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2F0002-9343%2882%2990593-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=7058827" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1982&pages=95-100&author=T.-F.+Y%C3%BCauthor=L.+Berger&title=Impaired+renal+function+in+gout%3B+Its+association+with+hypertensive+vascular+disease+and+intrinsic+renal+disease&doi=10.1016%2F0002-9343%2882%2990593-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0002-9343%2882%2990593-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9343%252882%252990593-9%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25BC%26aufirst%3DT.-F.%26aulast%3DBerger%26aufirst%3DL.%26atitle%3DImpaired%2520renal%2520function%2520in%2520gout%253B%2520Its%2520association%2520with%2520hypertensive%2520vascular%2520disease%2520and%2520intrinsic%2520renal%2520disease%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1982%26volume%3D72%26spage%3D95%26epage%3D100%26doi%3D10.1016%2F0002-9343%2882%2990593-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Ciompi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Caterina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernini, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelassi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L’Abbate, A.</span><span> </span><span class="NLM_article-title">Uric acid levels and platelet function in humans. An in-vivo ex-vivo study</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=6085297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaL3sXlslCks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1983&pages=143-147&author=M.+L.+Ciompiauthor=R.+De+Caterinaauthor=D.+Bertolucciauthor=W.+Berniniauthor=C.+Michelassiauthor=A.+L%E2%80%99Abbate&title=Uric+acid+levels+and+platelet+function+in+humans.+An+in-vivo+ex-vivo+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Uric acid levels and platelet function in humans.  An in-vivo ex-vivo study</span></div><div class="casAuthors">Ciompi, M. L.; De Caterina, R.; Bertolucci, D.; Bernini, W.; Michelassi, C.; L'Abbate, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Rheumatology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-7</span>CODEN:
                <span class="NLM_cas:coden">CERHDP</span>;
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">Platelet function (aggregation by ADP, adrenaline, collagen, and circulating platelet aggregates) before, during, and after dietary induction of hyperuricemia (RNA, 3 g/day) was studied in 5 healthy volunteers to assess the relationship between uric acid  [69-93-2] level and platelet function.  In the same subjects, during a 2nd period of RNA diet, the acute and chronic effects of a hypo-uricemizing agent, allopurinol, were assessed.  No significant correlation was detected between platelet function and uricemia either in the absence or in the presence of pharmacol. treatment with allopurinol.  On the basis of these results, the well known relationship between uric acid levels and ischemic heart disease does not appear to be mediated by an exaggerated platelet function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4oPLgoXUMHbVg90H21EOLACvtfcHk0li4z5S3rL5WyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslCks7k%253D&md5=aad3ca5c3ece5d562de3cb3f9817a96d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiompi%26aufirst%3DM.%2BL.%26aulast%3DDe%2BCaterina%26aufirst%3DR.%26aulast%3DBertolucci%26aufirst%3DD.%26aulast%3DBernini%26aufirst%3DW.%26aulast%3DMichelassi%26aufirst%3DC.%26aulast%3DL%25E2%2580%2599Abbate%26aufirst%3DA.%26atitle%3DUric%2520acid%2520levels%2520and%2520platelet%2520function%2520in%2520humans.%2520An%2520in-vivo%2520ex-vivo%2520study%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D1983%26volume%3D1%26spage%3D143%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curhan, G.</span><span> </span><span class="NLM_article-title">Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid. The Third National Health and Nutrition Examination Survey</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1002/art.20761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1002%2Fart.20761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15641075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FitVymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=283-289&author=H.+K.+Choiauthor=S.+Liuauthor=G.+Curhan&title=Intake+of+purine-rich+foods%2C+protein%2C+and+dairy+products+and+relationship+to+serum+levels+of+uric+acid.+The+Third+National+Health+and+Nutrition+Examination+Survey&doi=10.1002%2Fart.20761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey</span></div><div class="casAuthors">Choi Hyon K; Liu Simin; Curhan Gary</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-9</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  Various commonly consumed foods have long been suspected of affecting the serum uric acid level, but few data are available to support or refute this impression.  Our objective was to evaluate the relationship between dietary factors and serum uric acid levels in a nationally representative sample of men and women in the US.  METHODS:  Using data from 14,809 participants (6,932 men and 7,877 women) ages 20 years and older in the Third National Health and Nutrition Examination Survey (for the years 1988-1994), we examined the relationship between the intake of purine-rich foods, protein, and dairy products and serum levels of uric acid.  Diet was assessed with a food-frequency questionnaire.  We used multivariate linear regression to adjust for age, sex, total energy intake, body mass index, use of diuretics, beta-blockers, allopurinol, and uricosuric agents, self-reported hypertension and gout, serum creatinine level, and intake of alcohol.  RESULTS:  The serum uric acid level increased with increasing total meat or seafood intake and decreased with increasing dairy intake.  After adjusting for age, the differences in uric acid levels between the extreme quintiles of intake were 0.48 mg/dl for total meat (95% confidence interval [95% CI] 0.34, 0.61; P < 0.001 for trend), 0.16 mg/dl for seafood (95% CI 0.06, 0.27; P = 0.005 for trend), and -0.21 mg/dl for total dairy intake (95% CI -0.37, -0.04; P = 0.02 for trend).  After adjusting for other covariates, the differences between the extreme quintiles were attenuated but remained significant (P < 0.05 for all comparisons).  The total protein intake was not associated with the serum uric acid level in multivariate analyses (P = 0.74 for trend).  Those who consumed milk 1 or more times per day had a lower serum uric acid level than did those who did not drink milk (multivariate difference -0.25 [95% CI -0.40, -0.09]; P < 0.001 for trend).  Similarly, those who consumed yogurt at least once every other day had a lower serum uric acid level than did those who did not consume yogurt (multivariate difference -0.26 [95% CI -0.41, -0.12]; P < 0.001 for trend).  CONCLUSION:  These findings from a nationally representative sample of adults in the US suggest that higher levels of meat and seafood consumption are associated with higher serum levels of uric acid but that total protein intake is not.  Dairy consumption was inversely associated with the serum uric acid level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQy4oLfwrmagjAEfvC7EH1LfW6udTcc2eZrh5MXSCtBQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FitVymsg%253D%253D&md5=a7c87de81af75a89863eea32ead51440</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fart.20761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.20761%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCurhan%26aufirst%3DG.%26atitle%3DIntake%2520of%2520purine-rich%2520foods%252C%2520protein%252C%2520and%2520dairy%2520products%2520and%2520relationship%2520to%2520serum%2520levels%2520of%2520uric%2520acid.%2520The%2520Third%2520National%2520Health%2520and%2520Nutrition%2520Examination%2520Survey%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D283%26epage%3D289%26doi%3D10.1002%2Fart.20761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlson, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curhan, G.</span><span> </span><span class="NLM_article-title">Purine-rich foods, dairy and protein intake, and the risk of gout in men</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.1056/NEJMoa035700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1056%2FNEJMoa035700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15014182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitV2qur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1093-1103&author=H.+K.+Choiauthor=K.+Atkinsonauthor=E.+W.+Karlsonauthor=W.+Willettauthor=G.+Curhan&title=Purine-rich+foods%2C+dairy+and+protein+intake%2C+and+the+risk+of+gout+in+men&doi=10.1056%2FNEJMoa035700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Purine-rich foods, dairy and protein intake, and the risk of gout in men</span></div><div class="casAuthors">Choi, Hyon K.; Atkinson, Karen; Karlson, Elizabeth W.; Willett, Walter; Curhan, Gary</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1093-1103</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Purine-rich foods and high protein intakes may be risk factors for gout development.  Consumption of dairy products may protect against gout.  We investigated the assocn. of these dietary factors in new cases of gout prospectively over 12-yr period.  The relationship between dietary risk factors and new cases of gout was examd. in 47,150 men who had no history of gout at baseline.  The diet was assessed every 4 yr by food-frequency questionnaire.  During the 12-yr study there were 730 confirmed new cases of gout.  The multivariate relative risk of gout among men in the highest vs. lowest quintile of meat intake was 1.41 (95% CI 1.07-1.86); the corresponding relative risk assocd. with seafood intake was 1.51 (95% CI 1.17-1.95).  The incidence of gout decreased with increasing intakes of dairy products; the multivariate relative risk among men in the highest vs. lowest quintile was 0.56 (95% CI 0.42-0.74).  The level of consumption of purine-rich vegetables and the total protein intake were not assocd. with increased risk of gout.  Thus, higher levels of meat and seafood consumption were assocd. with increased risk of gout, whereas higher levels of dairy products consumption was assocd. with decreased risk.  Moderate intake of purine-rich vegetables or protein was not assocd. with increased risk of gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCuZGM3pHt-LVg90H21EOLACvtfcHk0ljYczJk6binOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitV2qur4%253D&md5=f3642d563b140796e2b6b1c268f78339</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa035700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa035700%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DKarlson%26aufirst%3DE.%2BW.%26aulast%3DWillett%26aufirst%3DW.%26aulast%3DCurhan%26aufirst%3DG.%26atitle%3DPurine-rich%2520foods%252C%2520dairy%2520and%2520protein%2520intake%252C%2520and%2520the%2520risk%2520of%2520gout%2520in%2520men%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1093%26epage%3D1103%26doi%3D10.1056%2FNEJMoa035700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Stafford, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerson, B. T.</span><span> </span><span class="NLM_article-title">Effect of purine restriction on serum and urine urate in normal subjects</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">165A</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span><span class="refDoi"> DOI: 10.1007/978-1-4684-4553-4_61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2F978-1-4684-4553-4_61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165A&publication_year=1984&pages=309-316&author=W.+Staffordauthor=B.+T.+Emmerson&title=Effect+of+purine+restriction+on+serum+and+urine+urate+in+normal+subjects&doi=10.1007%2F978-1-4684-4553-4_61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2F978-1-4684-4553-4_61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4684-4553-4_61%26sid%3Dliteratum%253Aachs%26aulast%3DStafford%26aufirst%3DW.%26aulast%3DEmmerson%26aufirst%3DB.%2BT.%26atitle%3DEffect%2520of%2520purine%2520restriction%2520on%2520serum%2520and%2520urine%2520urate%2520in%2520normal%2520subjects%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1984%26volume%3D165A%26spage%3D309%26epage%3D316%26doi%3D10.1007%2F978-1-4684-4553-4_61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Emmerson, B. T.</span><span> </span><span class="NLM_article-title">Identification of the causes of persistent hyperuricaemia</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1463</span><span class="refDoi"> DOI: 10.1016/0140-6736(91)93141-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2F0140-6736%2891%2993141-U" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1991&pages=1461-1463&author=B.+T.+Emmerson&title=Identification+of+the+causes+of+persistent+hyperuricaemia&doi=10.1016%2F0140-6736%2891%2993141-U"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0140-6736%2891%2993141-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0140-6736%252891%252993141-U%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerson%26aufirst%3DB.%2BT.%26atitle%3DIdentification%2520of%2520the%2520causes%2520of%2520persistent%2520hyperuricaemia%26jtitle%3DLancet%26date%3D1991%26volume%3D337%26spage%3D1461%26epage%3D1463%26doi%3D10.1016%2F0140-6736%2891%2993141-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Kong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Mammalian nucleoside transporters</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.2174/1389200043489162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F1389200043489162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=14965251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVCisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=63-84&author=W.+Kongauthor=K.+Engelauthor=J.+Wang&title=Mammalian+nucleoside+transporters&doi=10.2174%2F1389200043489162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian nucleoside transporters</span></div><div class="casAuthors">Kong, Wei; Engel, Karen; Wang, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nucleoside transporters mediate cellular uptake of physiol. nucleosides for nucleic acid synthesis in the salvage pathways in many cell types.  These transporters also play an important role in in vivo disposition and intracellular targeting of many nucleoside analogs used in anticancer and antiviral drug therapy.  In mammalian cells, there are two major nucleoside transporter gene families: the equilibrative nucleoside transporters (ENTs) and the concentrative nucleoside transporters (CNTs).  The ENTs are facilitated carrier proteins and the CNTs are Na+-dependent secondary active transporters.  Recent mol. cloning of a no. of ENT and CNT transporters has greatly advanced our understanding of the mol. and cellular mechanisms by which nucleosides and nucleoside analogs are transported across biol. membranes.  In this manuscript, we review the structure, function, tissue distribution, and cellular localization of various cloned mammalian nucleoside transporters.  Information on transporter interaction with various nucleoside drugs and analogs is presented.  Current knowledge on the regulation of nucleoside transporters in various cell types and tissues is reviewed.  The therapeutic significance of nucleoside transporters is discussed along with emerging data from recent clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZk2rVY91y7Vg90H21EOLACvtfcHk0lj2T66MQn2eKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVCisLg%253D&md5=cf44fb2dfaa5e21027a826508418a893</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F1389200043489162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200043489162%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DW.%26aulast%3DEngel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DMammalian%2520nucleoside%2520transporters%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2004%26volume%3D5%26spage%3D63%26epage%3D84%26doi%3D10.2174%2F1389200043489162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">King, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span> </span><span class="NLM_article-title">Nucleoside transporters: from scavengers to novel therapeutic targets</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1016/j.tips.2006.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.tips.2006.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16820221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=416-425&author=A.+E.+Kingauthor=M.+A.+Ackleyauthor=C.+E.+Cassauthor=J.+D.+Youngauthor=S.+A.+Baldwin&title=Nucleoside+transporters%3A+from+scavengers+to+novel+therapeutic+targets&doi=10.1016%2Fj.tips.2006.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside transporters: from scavengers to novel therapeutic targets</span></div><div class="casAuthors">King, Anne E.; Ackley, Michael A.; Cass, Carol E.; Young, James D.; Baldwin, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">416-425</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hydrophilic purine and pyrimidine nucleosides rely on specialized carrier proteins for their membrane translocation.  The recent identification of two gene families encoding equilibrative and concentrative nucleoside transporters in mammals and other organisms has provided the essential breakthrough to a more complete understanding of the biol. significance of nucleoside transport.  Although nucleoside salvage is a primary function of these proteins, recent data indicate functions beyond metabolic recycling.  In brain and spinal cord, for example, nucleoside transporters have the potential to regulate synaptic levels of neuroactive purines such as adenosine and, thereby, indirectly modulate physiol. processes through G-protein-coupled purine P1 receptors.  As described in this review, recent research indicates novel putative functions for CNS nucleoside transporters in sleep, arousal, drug and alc. addiction, nociception and analgesia.  The therapeutic use of nucleoside analog drugs and nucleoside transporter inhibitors in viral, neoplastic, cardiovascular and infectious disease is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIDQRtv6l-PrVg90H21EOLACvtfcHk0lj2T66MQn2eKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsro%253D&md5=8046d41e24553ca9add8e5b97873f9b1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BE.%26aulast%3DAckley%26aufirst%3DM.%2BA.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26atitle%3DNucleoside%2520transporters%253A%2520from%2520scavengers%2520to%2520novel%2520therapeutic%2520targets%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D416%26epage%3D425%26doi%3D10.1016%2Fj.tips.2006.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span> </span><span class="NLM_article-title">The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1007/s10555-007-9044-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs10555-007-9044-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17345146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=85-110&author=J.+Zhangauthor=F.+Visserauthor=K.+M.+Kingauthor=S.+A.+Baldwinauthor=J.+D.+Youngauthor=C.+E.+Cass&title=The+role+of+nucleoside+transporters+in+cancer+chemotherapy+with+nucleoside+drugs&doi=10.1007%2Fs10555-007-9044-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs</span></div><div class="casAuthors">Zhang, Jing; Visser, Frank; King, Karen M.; Baldwin, Stephen A.; Young, James D.; Cass, Carol E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-110</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Nucleoside analogs are important components of treatment regimens for various malignancies.  Nucleoside-specific membrane transporters mediate plasma membrane permeation of physiol. nucleosides and most nucleoside analogs, for which the initial event is cellular conversion of nucleosides to active agents. Understanding of the roles of nucleoside transporters in nucleoside drug toxicity and resistance will provide opportunities for potentiating anticancer efficacy and avoiding resistance.  Because transportability is a possible determinant of toxicity and resistance of many nucleoside analogs, nucleoside transporter abundance might be a prognostic marker to assess drug resistance.  Elucidation of the structural determinants of nucleoside analogs for interaction with transporter proteins as well as the structural features of transporter proteins required for permeant interaction and translocation will lead to "transportability guidelines" for the rational design and therapeutic application of nucleoside analogs as anticancer drugs.  It should eventually be possible to develop clin. assays that predict sensitivity and/or resistance to nucleoside anti-cancer drugs and thus to identify those patient populations that will most likely benefit from optimal nucleoside analog treatments.  This review discusses recent results from structure/function studies of human nucleoside transporters, the role of nucleoside transport processes in the cytotoxicity and resistance of several anticancer nucleoside analogs and strategies to improve the nucleoside transporter-related anticancer effects of nucleoside analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop6_0ME-AYJrVg90H21EOLACvtfcHk0ljI47Oo1T1fdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqt7c%253D&md5=a8487b1c6234b64f60dbd41f9c6425b8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9044-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9044-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DVisser%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DK.%2BM.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DCass%26aufirst%3DC.%2BE.%26atitle%3DThe%2520role%2520of%2520nucleoside%2520transporters%2520in%2520cancer%2520chemotherapy%2520with%2520nucleoside%2520drugs%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26spage%3D85%26epage%3D110%26doi%3D10.1007%2Fs10555-007-9044-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Molina-Arcas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor-Anglada, M.</span><span> </span><span class="NLM_article-title">Nucleoside transporter proteins</span> <span class="citation_source-journal">Curr. Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.2174/157016109789043892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F157016109789043892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=19485885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlaltrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=426-434&author=M.+Molina-Arcasauthor=F.+J.+Casadoauthor=M.+Pastor-Anglada&title=Nucleoside+transporter+proteins&doi=10.2174%2F157016109789043892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside transporter proteins</span></div><div class="casAuthors">Molina-Arcas, Miriam; Casado, F. Javier; Pastor-Anglada, Marcal</div><div class="citationInfo"><span class="NLM_cas:title">Current Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">426-434</span>CODEN:
                <span class="NLM_cas:coden">CVPUAY</span>;
        ISSN:<span class="NLM_cas:issn">1570-1611</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Concentrative nucleoside transporters (CNT; SLC28) and equilibrative nucleoside transporters (ENT; SLC29) mediate the uptake of natural nucleosides and a variety of nucleoside-derived drugs, mostly used in anticancer therapy.  SLC28 and SLC29 families consist in three and four members, resp., which differ in their substrate selectivity and their energy requirements.  Tissue distribution of these transporters is not homogeneous among tissues, and their expression can be regulated.  In epithelial, CNT and ENT proteins are mostly localized in the apical and basolateral membranes, resp., which results in nucleoside and nucleoside-derived drugs vectorial flux.  Nucleoside transporters can play physiol. roles other than salvages, such as the modulation of extracellular and intracellular adenosine concns.  Moreover, these transporters also have clin. significance.  ENT proteins are target of dipyridamole and dilazep, used as vasodilatory drugs in the treatment of heart and vascular diseases.  On the other hand, nucleoside transporters are responsible for the cellular uptake of currently used anticancer nucleoside-derived drugs, thus these membrane proteins might play a significant role in nucleoside-based chemotherapy.  Finally, several polymorphisms have been described in CNT and ENT proteins that could affect nucleoside homeostasis, adenosine signaling events or nucleoside-derived drug cytotoxicity or pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6QSfaVZrWuLVg90H21EOLACvtfcHk0ljI47Oo1T1fdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlaltrrF&md5=087c19c72d4fcb508444506bf83567c5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F157016109789043892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016109789043892%26sid%3Dliteratum%253Aachs%26aulast%3DMolina-Arcas%26aufirst%3DM.%26aulast%3DCasado%26aufirst%3DF.%2BJ.%26aulast%3DPastor-Anglada%26aufirst%3DM.%26atitle%3DNucleoside%2520transporter%2520proteins%26jtitle%3DCurr.%2520Vasc.%2520Pharmacol.%26date%3D2009%26volume%3D7%26spage%3D426%26epage%3D434%26doi%3D10.2174%2F157016109789043892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Damaraju, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span> </span><span class="NLM_article-title">Human nucleoside transporters: Biomarkers for response to nucleoside drugs</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1080/15257770903044499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1080%2F15257770903044499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=20183595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=450-463&author=V.+L.+Damarajuauthor=M.+B.+Sawyerauthor=J.+R.+Mackeyauthor=J.+D.+Youngauthor=C.+E.+Cass&title=Human+nucleoside+transporters%3A+Biomarkers+for+response+to+nucleoside+drugs&doi=10.1080%2F15257770903044499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Human nucleoside transporters: biomarkers for response to nucleoside drugs</span></div><div class="casAuthors">Damaraju, Vijaya L.; Sawyer, Michael B.; Mackey, John R.; Young, James D.; Cass, Carol E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">450-463</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">This review describes recent advances in developing human nucleoside transporters (hNTs) as biomarkers to predict response to nucleoside analog drugs with clin. activity.  Understanding processes that contribute to drug response or lack thereof will provide strategies to potentiate efficacy or avoid toxicities of nucleoside analog drugs.  HNT abundance, evaluated by immunohistochem. methods, has shown promise as a predictive marker to assess clin. drug response that could be used to identify patients who would most likely benefit from nucleoside analog drug treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7jJpO026jWrVg90H21EOLACvtfcHk0ljcSXOVa5uVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgsb7F&md5=f106473d7e0196be500b07a8942c8005</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F15257770903044499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770903044499%26sid%3Dliteratum%253Aachs%26aulast%3DDamaraju%26aufirst%3DV.%2BL.%26aulast%3DSawyer%26aufirst%3DM.%2BB.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DCass%26aufirst%3DC.%2BE.%26atitle%3DHuman%2520nucleoside%2520transporters%253A%2520Biomarkers%2520for%2520response%2520to%2520nucleoside%2520drugs%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2009%26volume%3D28%26spage%3D450%26epage%3D463%26doi%3D10.1080%2F15257770903044499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Parkinson, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaraju, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">Molecular biology of nucleoside transporters and their distributions and functions in the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span><span class="refDoi"> DOI: 10.2174/156802611795347582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F156802611795347582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=21401500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=948-972&author=F.+E.+Parkinsonauthor=V.+L.+Damarajuauthor=K.+Grahamauthor=S.+Y.+M.+Yaoauthor=S.+A.+Baldwinauthor=C.+E.+Cassauthor=J.+D.+Young&title=Molecular+biology+of+nucleoside+transporters+and+their+distributions+and+functions+in+the+brain&doi=10.2174%2F156802611795347582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of nucleoside transporters and their distributions and functions in the brain</span></div><div class="casAuthors">Parkinson, Fiona E.; Damaraju, Vijaya L.; Graham, Kathryn; Yao, Sylvia Y. M.; Baldwin, Stephen A.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">948-972</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Pyrimidine and purine nucleosides and their derivs. have crit. functions and pharmacol. applications in the brain.  Nucleosides and nucleobases are precursors of nucleotides, which serve as the energy-rich currency of intermediary metab. and as precursors of nucleic acids.  Nucleosides (e.g., adenosine) and nucleotides are key signaling mols. that modulate brain function through interaction with cell surface receptors.  Brain pathologies involving nucleosides and their metabolites range from epilepsy to neurodegenerative disorders and psychiatric conditions to cerebrovascular ischemia.  Nucleoside analogs are used clin. in the treatment of brain cancer and viral infections.  Nucleosides are hydrophilic mols., and transportability across cell membranes via specialized nucleoside transporter (NT) proteins is a crit. determinant of their metab. and, for nucleoside drugs, their pharmacol. actions.  In mammals, there are two types of nucleoside transport process: bidirectional equilibrative processes driven by chem. gradients, and unidirectional concentrative processes driven by sodium (and proton) electrochem. gradients.  In mammals, these processes, both of which are present in brain, are mediated by members of two structurally unrelated membrane protein families (ENT and CNT, resp.).  In this Chapter, we review current knowledge of cellular, physiol., pathophysiol. and therapeutic aspects of ENT and CNT distribution and function in the mammalian brain, including studies with NT inhibitors and new research involving NT knockout and transgenic mice.  We also describe recent progress in functional and mol. studies of ENT and CNT proteins, and summarize emerging evidence of other transporter families with demonstrated or potential roles in the transport of nucleosides and their derivs. in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcSfa1v5U49bVg90H21EOLACvtfcHk0ljcSXOVa5uVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLs%253D&md5=3ae60f56621756708a806d64cae57fa7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2174%2F156802611795347582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795347582%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DF.%2BE.%26aulast%3DDamaraju%26aufirst%3DV.%2BL.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520biology%2520of%2520nucleoside%2520transporters%2520and%2520their%2520distributions%2520and%2520functions%2520in%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D948%26epage%3D972%26doi%3D10.2174%2F156802611795347582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Gray, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, K. M.</span><span> </span><span class="NLM_article-title">The concentrative nucleoside transporter family, SLC28</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span><span class="refDoi"> DOI: 10.1007/s00424-003-1107-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs00424-003-1107-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=12856181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVygtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2004&pages=728-734&author=J.+H.+Grayauthor=R.+P.+Owenauthor=K.+M.+Giacomini&title=The+concentrative+nucleoside+transporter+family%2C+SLC28&doi=10.1007%2Fs00424-003-1107-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The concentrative nucleoside transporter family, SLC28</span></div><div class="casAuthors">Gray, Jennifer H.; Owen, Ryan P.; Giacomini, Kathleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">728-734</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The SLC28 family consists of three subtypes of sodium-dependent, concentrative nucleoside transporters, CNT1, CNT2, and CNT3 (SLC28A1, SLC28A2, and SLC28A3, resp.), that transport both naturally occurring nucleosides and synthetic nucleoside analogs used in the treatment of various diseases.  These subtypes differ in their substrate specificities: CNT1 is pyrimidine-nucleoside preferring, CNT2 is purine-nucleoside preferring, and CNT3 transports both pyrimidine and purine nucleosides.  Recent studies have identified key amino acid residues that are determinants of pyrimidine and purine specificity of CNT1 and CNT2.  The tissue distributions of the CNTs vary: CNT1 is localized primarily in epithelia, whereas CNT2 and CNT3 have more generalized distributions.  Nucleoside transporters in the SLC28 and SLC29 families play crit. roles in nucleoside salvage pathways where they mediate the first step of nucleotide biosynthesis.  In addn., these transporters work in concert to terminate adenosine signaling.  SLC28 family members are crucial determinants of response to a variety of anticancer and antiviral nucleoside analogs, as they modulate the entry of these analogs into target tissues.  Further, this family is involved in the absorption and disposition of many nucleoside analogs.  Several CNT single nucleoside polymorphisms (SNPs) have been identified, but have yet to be characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt0s05_IoTLLVg90H21EOLACvtfcHk0ljcSXOVa5uVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVygtr0%253D&md5=e1ab38f2dccfb8ea978a3263c0d8117b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00424-003-1107-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-003-1107-y%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DJ.%2BH.%26aulast%3DOwen%26aufirst%3DR.%2BP.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DThe%2520concentrative%2520nucleoside%2520transporter%2520family%252C%2520SLC28%26jtitle%3DPfluegers%2520Arch.%26date%3D2004%26volume%3D447%26spage%3D728%26epage%3D734%26doi%3D10.1007%2Fs00424-003-1107-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Smith, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slugoski, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">The broadly selective human Na<sup>+</sup>/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">25436</span><span class="NLM_x">–</span> <span class="NLM_lpage">25449</span><span class="refDoi"> DOI: 10.1074/jbc.M409454200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1074%2Fjbc.M409454200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15870078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslyltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25436-25449&author=K.+M.+Smithauthor=M.+D.+Slugoskiauthor=S.+K.+Loewenauthor=A.+M.+L.+Ngauthor=S.+Y.+M.+Yaoauthor=X.-Z.+Chenauthor=E.+Karpinskiauthor=C.+E.+Cassauthor=S.+A.+Baldwinauthor=J.+D.+Young&title=The+broadly+selective+human+Na%2B%2Fnucleoside+cotransporter+%28hCNT3%29+exhibits+novel+cation-coupled+nucleoside+transport+characteristics&doi=10.1074%2Fjbc.M409454200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Broadly Selective Human Na+/Nucleoside Cotransporter (hCNT3) Exhibits Novel Cation-coupled Nucleoside Transport Characteristics</span></div><div class="casAuthors">Smith, Kyla M.; Slugoski, Melissa D.; Loewen, Shaun K.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Chen, Xing-Zhen; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">25436-25449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The concentrative nucleoside transporter (CNT) protein family in humans is represented by three members, hCNT1, hCNT2, and hCNT3.  HCNT3, a Na+/nucleoside symporter, transports a broad range of physiol. purine and pyrimidine nucleosides as well as anticancer and antiviral nucleoside drugs, and belongs to a different CNT subfamily than hCNT1/2.  H+-dependent Escherichia coli NupC and Candida albicans CaCNT are also CNT family members.  The present study utilized heterologous expression in Xenopus oocytes to investigate the specificity, mechanism, energetics, and structural basis of hCNT3 cation coupling.  HCNT3 exhibited uniquely broad cation interactions with Na+, H+, and Li+ not shared by Na+-coupled hCNT1/2 or H+-coupled NupC/CaCNT.  Na+ and H+ activated hCNT3 through mechanisms to increase nucleoside apparent binding affinity.  Direct and indirect methods demonstrated cation/nucleoside coupling stoichiometries of 2:1 in the presence of Na+ and both Na+ plus H+, but only 1:1 in the presence of H+ alone, suggesting that hCNT3 possesses two Na+-binding sites, only one of which is shared by H+.  The H+-coupled hCNT3 did not transport guanosine or 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine, demonstrating that Na+- and H+-bound versions of hCNT3 have significantly different conformations of the nucleoside binding pocket and/or translocation channel.  Chimeric studies between hCNT1 and hCNT3 located hCNT3-specific cation interactions to the C-terminal half of hCNT3, setting the stage for site-directed mutagenesis expts. to identify the residues involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4bEqiGSKSFrVg90H21EOLACvtfcHk0lhsY71fPFKhHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslyltbs%253D&md5=ab23cba0b33a5b48384b4317d1e1fa87</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409454200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409454200%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DSlugoski%26aufirst%3DM.%2BD.%26aulast%3DLoewen%26aufirst%3DS.%2BK.%26aulast%3DNg%26aufirst%3DA.%2BM.%2BL.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DChen%26aufirst%3DX.-Z.%26aulast%3DKarpinski%26aufirst%3DE.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520broadly%2520selective%2520human%2520Na%252B%252Fnucleoside%2520cotransporter%2520%2528hCNT3%2529%2520exhibits%2520novel%2520cation-coupled%2520nucleoside%2520transport%2520characteristics%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25436%26epage%3D25449%26doi%3D10.1074%2Fjbc.M409454200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">The equilibrative nucleoside transporter family, SLC29</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span><span class="refDoi"> DOI: 10.1007/s00424-003-1103-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs00424-003-1103-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=12838422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2004&pages=735-743&author=S.+A.+Baldwinauthor=P.+R.+Bealauthor=S.+Y.+M.+Yaoauthor=A.+E.+Kingauthor=C.+E.+Cassauthor=J.+D.+Young&title=The+equilibrative+nucleoside+transporter+family%2C+SLC29&doi=10.1007%2Fs00424-003-1103-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The equilibrative nucleoside transporter family, SLC29</span></div><div class="casAuthors">Baldwin, Stephen A.; Beal, Paul R.; Yao, Sylvia Y. M.; King, Anne E.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">735-743</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The human SLC29 family of proteins contains four members, designated equilibrative nucleoside transporters (ENTs) because of the properties of the first-characterized family member, hENT1.  They belong to the widely-distributed eukaryotic ENT family of equilibrative and concentrative nucleoside/nucleobase transporters and are distantly related to a lysosomal membrane protein, CLN3, mutations in which cause neuronal ceroid lipofuscinosis.  A predicted topol. of 11 transmembrane helixes with a cytoplasmic N-terminus and an extracellular C-terminus has been exptl. confirmed for hENT1.  The best-characterized members of the family, hENT1 and hENT2, possess similar broad substrate specificities for purine and pyrimidine nucleosides, but hENT2 in addn. efficiently transports nucleobases.  The ENT3 and ENT4 isoforms have more recently also been shown to be genuine nucleoside transporters.  All four isoforms are widely distributed in mammalian tissues, although their relative abundance varies: ENT2 is particularly abundant in skeletal muscle.  In polarized cells ENT1 and ENT2 are found in the basolateral membrane and, in tandem with concentrative transporters of the SLC28 family, may play a role in transepithelial nucleoside transport.  The transporters play key roles in nucleoside and nucleobase uptake for salvage pathways of nucleotide synthesis, and are also responsible for the cellular uptake of nucleoside analogs used in the treatment of cancers and viral diseases.  In addn., by regulating the concn. of adenosine available to cell surface receptors, they influence many physiol. processes ranging from cardiovascular activity to neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotvcZfpp35T7Vg90H21EOLACvtfcHk0lhsY71fPFKhHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVygsbk%253D&md5=f8fda351e0b312d78e1e2fa21aab850c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00424-003-1103-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-003-1103-2%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DBeal%26aufirst%3DP.%2BR.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DKing%26aufirst%3DA.%2BE.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520equilibrative%2520nucleoside%2520transporter%2520family%252C%2520SLC29%26jtitle%3DPfluegers%2520Arch.%26date%3D2004%26volume%3D447%26spage%3D735%26epage%3D743%26doi%3D10.1007%2Fs00424-003-1103-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hiratochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuramochi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">690</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2012.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.ejphar.2012.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=22709993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=690&publication_year=2012&pages=183-191&author=M.+Hiratochiauthor=K.+Tataniauthor=K.+Shimizuauthor=Y.+Kuramochiauthor=N.+Kikuchiauthor=N.+Kamadaauthor=F.+Itohauthor=M.+Isaji&title=Hypouricemic+effects+of+novel+concentrative+nucleoside+transporter+2+inhibitors+through+suppressing+intestinal+absorption+of+purine+nucleosides&doi=10.1016%2Fj.ejphar.2012.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides</span></div><div class="casAuthors">Hiratochi, Masahiro; Tatani, Kazuya; Shimizu, Kazuo; Kuramochi, Yu; Kikuchi, Norihiko; Kamada, Noboru; Itoh, Fumiaki; Isaji, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">690</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">183-191</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed concentrative nucleoside transporter 2 (CNT2) inhibitors as a novel pharmacol. approach for improving hyperuricemia by inhibiting intestinal absorption of purines.  Dietary purine nucleosides are absorbed in the small intestines by CNTs expressed in the apical membrane.  In humans, the absorbed purine nucleosides are rapidly degraded to their final end product, uric acid, by xanthine oxidase.  Based on the expression profile of human CNTs in digestive tract tissues, we established a working hypothesis that mainly CNT2 contributes to the intestinal absorption of purine nucleosides.  In order to confirm this possibility, we developed CNT2 inhibitors and found that (2R,3R,4S,5R)-2-(6-amino-8-{[3'-(3-aminopropoxy)-biphenyl-4-ylmethyl]-amino}-9H-purin-9-yl)-5-hydroxymethyl-tetrahydrofuran-3,4-diol (KGO-2142) and 1-[3-(5-{[1-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydrofuran-2-yl)-1H-benzimidazol-2-ylamino]-methyl}-2-ethoxyphenoxy)-propyl]-piperidine-4-carboxylic acid amide (KGO-2173) were inhibitory.  These CNT2 inhibitors had potent inhibitory activity against inosine uptake via human CNT2, but they did not potently interfere with nucleoside uptake via human CNT1, CNT3 or equilibrative nucleoside transporters (ENTs) in vitro.  After oral administration of KGO-2173 along with [14C]-inosine, KGO-2173 significantly decreased the urinary excretion of radioactivity at 6 and 24 h in rats.  Since dietary purine nucleosides are not utilized in the body and are excreted into the urine rapidly, this decrease in radioactivity in the urine represented the inhibitory activity of KGO-2173 toward the absorption of [14C]-inosine in the small intestines.  KGO-2142 almost completely inhibited dietary RNA-induced hyperuricemia and the increase in urinary excretion of uric acid in cebus monkeys.  These novel CNT2 inhibitors, KGO-2142 and KGO-2173, could be useful therapeutic options for the treatment of hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_du09fjQTgrVg90H21EOLACvtfcHk0lhsY71fPFKhHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgu77K&md5=638d64359fef790478e2abcfb42e3964</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DHiratochi%26aufirst%3DM.%26aulast%3DTatani%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DKuramochi%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DN.%26aulast%3DKamada%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DHypouricemic%2520effects%2520of%2520novel%2520concentrative%2520nucleoside%2520transporter%25202%2520inhibitors%2520through%2520suppressing%2520intestinal%2520absorption%2520of%2520purine%2520nucleosides%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D690%26spage%3D183%26epage%3D191%26doi%3D10.1016%2Fj.ejphar.2012.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Tatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, S.</span><span> </span><span class="NLM_article-title">Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1021/ml500343r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500343r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=244-248&author=K.+Tataniauthor=M.+Hiratochiauthor=Y.+Nonakaauthor=M.+Isajiauthor=S.+Shuto&title=Identification+of+8-aminoadenosine+derivatives+as+a+new+class+of+human+concentrative+nucleoside+transporter+2+inhibitors&doi=10.1021%2Fml500343r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fml500343r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500343r%26sid%3Dliteratum%253Aachs%26aulast%3DTatani%26aufirst%3DK.%26aulast%3DHiratochi%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIsaji%26aufirst%3DM.%26aulast%3DShuto%26aufirst%3DS.%26atitle%3DIdentification%2520of%25208-aminoadenosine%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520human%2520concentrative%2520nucleoside%2520transporter%25202%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D244%26epage%3D248%26doi%3D10.1021%2Fml500343r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giltay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Functional expression of human intestinal Na<sup>+</sup>-dependent and Na<sup>+</sup>-independent nucleoside transporters in Xenopus laevis oocytes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span><span class="refDoi"> DOI: 10.1016/S0006-2952(97)00170-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2FS0006-2952%2897%2900170-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=1909-1918&author=G.+Chandrasenaauthor=R.+Giltayauthor=S.+D.+Patilauthor=A.+Bakkenauthor=J.+D.+Unadkat&title=Functional+expression+of+human+intestinal+Na%2B-dependent+and+Na%2B-independent+nucleoside+transporters+in+Xenopus+laevis+oocytes&doi=10.1016%2FS0006-2952%2897%2900170-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900170-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900170-6%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DGiltay%26aufirst%3DR.%26aulast%3DPatil%26aufirst%3DS.%2BD.%26aulast%3DBakken%26aufirst%3DA.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DFunctional%2520expression%2520of%2520human%2520intestinal%2520Na%252B-dependent%2520and%2520Na%252B-independent%2520nucleoside%2520transporters%2520in%2520Xenopus%2520laevis%2520oocytes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D53%26spage%3D1909%26epage%3D1918%26doi%3D10.1016%2FS0006-2952%2897%2900170-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Ngo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Ontogenic and longitudinal activity of Na<sup>+</sup>-nucleoside transporters in the human intestine</span> <span class="citation_source-journal">Am. J. Physiol.: Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">G475</span><span class="NLM_x">–</span> <span class="NLM_lpage">G481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2001&pages=G475-G481&author=L.+Y.+Ngoauthor=S.+D.+Patilauthor=J.+D.+Unadkat&title=Ontogenic+and+longitudinal+activity+of+Na%2B-nucleoside+transporters+in+the+human+intestine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DL.%2BY.%26aulast%3DPatil%26aufirst%3DS.%2BD.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DOntogenic%2520and%2520longitudinal%2520activity%2520of%2520Na%252B-nucleoside%2520transporters%2520in%2520the%2520human%2520intestine%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2001%26volume%3D280%26spage%3DG475%26epage%3DG481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Govindarajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakken, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor-Anglada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">In situ hydridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta</span> <span class="citation_source-journal">Am. J. Physiol. Regul. Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">R1809</span><span class="NLM_x">–</span> <span class="NLM_lpage">R1822</span><span class="refDoi"> DOI: 10.1152/ajpregu.00293.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1152%2Fajpregu.00293.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2007&pages=R1809-R1822&author=R.+Govindarajanauthor=A.+H.+Bakkenauthor=K.+L.+Hudkinsauthor=Y.+Laiauthor=F.+J.+Casadoauthor=M.+Pastor-Angladaauthor=C.-M.+Tseauthor=J.+Hayashiauthor=J.+D.+Unadkat&title=In+situ+hydridization+and+immunolocalization+of+concentrative+and+equilibrative+nucleoside+transporters+in+the+human+intestine%2C+liver%2C+kidneys%2C+and+placenta&doi=10.1152%2Fajpregu.00293.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00293.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00293.2007%26sid%3Dliteratum%253Aachs%26aulast%3DGovindarajan%26aufirst%3DR.%26aulast%3DBakken%26aufirst%3DA.%2BH.%26aulast%3DHudkins%26aufirst%3DK.%2BL.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DCasado%26aufirst%3DF.%2BJ.%26aulast%3DPastor-Anglada%26aufirst%3DM.%26aulast%3DTse%26aufirst%3DC.-M.%26aulast%3DHayashi%26aufirst%3DJ.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DIn%2520situ%2520hydridization%2520and%2520immunolocalization%2520of%2520concentrative%2520and%2520equilibrative%2520nucleoside%2520transporters%2520in%2520the%2520human%2520intestine%252C%2520liver%252C%2520kidneys%252C%2520and%2520placenta%26jtitle%3DAm.%2520J.%2520Physiol.%2520Regul.%2520Integr.%2520Comp.%2520Physiol.%26date%3D2007%26volume%3D293%26spage%3DR1809%26epage%3DR1822%26doi%3D10.1152%2Fajpregu.00293.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit59"><span> <span class="citation_source-book">The Japanese Pharmacopoeia</span>, <span class="NLM_edition">16</span>th ed.; Ministerial Notification No. 65; <span class="NLM_publisher-name">The Ministry of Health, Labour and Welfare</span>, March 24,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>pp 267, 292 (English version on the website <a href="http://jpdb.nihs.go.jp/jp16e/" class="extLink">http://jpdb.nihs.go.jp/jp16e/</a>). “JP2” is a 1:1 mixture of phosphate buffer solution (pH 6.8) and distilled water. The phosphate buffer solution could be prepared by dissolving 3.40 g of potassium dihydrogen phosphate and 3.55 g of disodium hydrogen phosphate in enough water to make 1000 mL.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Japanese+Pharmacopoeia%2C+16th+ed.%3B+Ministerial+Notification+No.+65%3B+The+Ministry+of+Health%2C+Labour+and+Welfare%2C+March+24%2C+2011%2C+pp+267%2C+292+%28English+version+on+the+website+http%3A%2F%2Fjpdb.nihs.go.jp%2Fjp16e%2F%29.+%E2%80%9CJP2%E2%80%9D+is+a+1%3A1+mixture+of+phosphate+buffer+solution+%28pH+6.8%29+and+distilled+water.+The+phosphate+buffer+solution+could+be+prepared+by+dissolving+3.40+g+of+potassium+dihydrogen+phosphate+and+3.55+g+of+disodium+hydrogen+phosphate+in+enough+water+to+make+1000+mL."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DThe%2520Japanese%2520Pharmacopoeia%26pub%3DThe%2520Ministry%2520of%2520Health%252C%2520Labour%2520and%2520Welfare%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Kasuga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonehara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyachi, H.</span><span> </span><span class="NLM_article-title">Improvement of water-solubility of biarylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ-selective partial agonists by disruption of molecular planarity/symmetry</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7164</span><span class="NLM_x">–</span> <span class="NLM_lpage">7173</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.bmc.2010.08.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7164-7173&author=J.+Kasugaauthor=M.+Ishikawaauthor=M.+Yoneharaauthor=M.+Makishimaauthor=Y.+Hashimotoauthor=H.+Miyachi&title=Improvement+of+water-solubility+of+biarylcarboxylic+acid+peroxisome+proliferator-activated+receptor+%28PPAR%29+%CE%B4-selective+partial+agonists+by+disruption+of+molecular+planarity%2Fsymmetry&doi=10.1016%2Fj.bmc.2010.08.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DKasuga%26aufirst%3DJ.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DYonehara%26aufirst%3DM.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DImprovement%2520of%2520water-solubility%2520of%2520biarylcarboxylic%2520acid%2520peroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529%2520%25CE%25B4-selective%2520partial%2520agonists%2520by%2520disruption%2520of%2520molecular%2520planarity%252Fsymmetry%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7164%26epage%3D7173%26doi%3D10.1016%2Fj.bmc.2010.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span><span class="refDoi"> DOI: 10.1021/jm101356p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry&doi=10.1021%2Fjm101356p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0lhI9EynBDxiOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554%26doi%3D10.1021%2Fjm101356p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Ritzel, M. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na<sup>+</sup>/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine</span> <span class="citation_source-journal">Mol. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.3109/09687689709044322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.3109%2F09687689709044322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10087507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK1MXhsl2ksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=203-211&author=M.+W.+L.+Ritzelauthor=S.+Y.+M.+Yaoauthor=A.+M.+L.+Ngauthor=J.+R.+Mackeyauthor=C.+E.+Cassauthor=J.+D.+Young&title=Molecular+cloning%2C+functional+expression+and+chromosomal+localization+of+a+cDNA+encoding+a+human+Na%2B%2Fnucleoside+cotransporter+%28hCNT2%29+selective+for+purine+nucleosides+and+uridine&doi=10.3109%2F09687689709044322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine</span></div><div class="casAuthors">Ritzel, Mabel W. L.; Yao, Sylvia Y. M.; Ng, Amy M. L.; Mackey, John R.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Membrane Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-211</span>CODEN:
                <span class="NLM_cas:coden">MMEBE7</span>;
        ISSN:<span class="NLM_cas:issn">0968-7688</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Two Na+-dependent nucleoside transporters implicated in adenosine and uridine transport in mammalian cells are distinguished functionally on the basis of substrate specificity: CNT1 is selective for pyrimidine nucleosides but also transports adenosine; CNT2 (also termed SPNT) is selective for purine nucleosides but also transports uridine.  Both proteins belong to a gene family that includes the NupC proton/nucleoside symporter of E. coli.  CDNAs encoding members of the CNT family have been isolated from rat tissues (jejunum, brain, liver; rCNT1 and rCNT2/SPNT) and, most recently, human kidney (hCNT1 and hSPNT1).  Here, the mol. cloning and functional characterization of a CNT2/SPNT-type transporter from human small intestine are described.  The encoded 658-residue protein (hCNT2 in the nomenclature) had the same predicted amino acid sequence as human kidney hSPNT1, except for a polymorphism at residue 75 (Arg substituted by Ser), and was 83 and 72% identical to rCNT2 and hCNT1, resp.  Sequence differences between hCNT2 and rCNT2 were greatest at the N-terminus.  In Xenopus oocytes, recombinant hCNT2 exhibited the functional characteristics of a Na+-dependent nucleoside transporter with selectivity for adenosine, other purine nucleosides and uridine (adenosine and uridine Kmapp values 8 and 40 μM, resp.).  HCNT2 transcripts were found in kidney and small intestine but, unlike rCNT2, were not detected in liver.  Deoxyadenosine, which undergoes net renal secretion in humans, was less readily transported than adenosine.  HCNT2 also mediated small, but significant, fluxes of the antiviral purine nucleoside analog 2',3'-dideoxyinosine.  HCNT2 is, therefore potentially involved in both the intestinal absorption and renal handling of purine nucleosides (including adenosine), uridine and purine nucleoside drugs.  The gene encoding hCNT2 was mapped to chromosome 15q15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSi0_9TUksJ7Vg90H21EOLACvtfcHk0lhI9EynBDxiOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsl2ksrk%253D&md5=9babfea6eee96c71978a5b9c542107de</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3109%2F09687689709044322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F09687689709044322%26sid%3Dliteratum%253Aachs%26aulast%3DRitzel%26aufirst%3DM.%2BW.%2BL.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DNg%26aufirst%3DA.%2BM.%2BL.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520cloning%252C%2520functional%2520expression%2520and%2520chromosomal%2520localization%2520of%2520a%2520cDNA%2520encoding%2520a%2520human%2520Na%252B%252Fnucleoside%2520cotransporter%2520%2528hCNT2%2529%2520selective%2520for%2520purine%2520nucleosides%2520and%2520uridine%26jtitle%3DMol.%2520Membr.%2520Biol.%26date%3D1998%26volume%3D15%26spage%3D203%26epage%3D211%26doi%3D10.3109%2F09687689709044322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Ritzel, M. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritzel, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowles, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">Molecular identification and characterization of novel human and mouse concentrative Na<sup>+</sup>-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system <i>cib</i>)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">2914</span><span class="NLM_x">–</span> <span class="NLM_lpage">2927</span><span class="refDoi"> DOI: 10.1074/jbc.M007746200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1074%2Fjbc.M007746200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=11032837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVGjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=2914-2927&author=M.+W.+L.+Ritzelauthor=A.+M.+L.+Ngauthor=S.+Y.+M.+Yaoauthor=K.+Grahamauthor=S.+K.+Loewenauthor=K.+M.+Smithauthor=R.+G.+Ritzelauthor=D.+A.+Mowlesauthor=P.+Carpenterauthor=X.-Z.+Chenauthor=E.+Karpinskiauthor=R.+J.+Hydeauthor=S.+A.+Baldwinauthor=C.+E.+Cassauthor=J.+D.+Young&title=Molecular+identification+and+characterization+of+novel+human+and+mouse+concentrative+Na%2B-nucleoside+cotransporter+proteins+%28hCNT3+and+mCNT3%29+broadly+selective+for+purine+and+pyrimidine+nucleosides+%28system+cib%29&doi=10.1074%2Fjbc.M007746200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)</span></div><div class="casAuthors">Ritzel, Mabel W. L.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Graham, Kathryn; Loewen, Shaun K.; Smith, Kyla M.; Ritzel, R. Gary; Mowles, Delores A.; Carpenter, Pat; Chen, Xing-Zhen; Karpinski, Edward; Hyde, Ralph J.; Baldwin, Stephen A.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2914-2927</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The human concentrative (Na+-linked) plasma membrane transport proteins hCNT1 and hCNT2 are selective for pyrimidine nucleosides (system cit) and purine nucleosides (system cif), resp.  Both have homologs in other mammalian species and belong to a gene family (CNT) that also includes hfCNT, a newly identified broad specificity pyrimidine and purine Na+-nucleoside symporter (system cib) from the ancient marine vertebrate, the Pacific hagfish (Eptatretus stouti).  The authors now report the cDNA cloning and characterization of cib homologs of hfCNT from human mammary gland, differentiated human myeloid HL-60 cells, and mouse liver.  The 691- and 703-residue human and mouse proteins, designated hCNT3 and mCNT3, resp., were 79% identical in amino acid sequence and contained 13 putative transmembrane helixes.  HCNT3 was 48, 47, and 57% identical to hCNT1, hCNT2, and hfCNT, resp.  When produced in Xenopus oocytes, both proteins exhibited Na+-dependent cib-type functional activities.  HCNT3 was electrogenic, and a sigmoidal dependence of uridine influx on Na+ concn. indicated a Na+:uridine coupling ratio of at least 2:1 for both hCNT3 and mCNT3 (cf 1:1 for hCNT1/2).  Phorbol myristate acetate-induced differentiation of HL-60 cells led to the parallel appearance of cib-type activity and hCNT3 mRNA.  Tissues contg. hCNT3 transcripts included pancreas, bone marrow, trachea, mammary gland, liver, prostate, and regions of intestine, brain, and heart.  The hCNT3 gene mapped to chromosome 9q22.2 and included an upstream phorbol myristate acetate response element.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQsjUSC-yYHbVg90H21EOLACvtfcHk0lhI9EynBDxiOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVGjtbg%253D&md5=39ece99c697f93b9c84118f6c1c3d933</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M007746200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M007746200%26sid%3Dliteratum%253Aachs%26aulast%3DRitzel%26aufirst%3DM.%2BW.%2BL.%26aulast%3DNg%26aufirst%3DA.%2BM.%2BL.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DLoewen%26aufirst%3DS.%2BK.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DRitzel%26aufirst%3DR.%2BG.%26aulast%3DMowles%26aufirst%3DD.%2BA.%26aulast%3DCarpenter%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.-Z.%26aulast%3DKarpinski%26aufirst%3DE.%26aulast%3DHyde%26aufirst%3DR.%2BJ.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520identification%2520and%2520characterization%2520of%2520novel%2520human%2520and%2520mouse%2520concentrative%2520Na%252B-nucleoside%2520cotransporter%2520proteins%2520%2528hCNT3%2520and%2520mCNT3%2529%2520broadly%2520selective%2520for%2520purine%2520and%2520pyrimidine%2520nucleosides%2520%2528system%2520cib%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D2914%26epage%3D2927%26doi%3D10.1074%2Fjbc.M007746200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Osada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoriya, K.</span><span> </span><span class="NLM_article-title">Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1016/0014-2999(93)90201-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2F0014-2999%2893%2990201-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=8243554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1993&pages=183-188&author=Y.+Osadaauthor=M.+Tsuchimotoauthor=H.+Fukushimaauthor=K.+Takahashiauthor=S.+Kondoauthor=M.+Hasegawaauthor=K.+Komoriya&title=Hypouricemic+effect+of+the+novel+xanthine+oxidase+inhibitor%2C+TEI-6720%2C+in+rodents&doi=10.1016%2F0014-2999%2893%2990201-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents</span></div><div class="casAuthors">Osada, Yoshio; Tsuchimoto, Masahiro; Fukushima, Hisashi; Takahashi, Katsushi; Kondo, Shiro; Hasegawa, Masaichi; Komoriya, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">183-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The authors studied the xanthine oxidase/xanthine dehydrogenase inhibitory activity and hypouricemic effect of a newly synthesized xanthine oxidase/xanthine dehydrogenase inhibitor, TEI-6720, 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, and compared its effects with those of allopurinol in rodents.  TEI-6720 was found to inhibit bovine milk xanthine oxidase, and mouse liver and rat liver xanthine oxidase/xanthine dehydrogenase with IC50 values of 1.4, 1.8 and 2.2 nM, resp.  On bovine milk xanthine oxidase, TEI-6720 exhibited mixed-type inhibition and the Ki value was 0.7 nM.  TEI-6720 displayed prolonged urate-lowering activity in normal mice and rats.  The authors evaluated the hypouricemic effect of TEI-6720 on hyperuricemia induced by the uricase inhibitor, K oxonate (250 mg/kg s.c., 1 h before the test drugs), and measured the total molarity of both serum allantoin and urate in rats.  Oral TEI-6720 and allopurinol had a hypouricemic effect 2 h after their administration to oxonate-pretreated rats with ED50 values of 1.5 and 5.0 mg/kg, resp.  Both compds. also reduced the combined molarity of uric acid and allantoin in rats.  The ED50 values of TEI-6720 and allopurinol were 2.1 and 6.9 mg/kg p.o., resp.  Thus, TEI-6720 appears to be useful for the treatment of hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX2Q3y8qGVDLVg90H21EOLACvtfcHk0ljqNV_3iX_i7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWitbk%253D&md5=53668fde3cc79e44162913118a737807</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990201-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990201-R%26sid%3Dliteratum%253Aachs%26aulast%3DOsada%26aufirst%3DY.%26aulast%3DTsuchimoto%26aufirst%3DM.%26aulast%3DFukushima%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DKomoriya%26aufirst%3DK.%26atitle%3DHypouricemic%2520effect%2520of%2520the%2520novel%2520xanthine%2520oxidase%2520inhibitor%252C%2520TEI-6720%252C%2520in%2520rodents%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D241%26spage%3D183%26epage%3D188%26doi%3D10.1016%2F0014-2999%2893%2990201-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Lang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span> </span><span class="NLM_article-title">Acquisition of human concentrative nucleoside transporter 2 (hCNT2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1143-1152&author=T.+T.+Langauthor=M.+Selnerauthor=J.+D.+Youngauthor=C.+E.+Cass&title=Acquisition+of+human+concentrative+nucleoside+transporter+2+%28hCNT2%29+activity+by+gene+transfer+confers+sensitivity+to+fluoropyrimidine+nucleosides+in+drug-resistant+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DT.%2BT.%26aulast%3DSelner%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DCass%26aufirst%3DC.%2BE.%26atitle%3DAcquisition%2520of%2520human%2520concentrative%2520nucleoside%2520transporter%25202%2520%2528hCNT2%2529%2520activity%2520by%2520gene%2520transfer%2520confers%2520sensitivity%2520to%2520fluoropyrimidine%2520nucleosides%2520in%2520drug-resistant%2520leukemia%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1143%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Shin, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landowski, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drach, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span> </span><span class="NLM_article-title">Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.1016/S0006-291X(03)01259-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2FS0006-291X%2803%2901259-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=696-703&author=H.-C.+Shinauthor=C.+P.+Landowskiauthor=D.+Sunauthor=B.+S.+Vigauthor=I.+Kimauthor=S.+Mittalauthor=M.+Laneauthor=G.+Rosaniaauthor=J.+C.+Drachauthor=G.+L.+Amidon&title=Functional+expression+and+characterization+of+a+sodium-dependent+nucleoside+transporter+hCNT2+cloned+from+human+duodenum&doi=10.1016%2FS0006-291X%2803%2901259-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901259-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901259-2%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DH.-C.%26aulast%3DLandowski%26aufirst%3DC.%2BP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DVig%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DMittal%26aufirst%3DS.%26aulast%3DLane%26aufirst%3DM.%26aulast%3DRosania%26aufirst%3DG.%26aulast%3DDrach%26aufirst%3DJ.%2BC.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26atitle%3DFunctional%2520expression%2520and%2520characterization%2520of%2520a%2520sodium-dependent%2520nucleoside%2520transporter%2520hCNT2%2520cloned%2520from%2520human%2520duodenum%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D307%26spage%3D696%26epage%3D703%26doi%3D10.1016%2FS0006-291X%2803%2901259-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1124/mol.65.3.558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1124%2Fmol.65.3.558" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=558-570&author=C.+Changauthor=P.+W.+Swaanauthor=L.+Y.+Ngoauthor=P.+Y.+Lumauthor=S.+D.+Patilauthor=J.+D.+Unadkat&title=Molecular+requirements+of+the+human+nucleoside+transporters+hCNT1%2C+hCNT2%2C+and+hENT1&doi=10.1124%2Fmol.65.3.558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.3.558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.3.558%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DNgo%26aufirst%3DL.%2BY.%26aulast%3DLum%26aufirst%3DP.%2BY.%26aulast%3DPatil%26aufirst%3DS.%2BD.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520requirements%2520of%2520the%2520human%2520nucleoside%2520transporters%2520hCNT1%252C%2520hCNT2%252C%2520and%2520hENT1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D558%26epage%3D570%26doi%3D10.1124%2Fmol.65.3.558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="note"><p class="first last">Preliminary studies have suggested the following characteristics of compound <b>22</b>: (a) Compound <b>22</b> is a highly selective inhibitor of hCNT2 rather than hCNT1. (b) Compound <b>22</b> is not a substrate for hCNT2. (c) Compound <b>22</b> is a competitive inhibitor of hCNT2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Halbfinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span> </span><span class="NLM_article-title">Molecular recognition of modified adenine nucleotides by the P2Y<sub>1</sub>-receptor. 1. A synthetic, biochemical, and NMR approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5325</span><span class="NLM_x">–</span> <span class="NLM_lpage">5337</span><span class="refDoi"> DOI: 10.1021/jm990156d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990156d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5325-5337&author=E.+Halbfingerauthor=D.+T.+Majorauthor=M.+Ritzmannauthor=J.+Ublauthor=G.+Reiserauthor=J.+L.+Boyerauthor=K.+T.+Hardenauthor=B.+Fischer&title=Molecular+recognition+of+modified+adenine+nucleotides+by+the+P2Y1-receptor.+1.+A+synthetic%2C+biochemical%2C+and+NMR+approach&doi=10.1021%2Fjm990156d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm990156d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990156d%26sid%3Dliteratum%253Aachs%26aulast%3DHalbfinger%26aufirst%3DE.%26aulast%3DMajor%26aufirst%3DD.%2BT.%26aulast%3DRitzmann%26aufirst%3DM.%26aulast%3DUbl%26aufirst%3DJ.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DHarden%26aufirst%3DK.%2BT.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DMolecular%2520recognition%2520of%2520modified%2520adenine%2520nucleotides%2520by%2520the%2520P2Y1-receptor.%25201.%2520A%2520synthetic%252C%2520biochemical%252C%2520and%2520NMR%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5325%26epage%3D5337%26doi%3D10.1021%2Fjm990156d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Gottlieb, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span><span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lh1niy-qhx8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Schaner, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, K. M.</span><span> </span><span class="NLM_article-title">Functional characterization of a human purine-selective, Na<sup>+</sup>-dependent nucleoside transporter (hSPNT1) in a mammalian expression system</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1487</span><span class="NLM_x">–</span> <span class="NLM_lpage">1491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10336543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1487-1491&author=M.+E.+Schanerauthor=J.+Wangauthor=L.+Zhangauthor=S.-F.+Suauthor=K.+M.+Gerstinauthor=K.+M.+Giacomini&title=Functional+characterization+of+a+human+purine-selective%2C+Na%2B-dependent+nucleoside+transporter+%28hSPNT1%29+in+a+mammalian+expression+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system</span></div><div class="casAuthors">Schaner, Marci E.; Wang, Juan; Zhang, Lei; Su, Sheng-Fang; Gerstin, Karin M.; Giacomini, Kathleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1487-1491</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nucleosides and nucleoside analogs are actively transported in the human kidney.  With the recent cloning of a purine-selective, Na+-dependent, nucleoside transporter (hSPNT1, also termed hCNT2) from human kidney, it is now possible to study the interaction of nucleosides and nucleoside analogs with this transport protein and gain a more detailed knowledge of the underlying mechanisms of nucleoside transport in the human kidney.  In this study we examd. the substrate selectivity of hSPNT1 for nucleosides and nucleoside analogs.  We detd. that the naturally occurring nucleosides adenosine, inosine, and uridine are substrates for this carrier, whereas thymidine is not.  The nucleoside analogs (0.5 mM) 2',3'-dideoxyadenosine; 2',3'-dideoxyinosine; and 2-chloro-2'-deoxyadenosine (2CdA), significantly inhibited the uptake of [3H]inosine in HeLa cells transiently transfected with hSPNT1.  However, there was no significant Na+-dependent uptake of [3H]2',3'-dideoxyinosine or [3H]2CdA in the transfected cells, suggesting that these nucleoside analogs are not permeants of hSPNT1.  Interestingly, 2CdA was considerably less potent in inhibiting [3H]inosine uptake in HeLa cells expressing hSPNT1 than in cells expressing the rat homolog rSPNT (IC50 = 371 μM vs. 13.8 μM), suggesting that there may be notable species differences in the kinetic interactions of some nucleoside analogs with purine-selective nucleoside transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraE4hTuLH30rVg90H21EOLACvtfcHk0lh1niy-qhx8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGnsbo%253D&md5=d6522563b973d6300f20b3e0ec1925e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchaner%26aufirst%3DM.%2BE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DS.-F.%26aulast%3DGerstin%26aufirst%3DK.%2BM.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DFunctional%2520characterization%2520of%2520a%2520human%2520purine-selective%252C%2520Na%252B-dependent%2520nucleoside%2520transporter%2520%2528hSPNT1%2529%2520in%2520a%2520mammalian%2520expression%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D1487%26epage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':[],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Christine R. Cuthbertson, Hui Guo, Armita Kyani, Joseph T. Madak, Zahra Arabzada, <span class="NLM_string-name hlFld-ContribAuthor">Nouri Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (6)
                                     , 1242-1252. <a href="https://doi.org/10.1021/acsptsci.0c00124" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00124%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DThe%252BDihydroorotate%252BDehydrogenase%252BInhibitor%252BBrequinar%252BIs%252BSynergistic%252Bwith%252BENT1%25252F2%252BInhibitors%26aulast%3DCuthbertson%26aufirst%3DChristine%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30082020%26date%3D23112020%26volume%3D3%26issue%3D6%26spage%3D1242%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devulapally  Mahesh</span>, <span class="hlFld-ContribAuthor ">Vanaparthi  Satheesh</span>, <span class="hlFld-ContribAuthor ">Sundaravel Vivek  Kumar</span>, and <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper(II)-Catalyzed Oxidative Coupling of Anilines, Methyl Arenes, and TMSN3 via C(sp3/sp2)–H Functionalization and C–N Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (24)
                                     , 6554-6557. <a href="https://doi.org/10.1021/acs.orglett.7b03264" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03264%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper%252528II%252529-Catalyzed%252BOxidative%252BCoupling%252Bof%252BAnilines%25252C%252BMethyl%252BArenes%25252C%252Band%252BTMSN3%252Bvia%252BC%252528sp3%25252Fsp2%252529%2525E2%252580%252593H%252BFunctionalization%252Band%252BC%2525E2%252580%252593N%252BBond%252BFormation%26aulast%3DMahesh%26aufirst%3DDevulapally%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19102017%26date%3D22112017%26date%3D15122017%26volume%3D19%26issue%3D24%26spage%3D6554%26epage%3D6557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Guo</span>, <span class="hlFld-ContribAuthor ">Tingting  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingyue  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Sun</span>, <span class="hlFld-ContribAuthor ">Junye  Zhang</span>, <span class="hlFld-ContribAuthor ">Meng  Yang</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Ning  Wu</span>, <span class="hlFld-ContribAuthor ">Wu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical behavior of MOF-801/MWCNT-COOH/AuNPs: A highly selective electrochemical sensor for determination of guanine and adenine. </span><span class="cited-content_cbyCitation_journal-name">Colloids and Surfaces A: Physicochemical and Engineering Aspects</span><span> <strong>2021,</strong> <em>627 </em>, 127195. <a href="https://doi.org/10.1016/j.colsurfa.2021.127195" title="DOI URL">https://doi.org/10.1016/j.colsurfa.2021.127195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.colsurfa.2021.127195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.colsurfa.2021.127195%26sid%3Dliteratum%253Aachs%26jtitle%3DColloids%2520and%2520Surfaces%2520A%253A%2520Physicochemical%2520and%2520Engineering%2520Aspects%26atitle%3DElectrochemical%252Bbehavior%252Bof%252BMOF-801%25252FMWCNT-COOH%25252FAuNPs%25253A%252BA%252Bhighly%252Bselective%252Belectrochemical%252Bsensor%252Bfor%252Bdetermination%252Bof%252Bguanine%252Band%252Badenine%26aulast%3DGuo%26aufirst%3DHao%26date%3D2021%26volume%3D627%26spage%3D127195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemical Studies Based on the Theoretical Design of Bioactive Compounds. </span><span class="cited-content_cbyCitation_journal-name">YAKUGAKU ZASSHI</span><span> <strong>2020,</strong> <em>140 </em>
                                    (3)
                                     , 329-344. <a href="https://doi.org/10.1248/yakushi.19-00208" title="DOI URL">https://doi.org/10.1248/yakushi.19-00208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/yakushi.19-00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fyakushi.19-00208%26sid%3Dliteratum%253Aachs%26jtitle%3DYAKUGAKU%2520ZASSHI%26atitle%3DMedicinal%252BChemical%252BStudies%252BBased%252Bon%252Bthe%252BTheoretical%252BDesign%252Bof%252BBioactive%252BCompounds%26aulast%3DShuto%26aufirst%3DSatoshi%26date%3D2020%26volume%3D140%26issue%3D3%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaowei  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Li</span>, <span class="hlFld-ContribAuthor ">Can  Wang</span>, <span class="hlFld-ContribAuthor ">Xinde  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Cheng</span>, <span class="hlFld-ContribAuthor ">Changgui  Li</span>, <span class="hlFld-ContribAuthor ">Yongyong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Common variants in the SLC28A2 gene are associated with serum uric acid level and hyperuricemia and gout in Han Chinese. </span><span class="cited-content_cbyCitation_journal-name">Hereditas</span><span> <strong>2019,</strong> <em>156 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41065-018-0078-0" title="DOI URL">https://doi.org/10.1186/s41065-018-0078-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41065-018-0078-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41065-018-0078-0%26sid%3Dliteratum%253Aachs%26jtitle%3DHereditas%26atitle%3DCommon%252Bvariants%252Bin%252Bthe%252BSLC28A2%252Bgene%252Bare%252Bassociated%252Bwith%252Bserum%252Buric%252Bacid%252Blevel%252Band%252Bhyperuricemia%252Band%252Bgout%252Bin%252BHan%252BChinese%26aulast%3DZhou%26aufirst%3DZhaowei%26date%3D2019%26date%3D2019%26volume%3D156%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Britt  Paulsen</span>, <span class="hlFld-ContribAuthor ">Kim Alex  Fredriksen</span>, <span class="hlFld-ContribAuthor ">Dirk  Petersen</span>, <span class="hlFld-ContribAuthor ">Louis  Maes</span>, <span class="hlFld-ContribAuthor ">An  Matheeussen</span>, <span class="hlFld-ContribAuthor ">Ali-Oddin  Naemi</span>, <span class="hlFld-ContribAuthor ">Anne Aamdal  Scheie</span>, <span class="hlFld-ContribAuthor ">Roger  Simm</span>, <span class="hlFld-ContribAuthor ">Rui  Ma</span>, <span class="hlFld-ContribAuthor ">Baojie  Wan</span>, <span class="hlFld-ContribAuthor ">Scott  Franzblau</span>, <span class="hlFld-ContribAuthor ">Lise-Lotte  Gundersen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (4)
                                     , 620-629. <a href="https://doi.org/10.1016/j.bmc.2019.01.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantimicrobial%252Bactivities%252Bof%252BN6-hydroxyagelasine%252Banalogs%252Band%252Brevision%252Bof%252Bthe%252Bstructure%252Bof%252Bageloximes%26aulast%3DPaulsen%26aufirst%3DBritt%26date%3D2019%26volume%3D27%26issue%3D4%26spage%3D620%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonard  Barasa</span>, <span class="hlFld-ContribAuthor ">Sabesan  Yoganathan</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient one-pot conversion of carboxylic acids into benzimidazoles
              via
              an HBTU-promoted methodology. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (62)
                                     , 35824-35830. <a href="https://doi.org/10.1039/C8RA07773H" title="DOI URL">https://doi.org/10.1039/C8RA07773H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA07773H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA07773H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAn%252Befficient%252Bone-pot%252Bconversion%252Bof%252Bcarboxylic%252Bacids%252Binto%252Bbenzimidazoles%252Bvia%252Ban%252BHBTU-promoted%252Bmethodology%26aulast%3DBarasa%26aufirst%3DLeonard%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D62%26spage%3D35824%26epage%3D35830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan-Zhu  Li</span>, <span class="hlFld-ContribAuthor ">Guo-Xiu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Bao-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Wen  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Compounds containing trace element copper or zinc exhibit as potent hyperuricemia inhibitors via xanthine oxidase inactivation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Trace Elements in Medicine and Biology</span><span> <strong>2018,</strong> <em>49 </em>, 72-78. <a href="https://doi.org/10.1016/j.jtemb.2018.04.019" title="DOI URL">https://doi.org/10.1016/j.jtemb.2018.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtemb.2018.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtemb.2018.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Trace%2520Elements%2520in%2520Medicine%2520and%2520Biology%26atitle%3DCompounds%252Bcontaining%252Btrace%252Belement%252Bcopper%252Bor%252Bzinc%252Bexhibit%252Bas%252Bpotent%252Bhyperuricemia%252Binhibitors%252Bvia%252Bxanthine%252Boxidase%252Binactivation%26aulast%3DLi%26aufirst%3DLan-Zhu%26date%3D2018%26volume%3D49%26spage%3D72%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianqiao  Yong</span>, <span class="hlFld-ContribAuthor ">Shaodan  Chen</span>, <span class="hlFld-ContribAuthor ">Yizhen  Xie</span>, <span class="hlFld-ContribAuthor ">Diling  Chen</span>, <span class="hlFld-ContribAuthor ">Jiyan  Su</span>, <span class="hlFld-ContribAuthor ">Ou  Shuai</span>, <span class="hlFld-ContribAuthor ">Chunwei  Jiao</span>, <span class="hlFld-ContribAuthor ">Dan  Zuo</span>. </span><span class="cited-content_cbyCitation_article-title">Cordycepin, a Characteristic Bioactive Constituent in Cordyceps militaris, Ameliorates Hyperuricemia through URAT1 in Hyperuricemic Mice. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fmicb.2018.00058" title="DOI URL">https://doi.org/10.3389/fmicb.2018.00058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2018.00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2018.00058%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DCordycepin%25252C%252Ba%252BCharacteristic%252BBioactive%252BConstituent%252Bin%252BCordyceps%252Bmilitaris%25252C%252BAmeliorates%252BHyperuricemia%252Bthrough%252BURAT1%252Bin%252BHyperuricemic%252BMice%26aulast%3DYong%26aufirst%3DTianqiao%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianqiao  Yong</span>, <span class="hlFld-ContribAuthor ">Shaodan  Chen</span>, <span class="hlFld-ContribAuthor ">Yizhen  Xie</span>, <span class="hlFld-ContribAuthor ">Diling  Chen</span>, <span class="hlFld-ContribAuthor ">Jiyan  Su</span>, <span class="hlFld-ContribAuthor ">Ou  Shuai</span>, <span class="hlFld-ContribAuthor ">Huiping  Hu</span>, <span class="hlFld-ContribAuthor ">Dan  Zuo</span>, <span class="hlFld-ContribAuthor ">Danling  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Hypouricemic Effects of
              Armillaria mellea
              on Hyperuricemic Mice Regulated through OAT1 and CNT2. </span><span class="cited-content_cbyCitation_journal-name">The American Journal of Chinese Medicine</span><span> <strong>2018,</strong> <em>46 </em>
                                    (03)
                                     , 585-599. <a href="https://doi.org/10.1142/S0192415X18500301" title="DOI URL">https://doi.org/10.1142/S0192415X18500301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1142/S0192415X18500301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1142%2FS0192415X18500301%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520American%2520Journal%2520of%2520Chinese%2520Medicine%26atitle%3DHypouricemic%252BEffects%252Bof%252BArmillaria%252Bmellea%252Bon%252BHyperuricemic%252BMice%252BRegulated%252Bthrough%252BOAT1%252Band%252BCNT2%26aulast%3DYong%26aufirst%3DTianqiao%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D03%26spage%3D585%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">M.A.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Syed Hassan  Mehdi</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 705-753. <a href="https://doi.org/10.1016/j.ejmech.2016.12.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bevolution%252Bof%252Bbenzimidazole%252Bderivatives%252Bin%252Bthe%252Blast%252Bquinquennial%252Bperiod%26aulast%3DAkhtar%26aufirst%3DWasim%26date%3D2017%26volume%3D126%26spage%3D705%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuichi  Yoshimura</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Glycosylation Reaction: A Key to Accessing Structurally Unique Nucleosides. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2017,</strong> <em>94 </em>
                                    (9)
                                     , 1625. <a href="https://doi.org/10.3987/REV-17-865" title="DOI URL">https://doi.org/10.3987/REV-17-865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/REV-17-865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FREV-17-865%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DDevelopment%252Bof%252Ba%252BGlycosylation%252BReaction%25253A%252BA%252BKey%252Bto%252BAccessing%252BStructurally%252BUnique%252BNucleosides%26aulast%3DYoshimura%26aufirst%3DYuichi%26date%3D2017%26volume%3D94%26issue%3D9%26spage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. A potent hCNT2 inhibitor discovered in our previous study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Simulation of substituent effects on the biphenyl structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>19</b> on the elevation of plasma uric acid levels derived from orally administered purine mixture (an equal mixture of adenosine, guanosine, and inosine, 50 mg/kg) in rats. Data are expressed as the mean ± SEM (<i>n</i> = 5): (##) <i>p</i> < 0.01 versus a group treated with only potassium oxonate (100 mg/kg); NS, not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>22</b> on the elevation of plasma uric acid levels derived from orally administered purine mixture (50 mg/kg) in rats. Data are expressed as the mean ± SEM (<i>n</i> = 5–11): (###) <i>p</i> < 0.001 versus a group treated with only potassium oxonate (100 mg/kg); (∗∗∗) <i>p</i> < 0.001 versus a group treated with potassium oxonate and purine mixture.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LiAlH<sub>4</sub>, THF, 60 °C; (b) 8-bromoadenosine, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (c) 3-bromopyridine or 4-bromopyridine hydrochloride, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2.0 M aq Na<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C; (d) CF<sub>3</sub>CO<sub>2</sub>Et, EtOH, rt; (e) 2.0 M aq NaOH, EtOH, 60 °C.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tf<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (b) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DMF, 80 °C; (c) LiAlH<sub>4</sub>, THF, 60 °C; (d) 8-bromoadenosine, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>5</b>, <b>7</b>–<b>9</b>, and <b>15</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BBr<sub>3</sub> (1.0 M in DCM), DCM, 30 °C; (b) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (c) LiAlH<sub>4</sub>, THF, 60 °C; (d) 8-bromo-2′,3′,5′-tris-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)adenosine,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(67)</a><i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (e) H<sub>2</sub>, 10% Pd–C, AcOEt, rt; (f) NH<sub>4</sub>F, MeOH, reflux; (g) R<sub>6</sub>I or R<sub>6</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 35–50 °C; (h) NH<sub>3</sub> (2.0 M in MeOH), rt; (i) NaBH<sub>4</sub>, EtOH, rt.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>18</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>7</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C; (b) LiAlH<sub>4</sub>, THF, 60 °C; (c) 8-bromoadenosine, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (d) H<sub>2</sub>, 10% Pd–C, MeOH, 50 °C.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>10</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (b) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DMF, 80 °C; (c) LiAlH<sub>4</sub>, THF, 60 °C; (d) 8-bromo-2′,3′,5′-tris-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)adenosine,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(67)</a><i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (e) H<sub>2</sub>, 10% Pd–C, AcOEt, rt; (f) NH<sub>4</sub>F, MeOH, reflux; (g) R<sub>9</sub>I, K<sub>2</sub>CO<sub>3</sub>, DMF, rt to 50 °C.</p></p></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaNO<sub>2</sub>, 75% (v/v) aq AcOH, rt; (b) H<sub>2</sub>, 10% Pd–C, MeOH, 50 °C.</p></p></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/medium/jm-2015-01884q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01884/20160422/images/large/jm-2015-01884q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01884&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide, MeCN, 80 °C, then TMSOTf, 1,2,3,4-tetra-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-ribofuranose, rt; (b) <i>t</i>-BuOK, MeOH, rt; (c) <b>47</b>, <i>i</i>-Pr<sub>2</sub>NEt, EtOH, 120 °C, in a screw tube; (d) H<sub>2</sub>, 10% Pd–C, MeOH, 50 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 69 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span> </span><span class="NLM_article-title">Urate oxidase: Primary structure and evolutionary implications</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9412</span><span class="NLM_x">–</span> <span class="NLM_lpage">9416</span><span class="refDoi"> DOI: 10.1073/pnas.86.23.9412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1073%2Fpnas.86.23.9412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9412-9416&author=X.+Wuauthor=C.+C.+Leeauthor=D.+M.+Muznyauthor=C.+T.+Caskey&title=Urate+oxidase%3A+Primary+structure+and+evolutionary+implications&doi=10.1073%2Fpnas.86.23.9412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.86.23.9412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.86.23.9412%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26atitle%3DUrate%2520oxidase%253A%2520Primary%2520structure%2520and%2520evolutionary%2520implications%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1989%26volume%3D86%26spage%3D9412%26epage%3D9416%26doi%3D10.1073%2Fpnas.86.23.9412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span> </span><span class="NLM_article-title">Two independent mutational events in the loss of urate oxidase during hominoid evolution</span> <span class="citation_source-journal">J. Mol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1007/BF00163854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2FBF00163854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1992&pages=78-84&author=X.+Wuauthor=D.+M.+Muznyauthor=C.+C.+Leeauthor=C.+T.+Caskey&title=Two+independent+mutational+events+in+the+loss+of+urate+oxidase+during+hominoid+evolution&doi=10.1007%2FBF00163854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF00163854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00163854%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26atitle%3DTwo%2520independent%2520mutational%2520events%2520in%2520the%2520loss%2520of%2520urate%2520oxidase%2520during%2520hominoid%2520evolution%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D1992%26volume%3D34%26spage%3D78%26epage%3D84%26doi%3D10.1007%2FBF00163854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Richette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardin, T.</span><span> </span><span class="NLM_article-title">Gout</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/S0140-6736(09)60883-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2FS0140-6736%2809%2960883-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=19692116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=318-328&author=P.+Richetteauthor=T.+Bardin&title=Gout&doi=10.1016%2FS0140-6736%2809%2960883-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Gout</span></div><div class="casAuthors">Richette, Pascal; Bardin, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">9711</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Gout is a common arthritis caused by deposition of monosodium urate crystals within joints after chronic hyperuricemia.  It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men.  Epidemiol. data are consistent with a rise in prevalence of gout.  Diet and genetic polymorphisms of renal transporters of urate seem to be the main causal factors of primary gout.  Gout and hyperuricemia are assocd. with hypertension, diabetes mellitus, metabolic syndrome, and renal and cardiovascular diseases.  Non-steroidal anti-inflammatory drugs and colchicine remain the most widely recommended drugs to treat acute attacks.  Oral corticosteroids could be an alternative to these drugs.  Interleukin 1β is a pivotal mediator of acute gout and could become a therapeutic target.  When serum uric acid concns. are lowered below monosodium urate satn. point, the crystals dissolve and gout can be cured.  Patient education, appropriate lifestyle advice, and treatment of comorbidities are an important part of management of patients with gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoauG4iOInjKLVg90H21EOLACvtfcHk0li8tw8i_YR1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSktg%253D%253D&md5=61694a6c4492214f16781a881c2a67bc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2960883-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252960883-7%26sid%3Dliteratum%253Aachs%26aulast%3DRichette%26aufirst%3DP.%26aulast%3DBardin%26aufirst%3DT.%26atitle%3DGout%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D318%26epage%3D328%26doi%3D10.1016%2FS0140-6736%2809%2960883-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lehejčková, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demnerová, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Králová, B.</span><span> </span><span class="NLM_article-title">Screening of microorganisms with uricase activity</span> <span class="citation_source-journal">Biotechnol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1007/BF01040862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2FBF01040862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1986&pages=341-342&author=R.+Lehej%C4%8Dkov%C3%A1author=K.+Demnerov%C3%A1author=B.+Kr%C3%A1lov%C3%A1&title=Screening+of+microorganisms+with+uricase+activity&doi=10.1007%2FBF01040862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF01040862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01040862%26sid%3Dliteratum%253Aachs%26aulast%3DLehej%25C4%258Dkov%25C3%25A1%26aufirst%3DR.%26aulast%3DDemnerov%25C3%25A1%26aufirst%3DK.%26aulast%3DKr%25C3%25A1lov%25C3%25A1%26aufirst%3DB.%26atitle%3DScreening%2520of%2520microorganisms%2520with%2520uricase%2520activity%26jtitle%3DBiotechnol.%2520Lett.%26date%3D1986%26volume%3D8%26spage%3D341%26epage%3D342%26doi%3D10.1007%2FBF01040862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Shaaban, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelmegeed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, Y. M.</span><span> </span><span class="NLM_article-title">Cloning, expression, and purification of recombinant uricase enzyme from <i>Pseudomonas aeruginosa</i> Ps43 using <i>Escherichia coli</i></span> <span class="citation_source-journal">J. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span><span class="refDoi"> DOI: 10.4014/jmb.1410.10041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.4014%2Fjmb.1410.10041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=25588559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CmtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=887-892&author=M.+I.+Shaabanauthor=E.+Abdelmegeedauthor=Y.+M.+Ali&title=Cloning%2C+expression%2C+and+purification+of+recombinant+uricase+enzyme+from+Pseudomonas+aeruginosa+Ps43+using+Escherichia+coli&doi=10.4014%2Fjmb.1410.10041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression, and purification of recombinant uricase enzyme from Pseudomonas aeruginosa Ps43 using Escherichia coli</span></div><div class="casAuthors">Shaaban, Mona I.; Abdelmegeed, Eman; Ali, Youssif M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-892</span>CODEN:
                <span class="NLM_cas:coden">JOMBES</span>;
        ISSN:<span class="NLM_cas:issn">1017-7825</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Microbiology and Biotechnology</span>)
        </div><div class="casAbstract">Uricase is an important microbial enzyme that can be used in the clin. treatment of gout, hyperuricemia, and tumor lysis syndrome.  A total of 127 clin. isolates of Pseudomonas aeruginosa were tested for uricase prodn.  A Pseudomonas strain named Ps43 showed the highest level of native uricase enzyme expression.  The open reading frame of the uricase enzyme was amplified from Ps43 and cloned into the expression vector pRSET-B.  Uricase was expressed using E. coli BL21 (DE3).  The ORF was sequenced and assigned GenBank Accession No. KJ718888.  The nucleotide sequence anal. was identical to the coding sequence of uricase gene puuD of P. aeruginosa PAO1.  The authors report the successful expression of P. aeruginosa uricase in Escherichia coli.  E. coli showed an induced protein with a mol. mass of ∼58 kDa that was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting.  The authors also established efficient protein purifn. using the Ni-Sepharose column with activity of the purified enzyme of 2.16 1U and a 2-fold increase in the specific activity of the pure enzyme compared with the crude enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPnOQJuE-AC7Vg90H21EOLACvtfcHk0li8tw8i_YR1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CmtLjP&md5=6e5bb815c5fc93caa7432452cab7bf89</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4014%2Fjmb.1410.10041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4014%252Fjmb.1410.10041%26sid%3Dliteratum%253Aachs%26aulast%3DShaaban%26aufirst%3DM.%2BI.%26aulast%3DAbdelmegeed%26aufirst%3DE.%26aulast%3DAli%26aufirst%3DY.%2BM.%26atitle%3DCloning%252C%2520expression%252C%2520and%2520purification%2520of%2520recombinant%2520uricase%2520enzyme%2520from%2520Pseudomonas%2520aeruginosa%2520Ps43%2520using%2520Escherichia%2520coli%26jtitle%3DJ.%2520Microbiol.%2520Biotechnol.%26date%3D2015%26volume%3D25%26spage%3D887%26epage%3D892%26doi%3D10.4014%2Fjmb.1410.10041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nanda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeesh Babu, P. E.</span><span> </span><span class="NLM_article-title">Isolation, screening and production studies of uricase producing bacteria from poultry sources</span> <span class="citation_source-journal">Prep. Biochem. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1080/10826068.2013.867875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1080%2F10826068.2013.867875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24279683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=811-821&author=P.+Nandaauthor=P.+E.+Jagadeesh+Babu&title=Isolation%2C+screening+and+production+studies+of+uricase+producing+bacteria+from+poultry+sources&doi=10.1080%2F10826068.2013.867875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">ISOLATION, SCREENING AND PRODUCTION STUDIES OF URICASE PRODUCING BACTERIA FROM POULTRY SOURCES</span></div><div class="casAuthors">Nanda, Pooja; Jagadeesh Babu, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Preparative Biochemistry & Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">811-821</span>CODEN:
                <span class="NLM_cas:coden">PBBIF4</span>;
        ISSN:<span class="NLM_cas:issn">1082-6068</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Uricase (urate oxidase EC 1.7.3.3) is a therapeutic enzyme that is widely used to catalyze the enzymic oxidn. of uric acid in the treatment of hyperuricemia and gout diseases.  In this study, three bacterial species capable of producing extracellular uricase were isolated from a poultry source and screened based on the size of the clear zone using a uric acid agar plate.  The bacterial species capable of producing uricase with the highest uricolytic activity was identified as Bacillus cereus strain DL3 using a 16SrRNA gene sequencing approach.  The time-course study of uricase prodn. was performed and the medium was optimized.  CM-cellulose and asparagine were the best carbon and nitrogen sources.  Maximum uricolytic activity was obsd. at pH 7.0 with an inducer concn. of 2.0 g/L.  Inoculum size of 5% gave max. uricolytic activity.  The max. uricolytic activity of 15.43 U/mL was achieved at optimized conditions, which is 1.61 times more than the initial activity.  Further, enzymic stability was detd. at different pH and temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFU-9UlEvlfLVg90H21EOLACvtfcHk0ljqRRU5LHRsMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgsbrM&md5=1b00e42726be4b5f887b2de6e6fb5b2c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F10826068.2013.867875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10826068.2013.867875%26sid%3Dliteratum%253Aachs%26aulast%3DNanda%26aufirst%3DP.%26aulast%3DJagadeesh%2BBabu%26aufirst%3DP.%2BE.%26atitle%3DIsolation%252C%2520screening%2520and%2520production%2520studies%2520of%2520uricase%2520producing%2520bacteria%2520from%2520poultry%2520sources%26jtitle%3DPrep.%2520Biochem.%2520Biotechnol.%26date%3D2014%26volume%3D44%26spage%3D811%26epage%3D821%26doi%3D10.1080%2F10826068.2013.867875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chang, B. S. W.</span><span> </span><span class="NLM_article-title">Ancient insights into uric acid metabolism in primates</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">3657</span><span class="NLM_x">–</span> <span class="NLM_lpage">3658</span><span class="refDoi"> DOI: 10.1073/pnas.1401037111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1073%2Fpnas.1401037111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=3657-3658&author=B.+S.+W.+Chang&title=Ancient+insights+into+uric+acid+metabolism+in+primates&doi=10.1073%2Fpnas.1401037111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1401037111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1401037111%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DB.%2BS.%2BW.%26atitle%3DAncient%2520insights%2520into%2520uric%2520acid%2520metabolism%2520in%2520primates%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D3657%26epage%3D3658%26doi%3D10.1073%2Fpnas.1401037111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Álvarez-Lario, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macarrón-Vicente, J.</span><span> </span><span class="NLM_article-title">Uric acid and evolution</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2010</span><span class="NLM_x">–</span> <span class="NLM_lpage">2015</span><span class="refDoi"> DOI: 10.1093/rheumatology/keq204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1093%2Frheumatology%2Fkeq204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=2010-2015&author=B.+%C3%81lvarez-Larioauthor=J.+Macarr%C3%B3n-Vicente&title=Uric+acid+and+evolution&doi=10.1093%2Frheumatology%2Fkeq204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeq204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeq204%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2581lvarez-Lario%26aufirst%3DB.%26aulast%3DMacarr%25C3%25B3n-Vicente%26aufirst%3DJ.%26atitle%3DUric%2520acid%2520and%2520evolution%26jtitle%3DRheumatology%26date%3D2010%26volume%3D49%26spage%3D2010%26epage%3D2015%26doi%3D10.1093%2Frheumatology%2Fkeq204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mount, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reginato, A. M.</span><span> </span><span class="NLM_article-title">Pathogenesis of gout</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.7326/0003-4819-143-7-200510040-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.7326%2F0003-4819-143-7-200510040-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16204163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2005&pages=499-516&author=H.+K.+Choiauthor=D.+B.+Mountauthor=A.+M.+Reginato&title=Pathogenesis+of+gout&doi=10.7326%2F0003-4819-143-7-200510040-00009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of gout</span></div><div class="casAuthors">Choi, Hyon K.; Mount, David B.; Reginato, Anthony M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-516</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians</span>)
        </div><div class="casAbstract">A review.  Gout is a type of inflammatory arthritis that is triggered by the crystn. of uric acid within the joints and is often assocd. with hyperuricemia.  Researchers have recently made great advances in defining the pathogenesis of gout, including elucidating its risk factors and tracing the mol. mechanisms of renal urate transport and crystal-induced inflammation.  Key aspects of the pathogenesis of gout are reviewed with a focus on the recent advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKRcGVzwvIjrVg90H21EOLACvtfcHk0ljqRRU5LHRsMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKmsrrN&md5=fe9ddad02c650ee8ebd76029c56bc793</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-143-7-200510040-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-143-7-200510040-00009%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DMount%26aufirst%3DD.%2BB.%26aulast%3DReginato%26aufirst%3DA.%2BM.%26atitle%3DPathogenesis%2520of%2520gout%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2005%26volume%3D143%26spage%3D499%26epage%3D516%26doi%3D10.7326%2F0003-4819-143-7-200510040-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Liebman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushinsky, D. A.</span><span> </span><span class="NLM_article-title">Uric acid nephrolithiasis</span> <span class="citation_source-journal">Curr. Rheumatol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1007/s11926-007-0040-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11926-007-0040-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17531180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVentbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=251-257&author=S.+E.+Liebmanauthor=J.+G.+Taylorauthor=D.+A.+Bushinsky&title=Uric+acid+nephrolithiasis&doi=10.1007%2Fs11926-007-0040-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Uric acid nephrolithiasis</span></div><div class="casAuthors">Liebman, Scott E.; Taylor, Jeremy G.; Bushinsky, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Rheumatology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-257</span>CODEN:
                <span class="NLM_cas:coden">CRRUCI</span>;
        ISSN:<span class="NLM_cas:issn">1523-3774</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Uric acid nephrolithiasis is typically found in individuals with a low urine pH and a normal concn. of urinary uric acid.  Patients with a history of gout are at greater risk of forming uric acid stones, as are patients with obesity, diabetes, or the complete metabolic syndrome.  The unifying renal tubular abnormality of these disorders appears to be the excretion of abnormally acidic urine.  This article focuses on the relationship of these disorders to the development of uric acid stones.  The diagnosis of uric acid stones can be elusive, because pure uric acid stones are radiolucent on plain radiographs.  Ultrasound, or preferably noncontrast helical CT scanning, is required for their detection.  The treatment of uric acid stones should focus on alkalinization of the urine with citrate or bicarbonate salts.  Addnl. interventions such as increase in fluid intake and decrease in animal protein ingestion are often beneficial.  Patients with documented hyperuricemia often require specific therapy to lower serum uric acid concn. and subsequent excretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk4IAECj4IV7Vg90H21EOLACvtfcHk0ljqRRU5LHRsMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVentbnK&md5=f00bc0f4e3bffd0e92a1d2f8dac23c4a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs11926-007-0040-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-007-0040-z%26sid%3Dliteratum%253Aachs%26aulast%3DLiebman%26aufirst%3DS.%2BE.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DBushinsky%26aufirst%3DD.%2BA.%26atitle%3DUric%2520acid%2520nephrolithiasis%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D251%26epage%3D257%26doi%3D10.1007%2Fs11926-007-0040-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Jalal, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chonchol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targher, G.</span><span> </span><span class="NLM_article-title">Uric acid as a target of therapy in CKD</span> <span class="citation_source-journal">Am. J. Kidney Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1053/j.ajkd.2012.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1053%2Fj.ajkd.2012.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=23058478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2jsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=134-146&author=D.+I.+Jalalauthor=M.+Choncholauthor=W.+Chenauthor=G.+Targher&title=Uric+acid+as+a+target+of+therapy+in+CKD&doi=10.1053%2Fj.ajkd.2012.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Uric Acid as a Target of Therapy in CKD</span></div><div class="casAuthors">Jalal, Diana I.; Chonchol, Michel; Chen, Wei; Targher, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The prevalence of chronic kidney disease (CKD) has increased and will continue to increase in the United States and worldwide.  This is alarming considering that CKD is an irreversible condition and patients who progress to chronic kidney failure have reduced quality of life and high mortality rates.  As such, it is imperative to identify modifiable risk factors to develop strategies to slow CKD progression.  One such factor is hyperuricemia.  Recent observational studies have assocd. hyperuricemia with kidney disease.  In addn., hyperuricemia is largely prevalent in patients with CKD.  Data from exptl. studies have shown several potential mechanisms by which hyperuricemia may contribute to the development and progression of CKD.  In this article, we offer a crit. review of the exptl. evidence linking hyperuricemia to CKD, highlight gaps in our knowledge on the topic as it stands today, and review the observational and interventional studies that have examd. the potential nephroprotective effect of decreasing uric acid levels in patients with CKD.  Although uric acid also may be linked to cardiovascular disease and mortality in patients with CKD, this review focuses only on uric acid as a potential therapeutic target to prevent kidney disease onset and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9kaNI0pfO97Vg90H21EOLACvtfcHk0ljfQmY__Y3igA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2jsrrO&md5=f7317150c29fef9df0463df30b42afd0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2012.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2012.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DJalal%26aufirst%3DD.%2BI.%26aulast%3DChonchol%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DTargher%26aufirst%3DG.%26atitle%3DUric%2520acid%2520as%2520a%2520target%2520of%2520therapy%2520in%2520CKD%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2013%26volume%3D61%26spage%3D134%26epage%3D146%26doi%3D10.1053%2Fj.ajkd.2012.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">De Angelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Renzo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianci, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naticchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giarrizzo, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splendiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lorenzo, A.</span><span> </span><span class="NLM_article-title">Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study</span> <span class="citation_source-journal">Eur. Rev. Med. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=179-184&author=S.+De+Angelisauthor=A.+Noceauthor=L.+Di+Renzoauthor=R.+Cianciauthor=A.+Naticchiaauthor=G.+F.+Giarrizzoauthor=F.+Giordanoauthor=C.+Tozzoauthor=G.+Splendianiauthor=A.+De+Lorenzo&title=Is+rasburicase+an+effective+alternative+to+allopurinol+for+management+of+hyperuricemia+in+renal+failure+patients%3F+A+double+blind-randomized+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BAngelis%26aufirst%3DS.%26aulast%3DNoce%26aufirst%3DA.%26aulast%3DDi%2BRenzo%26aufirst%3DL.%26aulast%3DCianci%26aufirst%3DR.%26aulast%3DNaticchia%26aufirst%3DA.%26aulast%3DGiarrizzo%26aufirst%3DG.%2BF.%26aulast%3DGiordano%26aufirst%3DF.%26aulast%3DTozzo%26aufirst%3DC.%26aulast%3DSplendiani%26aufirst%3DG.%26aulast%3DDe%2BLorenzo%26aufirst%3DA.%26atitle%3DIs%2520rasburicase%2520an%2520effective%2520alternative%2520to%2520allopurinol%2520for%2520management%2520of%2520hyperuricemia%2520in%2520renal%2520failure%2520patients%253F%2520A%2520double%2520blind-randomized%2520study%26jtitle%3DEur.%2520Rev.%2520Med.%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D11%26spage%3D179%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Schlesinger, N.</span><span> </span><span class="NLM_article-title">Dietary factors and hyperuricaemia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4133</span><span class="NLM_x">–</span> <span class="NLM_lpage">4138</span><span class="refDoi"> DOI: 10.2174/138161205774913273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F138161205774913273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16375734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KgtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=4133-4138&author=N.+Schlesinger&title=Dietary+factors+and+hyperuricaemia&doi=10.2174%2F138161205774913273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary factors and hyperuricaemia</span></div><div class="casAuthors">Schlesinger, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4133-4138</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The connection of gout and hyperuricemia with gluttony, overindulgence in food and alc. and obesity dates from ancient times.  Studies from different parts of the world suggest that the incidence and severity of hyperuricemia and gout may be increasing.  Uric acid (urate) is the end product of purine degrdn.  Although most uric acid is derived from the metab. of endogenous purine, eating foods rich in purines contributes to the total pool of uric acid.  Sustained hyperuricemia is a risk factor for acute gouty arthritis, chronic tophaceous gout, renal stones and possibly cardiovascular events and mortality.  Before starting lifelong urate-lowering drug therapy, it is important to identify and treat underlying disorders that may be contributing to hyperuricemia.  It is relevant to recognize the strong assocn. of the insulin resistance syndrome (IRS) (abdominal obesity, dyslipidemia, hypertension, raised serum insulin levels and glucose intolerance) with hyperuricemia.  Consumption of meat, seafood and alc. beverages in moderation and attention to food portion size is important.  Moderation in the consumption of not only beer but also other forms of alc. is essential.  In the obese, controlled wt. management has the potential to lower serum urate in a quant. similar way to relatively unpalatable "low purine" diets.  Non-fat milk and low-fat yogurt have a variety of health benefits and dairy products may have clin. meaningful antihyperuricemic effects.  In addn., fruits, such as cherries and high intakes of vegetable protein diet may reduce serum urate levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKyaMRIGepm7Vg90H21EOLACvtfcHk0ljfQmY__Y3igA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KgtrnL&md5=af6032e1228fd26d6e3bb06ec0af53ef</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138161205774913273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161205774913273%26sid%3Dliteratum%253Aachs%26aulast%3DSchlesinger%26aufirst%3DN.%26atitle%3DDietary%2520factors%2520and%2520hyperuricaemia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D4133%26epage%3D4138%26doi%3D10.2174%2F138161205774913273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Riegersperger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, D.</span><span> </span><span class="NLM_article-title">Allopurinol, uric acid, and oxidative stress in cardiorenal disease</span> <span class="citation_source-journal">Int. Urol. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1007/s11255-011-9929-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11255-011-9929-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=21547469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=441-449&author=M.+Riegerspergerauthor=A.+Covicauthor=D.+Goldsmith&title=Allopurinol%2C+uric+acid%2C+and+oxidative+stress+in+cardiorenal+disease&doi=10.1007%2Fs11255-011-9929-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Allopurinol, uric acid, and oxidative stress in cardiorenal disease</span></div><div class="casAuthors">Riegersperger, Markus; Covic, Adrian; Goldsmith, David</div><div class="citationInfo"><span class="NLM_cas:title">International Urology and Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">IURNAE</span>;
        ISSN:<span class="NLM_cas:issn">0301-1623</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In humans, the hepatic end product of purine metab. is uric acid.  Serum uric acid levels physiol. and gradually rise during human lifetime.  Hyperuricemia also arises from excess dietary purine or ethanol intake, decreased renal excretion of uric acid, tumor lysis in lymphoma, leukemia or solid tumors, and sometimes pharmacotherapy.  The definition of hyperuricemia is currently arbitrary.  Hyperuricemia is assocd. with chronic kidney disease, arterial hypertension, coronary artery and heart disease, cerebrovascular disease and diabetes mellitus.  Xanthine oxidase, a hepatic enzyme, catalyzes the prodn. of uric acid, nitric oxide, and reactive oxygen species, which potentially damage DNA, RNA and proteins, inactivate enzymes, oxidize amino acids and convert poly-unsatd. fatty acids to lipids.  This is believed to contribute to atherosclerosis, endothelial dysfunction, renovascular hypertension, and cardiovascular disease.  Xanthine oxidase inhibition efficiently blocks uric acid generation, and this improves glomerular filtration rates, systemic blood pressure, and cerebro-cardiovascular outcomes.  Here, data from animal, in vivo, retro- and prospective, and interventional studies are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp72ZpwULCfvbVg90H21EOLACvtfcHk0lgC1ET45-8m2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVylsL8%253D&md5=528a2cb6911886687cb92135061a2da8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs11255-011-9929-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11255-011-9929-6%26sid%3Dliteratum%253Aachs%26aulast%3DRiegersperger%26aufirst%3DM.%26aulast%3DCovic%26aufirst%3DA.%26aulast%3DGoldsmith%26aufirst%3DD.%26atitle%3DAllopurinol%252C%2520uric%2520acid%252C%2520and%2520oxidative%2520stress%2520in%2520cardiorenal%2520disease%26jtitle%3DInt.%2520Urol.%2520Nephrol.%26date%3D2011%26volume%3D43%26spage%3D441%26epage%3D449%26doi%3D10.1007%2Fs11255-011-9929-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yamanaka, H.</span><span> </span><span class="NLM_article-title">Japanese guideline for the management of hyperuricemia and gout: Second edition</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.1080/15257770.2011.596496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1080%2F15257770.2011.596496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=22132951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKjurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=1018-1029&author=H.+Yamanaka&title=Japanese+guideline+for+the+management+of+hyperuricemia+and+gout%3A+Second+edition&doi=10.1080%2F15257770.2011.596496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition</span></div><div class="casAuthors">Yamanaka, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1018-1029</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Gout is a urate deposition disease caused by persistent hyperuricemia.  Because gout patients present with a variety of clin. symptoms, it is necessary to have a guideline for the std. management and care of gout and hyperuricemia.  The Japanese Society of Gout and Nucleic Acid Metab., a scientific society committed to study nucleic acid metab. and related diseases, established the 1st edition of the "Guideline for the Management of Hyperuricemia and Gout" in 2002, and published the revised version in Jan. 2010.  This second edition is not only evidence based on a search of systemic literature, but also includes consensus levels by a Delphi exercise to det. the strength of the recommendations.  A draft version of this guideline was reviewed by internal and external reviewers as well as a patient.  In this guideline, key messages from each chapter are listed as statements together with the evidence level, consensus level, and strength of the recommendation.  In this proceeding, several selected chapters on the clin. management of gout and hyperuricemia are described.  We hope this guideline is appropriately used for the std. management and care of patients with hyperuricemia and gout in daily practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Vj8Yy2vAwLVg90H21EOLACvtfcHk0lizE6QXCNEapA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKjurbI&md5=fa13d1fbafbc6745eb6a4e8e61bea031</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F15257770.2011.596496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770.2011.596496%26sid%3Dliteratum%253Aachs%26aulast%3DYamanaka%26aufirst%3DH.%26atitle%3DJapanese%2520guideline%2520for%2520the%2520management%2520of%2520hyperuricemia%2520and%2520gout%253A%2520Second%2520edition%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2011%26volume%3D30%26spage%3D1018%26epage%3D1029%26doi%3D10.1080%2F15257770.2011.596496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Edwards, N. L.</span><span> </span><span class="NLM_article-title">The role of hyperuricemia and gout in kidney and cardiovascular disease</span> <span class="citation_source-journal">Cleveland Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">S13</span><span class="NLM_x">–</span> <span class="NLM_lpage">S16</span><span class="refDoi"> DOI: 10.3949/ccjm.75.Suppl_5.S13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.3949%2Fccjm.75.Suppl_5.S13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=S13-S16&issue=Suppl.+5&author=N.+L.+Edwards&title=The+role+of+hyperuricemia+and+gout+in+kidney+and+cardiovascular+disease&doi=10.3949%2Fccjm.75.Suppl_5.S13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3949%2Fccjm.75.Suppl_5.S13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.75.Suppl_5.S13%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DN.%2BL.%26atitle%3DThe%2520role%2520of%2520hyperuricemia%2520and%2520gout%2520in%2520kidney%2520and%2520cardiovascular%2520disease%26jtitle%3DCleveland%2520Clin.%2520J.%2520Med.%26date%3D2008%26volume%3D75%26issue%3DSuppl.%25205%26spage%3DS13%26epage%3DS16%26doi%3D10.3949%2Fccjm.75.Suppl_5.S13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zoccali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamaci, F.</span><span> </span><span class="NLM_article-title">Uric acid, hypertension, and cardiovascular and renal complications</span> <span class="citation_source-journal">Curr. Hypertens. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1007/s11906-013-0391-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11906-013-0391-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24072559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGmsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=531-537&author=C.+Zoccaliauthor=F.+Mallamaci&title=Uric+acid%2C+hypertension%2C+and+cardiovascular+and+renal+complications&doi=10.1007%2Fs11906-013-0391-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Uric Acid, Hypertension, and Cardiovascular and Renal Complications</span></div><div class="casAuthors">Zoccali, Carmine; Mallamaci, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Current Hypertension Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-537</span>CODEN:
                <span class="NLM_cas:coden">CHRUCG</span>;
        ISSN:<span class="NLM_cas:issn">1522-6417</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Over the last decade, the biol. interference of uric acid with the cardiovascular (CV) system and the kidney has been intensively investigated, and several exptl. studies in animal models and in vitro documented that hyperuricemia may trigger hypertension and incite endothelial dysfunction, vascular damage and renal disease.  A substantial proportion of epidemiol. studies are compatible with the hypothesis that hyperuricemia may be noxious to the CV system and the kidney as well.  However, there are still no well-powered trials testing whether uric acid-lowering interventions may reduce BP or attenuate the risk for adverse CV and renal outcomes.  Evidence still remains largely insufficient to recommend changes in the current policy of not prescribing uric acid-lowering drugs to individuals with asymptomatic hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTNZy1lobiWbVg90H21EOLACvtfcHk0lizE6QXCNEapA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGmsLvF&md5=4683311b4d2ddd3ce020b0378a772c2f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs11906-013-0391-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-013-0391-y%26sid%3Dliteratum%253Aachs%26aulast%3DZoccali%26aufirst%3DC.%26aulast%3DMallamaci%26aufirst%3DF.%26atitle%3DUric%2520acid%252C%2520hypertension%252C%2520and%2520cardiovascular%2520and%2520renal%2520complications%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2013%26volume%3D15%26spage%3D531%26epage%3D537%26doi%3D10.1007%2Fs11906-013-0391-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fenech, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajzbaum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazighi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacher, J.</span><span> </span><span class="NLM_article-title">Serum uric acid and cardiovascular risk: State of the art and perspectives</span> <span class="citation_source-journal">Jt., Bone, Spine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/j.jbspin.2014.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.jbspin.2014.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24565888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivF2ms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=392-397&author=G.+Fenechauthor=G.+Rajzbaumauthor=M.+Mazighiauthor=J.+Blacher&title=Serum+uric+acid+and+cardiovascular+risk%3A+State+of+the+art+and+perspectives&doi=10.1016%2Fj.jbspin.2014.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid and cardiovascular risk: State of the art and perspectives</span></div><div class="casAuthors">Fenech, Goel; Rajzbaum, Gerald; Mazighi, Mikael; Blacher, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Joint, Bone, Spine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-397</span>CODEN:
                <span class="NLM_cas:coden">JBSPFA</span>;
        ISSN:<span class="NLM_cas:issn">1297-319X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Hyperuricemia is commonly found in subjects with cardiovascular disease, but its role as risk factor is very controversial.  Although several studies reported serum uric acid as a marker of an underlying pathophysiol. process, other studies hypothesis a potential causal link between serum uric acid and cardiovascular diseases.  Some studies suggest that uric acid is biol. active and may have an atherogenesis role in development of cardiovascular diseases, although the mechanisms are not fully understood.  Other studies have shown that uric acid can independently predict the development of some cardiovascular risk factors such as hypertension and metabolic syndrome, as well as myocardial infarction and stroke.  The relations between serum uric acid and established cardiovascular risk factors are complex, and these latter could be considered as confounding factors.  In this report, we review the inextricably link of serum uric acid to known cardiovascular risk factors, and we describe the possible mechanisms and potential causative role between serum uric acid and cardiovascular events in the general population, in subjects with cardiovascular risk factors and in those with pre-existing cardiovascular diseases.  Limited information however is available concerning the impact of urate-lowering treatments on cardiovascular events, whereas only a pos. therapeutic trial could give definite answers to the difficult problem of causality of uric acid in relation to cardiovascular risk.  Thus, it is time to propose the design of a therapeutic trial, integrating cardiologists and rheumatologists, in order to further decrease cardiovascular risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kXyDRE7fPrVg90H21EOLACvtfcHk0lizE6QXCNEapA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivF2ms7Y%253D&md5=b011f05697bec01b2bb670e7bee161a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jbspin.2014.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbspin.2014.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DFenech%26aufirst%3DG.%26aulast%3DRajzbaum%26aufirst%3DG.%26aulast%3DMazighi%26aufirst%3DM.%26aulast%3DBlacher%26aufirst%3DJ.%26atitle%3DSerum%2520uric%2520acid%2520and%2520cardiovascular%2520risk%253A%2520State%2520of%2520the%2520art%2520and%2520perspectives%26jtitle%3DJt.%252C%2520Bone%252C%2520Spine%26date%3D2014%26volume%3D81%26spage%3D392%26epage%3D397%26doi%3D10.1016%2Fj.jbspin.2014.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Gosling, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matisoo-Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merriman, T. R.</span><span> </span><span class="NLM_article-title">Hyperuricaemia in the Pacific: why the elevated serum urate levels?</span> <span class="citation_source-journal">Rheumatol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.1007/s00296-013-2922-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs00296-013-2922-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=24378761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVaitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=743-757&author=A.+L.+Goslingauthor=E.+Matisoo-Smithauthor=T.+R.+Merriman&title=Hyperuricaemia+in+the+Pacific%3A+why+the+elevated+serum+urate+levels%3F&doi=10.1007%2Fs00296-013-2922-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperuricaemia in the Pacific: why the elevated serum urate levels?</span></div><div class="casAuthors">Gosling, Anna L.; Matisoo-Smith, Elizabeth; Merriman, Tony R.</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Pacific Island populations, particularly those of Polynesian descent, have a high prevalence of hyperuricemia and gout.  This is due to an inherently higher urate level among these populations with a demonstrated genetic predisposition.  While an excess of urate can cause pathol., urate is also important for human health.  It has been implicated as an antioxidant, has a neuroprotective role and is involved in innate immune responses.  This paper provides a brief review of urate levels worldwide, with a particular focus on island Southeast Asia and the Pacific.  We then present possible evolutionary explanations for the elevated serum urate levels among Pacific populations in the context of the physiol. importance of urate and of the settlement history of the region.  Finally, we propose that ancestry may play a significant role in hyperuricemia in these populations and that exposure to malaria prior to population expansion into the wider Pacific may have driven genetic selection for variants contributing to high serum urate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowXhePv-Men7Vg90H21EOLACvtfcHk0ljkmw30abLEYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVaitA%253D%253D&md5=b0b6800f9efeca2ec92bfe04e352f045</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00296-013-2922-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-013-2922-x%26sid%3Dliteratum%253Aachs%26aulast%3DGosling%26aufirst%3DA.%2BL.%26aulast%3DMatisoo-Smith%26aufirst%3DE.%26aulast%3DMerriman%26aufirst%3DT.%2BR.%26atitle%3DHyperuricaemia%2520in%2520the%2520Pacific%253A%2520why%2520the%2520elevated%2520serum%2520urate%2520levels%253F%26jtitle%3DRheumatol.%2520Int.%26date%3D2014%26volume%3D34%26spage%3D743%26epage%3D757%26doi%3D10.1007%2Fs00296-013-2922-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Blond, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudable, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laville, M.</span><span> </span><span class="NLM_article-title">Nonalcoholic fatty liver disease and hyperuricemia: A close relation with hepatic insulin resistance after nicotinic acid treatment?</span> <span class="citation_source-journal">Horm. Metab. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1055/s-0034-1390463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1055%2Fs-0034-1390463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=25350520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVersrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=546-547&author=E.+Blondauthor=J.+Goudableauthor=M.+Laville&title=Nonalcoholic+fatty+liver+disease+and+hyperuricemia%3A+A+close+relation+with+hepatic+insulin+resistance+after+nicotinic+acid+treatment%3F&doi=10.1055%2Fs-0034-1390463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nonalcoholic Fatty Liver Disease and Hyperuricemia: A Close Relation with Hepatic Insulin Resistance after Nicotinic Acid Treatment?</span></div><div class="casAuthors">Blond, E.; Goudable, J.; Laville, M.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">546-547</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">This review highlights on nonalcoholic fatty liver disease and hyperuricemia and its close relation with hepatic insulin resistance after nicotinic acid (NA) treatment.  NA is known to generate insulin resistance state and get an improvement of lipid profile, but mol. mechanisms explaining discrepancy between its beneficial effects on lipids metab. and deleterious effects on glucose metab. remain to be defined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn7A17DyQYLLVg90H21EOLACvtfcHk0ljkmw30abLEYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVersrrJ&md5=f7dac4793885ef1a3e4d882d375328c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1055%2Fs-0034-1390463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0034-1390463%26sid%3Dliteratum%253Aachs%26aulast%3DBlond%26aufirst%3DE.%26aulast%3DGoudable%26aufirst%3DJ.%26aulast%3DLaville%26aufirst%3DM.%26atitle%3DNonalcoholic%2520fatty%2520liver%2520disease%2520and%2520hyperuricemia%253A%2520A%2520close%2520relation%2520with%2520hepatic%2520insulin%2520resistance%2520after%2520nicotinic%2520acid%2520treatment%253F%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2015%26volume%3D47%26spage%3D546%26epage%3D547%26doi%3D10.1055%2Fs-0034-1390463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Abeles, A. M.</span><span> </span><span class="NLM_article-title">Hyperuricemia, gout, and cardiovascular disease: An update</span> <span class="citation_source-journal">Curr. Rheumatol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="refDoi"> DOI: 10.1007/s11926-015-0495-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs11926-015-0495-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=25740704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhsVelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=13&author=A.+M.+Abeles&title=Hyperuricemia%2C+gout%2C+and+cardiovascular+disease%3A+An+update&doi=10.1007%2Fs11926-015-0495-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperuricemia, gout, and cardiovascular disease: an update</span></div><div class="casAuthors">Abeles Aryeh M</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Across the globe, both gout and hyperuricemia have become increasingly common over the last few decades.  The burden of gouty disease is made heavier by its association with several comorbid conditions, including hypertension, cardiovascular disease, and chronic kidney disease.  Accruing evidence from prospective studies suggests that gout is an independent risk factor for developing cardiovascular disease and for higher cardiovascular mortality.  While asymptomatic hyperuricemia does not seem to be an independent risk factor for cardiovascular disease, increasing data implicates hyperuricemia as a risk factor for developing incidental hypertension.  Important questions that remain unanswered include whether addressing asymptomatic hyperuricemia forestalls the onset of hypertension, and whether treating gout with urate-lowering agents improves cardiovascular outcomes.  This article reviews the most recent data regarding the relationship between hyperuricemia, gout, hypertension, and cardiovascular disease, as well as emerging evidence as to whether treatment of hyperuricemia and gout improves cardiovascular outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_Ry_IfB6dF4NpW7w2tapOfW6udTcc2ebfeVslcEKUR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhsVelug%253D%253D&md5=66bb36218795936c207a9bfed5265f11</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs11926-015-0495-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-015-0495-2%26sid%3Dliteratum%253Aachs%26aulast%3DAbeles%26aufirst%3DA.%2BM.%26atitle%3DHyperuricemia%252C%2520gout%252C%2520and%2520cardiovascular%2520disease%253A%2520An%2520update%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2015%26volume%3D17%26spage%3D13%26doi%3D10.1007%2Fs11926-015-0495-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lima, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins-Santos, M. E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, V. E.</span><span> </span><span class="NLM_article-title">Uric acid as a modulator of glucose and lipid metabolism</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1016/j.biochi.2015.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.biochi.2015.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=17-23&author=W.+G.+Limaauthor=M.+E.+S.+Martins-Santosauthor=V.+E.+Chaves&title=Uric+acid+as+a+modulator+of+glucose+and+lipid+metabolism&doi=10.1016%2Fj.biochi.2015.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2015.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2015.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DW.%2BG.%26aulast%3DMartins-Santos%26aufirst%3DM.%2BE.%2BS.%26aulast%3DChaves%26aufirst%3DV.%2BE.%26atitle%3DUric%2520acid%2520as%2520a%2520modulator%2520of%2520glucose%2520and%2520lipid%2520metabolism%26jtitle%3DBiochimie%26date%3D2015%26volume%3D116%26spage%3D17%26epage%3D23%26doi%3D10.1016%2Fj.biochi.2015.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ishizaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakado, M.</span><span> </span><span class="NLM_article-title">Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1161/01.ATV.0000161274.87407.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.ATV.0000161274.87407.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15746438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1038-1044&author=N.+Ishizakaauthor=Y.+Ishizakaauthor=E.+Todaauthor=R.+Nagaiauthor=M.+Yamakado&title=Association+between+serum+uric+acid%2C+metabolic+syndrome%2C+and+carotid+atherosclerosis+in+Japanese+individuals&doi=10.1161%2F01.ATV.0000161274.87407.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals</span></div><div class="casAuthors">Ishizaka, Nobukazu; Ishizaka, Yuko; Toda, Ei-Ichi; Nagai, Ryozo; Yamakado, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1038-1044</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">There are few data available on possible independent assocn. between uric acid and carotid atherosclerosis.  Here the authors first sought to investigate assocn. between uric acid levels and metabolic syndrome in Japanese; second, the authors assessed whether there is an independent assocn. of uric acid with prevalence of carotid atherosclerosis in individuals subdivided according to gender and metabolic syndrome status.  Cross-sectional data from 8144 individuals who underwent general health screening were analyzed.  After adjusting for age, total cholesterol, and smoking status, the odds ratios (95% CI) of sex-specific quartiles of serum uric acid for metabolic syndrome were 1.0, 1.06 (0.60 to 1.87), 2.18 (1.30 to 3.64), and 4.17 (2.56 to 6.79) in women, and 1.0, 0.92 (0.74 to 1.14), 1.52 (1.25 to 1.65), and 1.97 (1.61 to 2.40) in men.  After adjusting for age, serum levels, total cholesterol, and smoking status, prevalence of carotid plaque was higher in subjects in the second, third, and fourth quartiles of uric acid level with odds ratios (95% CI) of 1.24 (1.01 to 1.52), 1.37 (1.11 to 1.68), and 1.31 (1.05 to 1.63), resp., in men without metabolic syndrome but not in men with metabolic syndrome or in women with or without metabolic syndrome.  The prevalence of metabolic syndrome showed a graded increase according to serum uric acid values in both genders.  In men who did not have metabolic syndrome, uric acid was found to be an independent risk factor for incidence of carotid plaque.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzv9qnjWbkLVg90H21EOLACvtfcHk0liao1jt_OAbBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVCjtLo%253D&md5=052f038b22573d54f1ee252ae90a7299</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000161274.87407.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000161274.87407.26%26sid%3Dliteratum%253Aachs%26aulast%3DIshizaka%26aufirst%3DN.%26aulast%3DIshizaka%26aufirst%3DY.%26aulast%3DToda%26aufirst%3DE.%26aulast%3DNagai%26aufirst%3DR.%26aulast%3DYamakado%26aufirst%3DM.%26atitle%3DAssociation%2520between%2520serum%2520uric%2520acid%252C%2520metabolic%2520syndrome%252C%2520and%2520carotid%2520atherosclerosis%2520in%2520Japanese%2520individuals%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D1038%26epage%3D1044%26doi%3D10.1161%2F01.ATV.0000161274.87407.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lohsoonthorn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanamun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. A.</span><span> </span><span class="NLM_article-title">Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span><span class="refDoi"> DOI: 10.1016/j.arcmed.2006.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.arcmed.2006.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16971230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=883-889&author=V.+Lohsoonthornauthor=B.+Dhanamunauthor=M.+A.+Williams&title=Prevalence+of+hyperuricemia+and+its+relationship+with+metabolic+syndrome+in+Thai+adults+receiving+annual+health+exams&doi=10.1016%2Fj.arcmed.2006.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams</span></div><div class="casAuthors">Lohsoonthorn, Vitool; Dhanamun, Bodi; Williams, Michelle A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-889</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Assocns. between hyperuricemia, metabolic syndrome, cardiovascular disease and diabetes have been reported.  Limited information, however, is available concerning the prevalence and correlates of hyperuricemia among Thai men and women.  We sought to est. the prevalence of hyperuricemia among a population of patients receiving annual health exams and to evaluate its relationship with metabolic syndrome (MetS).  We conducted a cross-sectional study of 1381 patients (376 men and 1005 women) who first participated in annual health examns. at the Preventive Medicine Clinic of the King Chulalongkorn Memorial Hospital in Bangkok, Thailand during the period July 1999 through Feb. 2000.  Hyperuricemia was defined as >7.0 mg/dL in men and >6.0 mg/dL in women.  MetS was defined using the modified ATP III criteria.  Results: The overall prevalence of the hyperuricemia was 10.6%.  The condition was more common in men than in women (18.4 vs. 7.8%).  Among women, serum uric acid was statistically significantly correlated with body mass index (BMI), systolic and diastolic blood pressure, high-d. lipoprotein-cholesterol, triglyceride and fasting plasma glucose (all p < 0.05).  Men with serum uric acid concns. >6.7 mg/dL (upper quartile) had a 3.91-fold increased in risk of MetS (95% CI:1.36-11.23), as compared with those who had concns. <5.1 mg/dL (lowest quartile).  Among women, the risk of MetS increased at least 2-fold for concn. of serum uric acid concns. >4.0 mg/dL (p for trend <0.001).  Hyperuricemia is prevalent among Thai men and women receiving routine health exams.  Addnl., serum uric acid is pos. assocd. with MetS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJXY4GU-YcrVg90H21EOLACvtfcHk0liao1jt_OAbBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWmu7o%253D&md5=3a539bf2ec33a7ab5231239a70df525e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2006.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2006.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DLohsoonthorn%26aufirst%3DV.%26aulast%3DDhanamun%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DM.%2BA.%26atitle%3DPrevalence%2520of%2520hyperuricemia%2520and%2520its%2520relationship%2520with%2520metabolic%2520syndrome%2520in%2520Thai%2520adults%2520receiving%2520annual%2520health%2520exams%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2006%26volume%3D37%26spage%3D883%26epage%3D889%26doi%3D10.1016%2Fj.arcmed.2006.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Onat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyarel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenç, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karabulut, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albayrak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sari, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keleş, I.</span><span> </span><span class="NLM_article-title">Serum uric acid is a determinant of metabolic syndrome in a population-based study</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1016/j.amjhyper.2006.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.amjhyper.2006.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17027827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=1055-1062&author=A.+Onatauthor=H.+Uyarelauthor=G.+Hergen%C3%A7author=A.+Karabulutauthor=S.+Albayrakauthor=I.+Sariauthor=M.+Yaziciauthor=I.+Kele%C5%9F&title=Serum+uric+acid+is+a+determinant+of+metabolic+syndrome+in+a+population-based+study&doi=10.1016%2Fj.amjhyper.2006.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid is a determinant of metabolic syndrome in a population-based study</span></div><div class="casAuthors">Onat, Altan; Uyarel, Hueseyin; Hergenc, Guelay; Karabulut, Ahmet; Albayrak, Sinan; Sari, Ibrahim; Yazici, Mehmet; Keles, Ibrahim</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1055-1062</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Detn. of serum uric acid concns. and role in risk of metabolic syndrome (MS) were investigated in 1877 participants in a cross-sectional population-based study including a brief follow-up.  The MS was identified by modified criteria of the Adult Treatment Panel III, and coronary heart disease (CHD) by clin. findings and Minnesota coding of resting electrocardiograms.  Uric acid concns. were measured by the uricase method.  Metabolic syndrome was present in 39.1% of the cohort.  Linear regression anal. of uric acid levels in a model comprising 13 variables identified gender, waist girth, total cholesterol (TC), alc. usage, triglycerides, log C-reactive protein (CRP), and log γ-glutamyl transferase (GGT), and in women diuretic use and elevated blood pressure (BP), as significant independent covariates whereby the largest contribution (1.6 mg/dL) was generated by waist girth.  Logistic regression anal. of serum uric acid for MS disclosed for the top vs. the bottom tertile an odds ratio (OR) of 1.89 (95% confidence interval [CI]: 1.45-2.46) in men and women combined, after adjustment for sex, age, TC, log CRP, log GGT, alc., and diuretic drug use, presence of diabetes/impaired fasting glucose, elevated BP, and smoking status.  This corresponded to an increase by 35% in MS likelihood for each 1 SD uric acid increment.  This rate declined to a significant 15% by inclusion of waist girth into the model.  The OR of uric acid concns. for prevalent and incident CHD, adjusted for age, MS, smoking, and diuretic use, was not significant among women and only tended toward significance in men.  Abdominal obesity is the main determinant of uric acid variance.  An increment of 1 SD in serum uric acid levels are assocd. in both sexes with a 35% higher MS likelihood, independent of 10 risk factors related to MS.  After adjustment for waist girth, a more modest but significant likelihood persists, which suggests that serum uric acid is a determinant of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfdxVd9I0zobVg90H21EOLACvtfcHk0liao1jt_OAbBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrtb7M&md5=f2a7f963738efe3196717219c42a75dc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2006.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2006.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DOnat%26aufirst%3DA.%26aulast%3DUyarel%26aufirst%3DH.%26aulast%3DHergen%25C3%25A7%26aufirst%3DG.%26aulast%3DKarabulut%26aufirst%3DA.%26aulast%3DAlbayrak%26aufirst%3DS.%26aulast%3DSari%26aufirst%3DI.%26aulast%3DYazici%26aufirst%3DM.%26aulast%3DKele%25C5%259F%26aufirst%3DI.%26atitle%3DSerum%2520uric%2520acid%2520is%2520a%2520determinant%2520of%2520metabolic%2520syndrome%2520in%2520a%2520population-based%2520study%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2006%26volume%3D19%26spage%3D1055%26epage%3D1062%26doi%3D10.1016%2Fj.amjhyper.2006.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, E. S.</span><span> </span><span class="NLM_article-title">Prevalence of the metabolic syndrome in individuals with hyperuricemia</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1016/j.amjmed.2006.06.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.amjmed.2006.06.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17466656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A280%3ADC%252BD2s3lvVCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=442-447&author=H.+K.+Choiauthor=E.+S.+Ford&title=Prevalence+of+the+metabolic+syndrome+in+individuals+with+hyperuricemia&doi=10.1016%2Fj.amjmed.2006.06.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of the metabolic syndrome in individuals with hyperuricemia</span></div><div class="casAuthors">Choi Hyon K; Ford Earl S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">442-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The link between hyperuricemia and insulin resistance has been noted, but the prevalence of the metabolic syndrome by recent definitions among individuals with hyperuricemia remains unclear.  Our objective was to determine the prevalence of the metabolic syndrome according to serum uric acid levels in a nationally representative sample of US adults.  METHODS:  By using data from 8669 participants aged 20 years and more in The Third National Health and Nutrition Examination Survey (1988-1994), we determined the prevalence of the metabolic syndrome at different serum uric acid levels.  We used both the revised and original National Cholesterol Education Program Adult Treatment Panel (NCEP/ATP) III criteria to define the metabolic syndrome.  RESULTS:  The prevalences of the metabolic syndrome according to the revised NCEP/ATP III criteria were 18.9% (95% confidence interval [CI], 16.8-21.0) for uric acid levels less than 6 mg/dL, 36.0% (95% CI, 32.5-39.6) for uric acid levels from 6 to 6.9 mg/dL, 40.8% (95% CI, 35.3-46.4) for uric acid levels from 7 to 7.9 mg/dL, 59.7% (95% CI, 53.0-66.4) for uric acid levels from 8 to 8.9 mg/dL, 62.0% (95% CI, 53.0-66.4) for uric acid levels from 9 to 9.9 mg/dL, and 70.7% for uric acid levels of 10 mg/dL or greater.  The increasing trends persisted in subgroups stratified by sex, age group, alcohol intake, body mass index, hypertension, and diabetes.  For example, among individuals with normal body mass index (<25 kg/m2), the prevalence increased from 5.9% (95% CI, 4.8-7.0), for a uric acid level of less than 6 mg/dL, to 59.0%, (95% CI, 20.1-97.9) for a uric acid level of 10 mg/dL or greater.  With the original NCEP/ATP criteria, the corresponding prevalences were slightly lower.  CONCLUSIONS:  These findings from a nationally representative sample of US adults indicate that the prevalence of the metabolic syndrome increases substantially with increasing levels of serum uric acid.  Physicians should recognize the metabolic syndrome as a frequent comorbidity of hyperuricemia and treat it to prevent serious complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdLt9pbzpipdFxYDaSSP8XfW6udTcc2eYO_FPTkjbS6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3lvVCntg%253D%253D&md5=81c7df9a5fc05a91dd16ca4e23283d25</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2006.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2006.06.040%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DFord%26aufirst%3DE.%2BS.%26atitle%3DPrevalence%2520of%2520the%2520metabolic%2520syndrome%2520in%2520individuals%2520with%2520hyperuricemia%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2007%26volume%3D120%26spage%3D442%26epage%3D447%26doi%3D10.1016%2Fj.amjmed.2006.06.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Numata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyatake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, H.</span><span> </span><span class="NLM_article-title">Comparison of serum uric acid levels between Japanese with and without metabolic syndrome</span> <span class="citation_source-journal">Diabetes Res. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e5</span><span class="refDoi"> DOI: 10.1016/j.diabres.2007.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.diabres.2007.10.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=e1-e5&author=T.+Numataauthor=N.+Miyatakeauthor=J.+Wadaauthor=H.+Makino&title=Comparison+of+serum+uric+acid+levels+between+Japanese+with+and+without+metabolic+syndrome&doi=10.1016%2Fj.diabres.2007.10.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.diabres.2007.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabres.2007.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DNumata%26aufirst%3DT.%26aulast%3DMiyatake%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DJ.%26aulast%3DMakino%26aufirst%3DH.%26atitle%3DComparison%2520of%2520serum%2520uric%2520acid%2520levels%2520between%2520Japanese%2520with%2520and%2520without%2520metabolic%2520syndrome%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2008%26volume%3D80%26spage%3De1%26epage%3De5%26doi%3D10.1016%2Fj.diabres.2007.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meriwether, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, S. N.</span><span> </span><span class="NLM_article-title">Uric acid and the development of metabolic syndrome in women and men</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1016/j.metabol.2008.01.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.metabol.2008.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=18502269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVaqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=845-852&author=X.+Suiauthor=T.+S.+Churchauthor=R.+A.+Meriwetherauthor=F.+Lobeloauthor=S.+N.+Blair&title=Uric+acid+and+the+development+of+metabolic+syndrome+in+women+and+men&doi=10.1016%2Fj.metabol.2008.01.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Uric acid and the development of metabolic syndrome in women and men</span></div><div class="casAuthors">Sui, Xuemei; Church, Timothy S.; Meriwether, Rebecca A.; Lobelo, Felipe; Blair, Steven N.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Assocns. between serum uric acid (UA) levels and metabolic syndrome (MetS) have been reported in cross-sectional studies.  Limited information, however, is available concerning the prospective assocn. of UA and the risk of developing MetS.  The authors evaluated UA as a risk factor for incident MetS in a prospective study of 8429 men and 1260 women (aged 20-82 years) who were free of MetS and for whom measures of waist girth, resting blood pressure, fasting lipids, and glucose were taken during baseline and follow-up examns. between 1977 and 2003.  Hyperuricemia was defined as >7.0 mg/dL in men and >6.0 mg/dL in women.  Metabolic syndrome was defined with the National Cholesterol Education Program Adult Treatment Panel III criteria.  The overall prevalence of hyperuricemia was 17%.  During a mean follow-up of 5.7 years, 1120 men and 44 women developed MetS.  Men with serum UA concns. ≥6.5 mg/dL (upper third) had a 1.60-fold increase in risk of MetS (95% confidence interval, 1.34-1.91) as compared with those who had concns. <5.5 mg/dL (lowest third).  Among women, the risk of MetS was at least 2-fold higher for serum UA concns. ≥4.6 mg/dL (P for trend =.02).  Higher serum UA is a strong and independent predictor of incident MetS in men and women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUyJlDaEmdX7Vg90H21EOLACvtfcHk0ljZZuNwBevv9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVaqtL8%253D&md5=e1cf9191e58c0016b49034df5976e3da</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2008.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2008.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DX.%26aulast%3DChurch%26aufirst%3DT.%2BS.%26aulast%3DMeriwether%26aufirst%3DR.%2BA.%26aulast%3DLobelo%26aufirst%3DF.%26aulast%3DBlair%26aufirst%3DS.%2BN.%26atitle%3DUric%2520acid%2520and%2520the%2520development%2520of%2520metabolic%2520syndrome%2520in%2520women%2520and%2520men%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2008%26volume%3D57%26spage%3D845%26epage%3D852%26doi%3D10.1016%2Fj.metabol.2008.01.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Taniguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span> </span><span class="NLM_article-title">Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1215</span><span class="refDoi"> DOI: 10.1097/00004872-200107000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1097%2F00004872-200107000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=11446710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVGktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=1209-1215&author=Y.+Taniguchiauthor=T.+Hayashiauthor=K.+Tsumuraauthor=G.+Endoauthor=S.+Fujiiauthor=K.+Okada&title=Serum+uric+acid+and+the+risk+for+hypertension+and+Type+2+diabetes+in+Japanese+men%3A+The+Osaka+Health+Survey&doi=10.1097%2F00004872-200107000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka health survey</span></div><div class="casAuthors">Taniguchi, Yuki; Hayashi, Tomoshige; Tsumura, Kei; Endo, Ginji; Fujii, Satoru; Okada, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1209-1215</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective To investigate the assocn. of serum uric acid level with the risk for hypertension and Type 2 diabetes.  Design Prospective cohort study.  Setting Work site in Osaka, Japan.  Participants A total of 6356 Japanese men, aged 35-60 yr with systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg, normal glucose intolerance, and no history of hypertension or diabetes at baseline.  Main outcome measures Blood pressure was measured by std. techniques, using 160/95 mmHg for diagnosis of hypertension.  Type 2 diabetes was defined as a fasting plasma glucose level ≥ 126 mg/dL or a 2 h post-loaded plasma glucose level ≥ 200 mg/dL.  Results During the 61 716 person-years follow-up period, we confirmed 639 cases of hypertension and 454 cases of Type 2 diabetes.  Serum uric acid level was assocd. with an increased risk for hypertension but not for Type 2 diabetes.  After adjustment for known risk factors, including daily alc. consumption, the serum uric acid level was assocd. with an increased risk for hypertension; the relative risks for hypertension were 1.00 for quintile 1 of the serum uric acid level, 1.24 [95% confidence interval (Cl), 0.94-1.65] for quintile 2, 1.34 (Cl, 1.03-1.76) for quintile 3, 1.76 (Cl, 1.35-2.29) for quintile 4, and 2.01 (Cl, 1.56-2.60) for quintile 5 (P for trend < 0.001).  Even among both non-drinkers and lean subjects, serum uric acid level was assocd. with an increased risk for hypertension.  Conclusions Serum uric acid level was assocd. with an increased risk for hypertension but not for Type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt8vegcP9eA7Vg90H21EOLACvtfcHk0ljZZuNwBevv9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVGktr8%253D&md5=812aea7a891adfa6d10ae9c5b0796c8c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F00004872-200107000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200107000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DG.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DSerum%2520uric%2520acid%2520and%2520the%2520risk%2520for%2520hypertension%2520and%2520Type%25202%2520diabetes%2520in%2520Japanese%2520men%253A%2520The%2520Osaka%2520Health%2520Survey%26jtitle%3DJ.%2520Hypertens.%26date%3D2001%26volume%3D19%26spage%3D1209%26epage%3D1215%26doi%3D10.1097%2F00004872-200107000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Nakanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatara, K.</span><span> </span><span class="NLM_article-title">Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers</span> <span class="citation_source-journal">Eur. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1023/A:1024600905574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1023%2FA%3A1024600905574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=12908717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVemsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=523-530&author=N.+Nakanishiauthor=M.+Okamotoauthor=H.+Yoshidaauthor=Y.+Matsuoauthor=K.+Suzukiauthor=K.+Tatara&title=Serum+uric+acid+and+risk+for+development+of+hypertension+and+impaired+fasting+glucose+or+Type+II+diabetes+in+Japanese+male+office+workers&doi=10.1023%2FA%3A1024600905574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers</span></div><div class="casAuthors">Nakanishi, N.; Okamoto, M.; Yoshida, H.; Matsuo, Y.; Suzuki, K.; Tatara, K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Epidemiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-530</span>CODEN:
                <span class="NLM_cas:coden">EJEPE8</span>;
        ISSN:<span class="NLM_cas:issn">0393-2990</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We examd. the assocn. of serum uric acid (SUA) with development of hypertension (blood pressure ≥ 140/90 mmHg and/or medication for hypertension) and impaired fasting glucose (IFG) (a fasting plasma glucose level 6.1-6.9 mmol/l) or Type II (non-insulin-dependent) diabetes (a fasting plasma glucose level ≥ 7.0 mmol/l and/or medication for diabetes) over a 6-yr follow-up among 2310 Japanese male office workers aged 35-59 yr who did not have hypertension, IFG, Type II diabetes, or past history of cardiovascular disease at study entry.  After controlling for potential predictors of hypertension and diabetes, the relative risk for hypertension compared with quintile 1 of SUA level was 1.27 [95% confidence interval (CI): 1.00-1.62] for quintile 2, 1.34 (95% CI: 1.08-1.74) for quintile 3, 1.48 (95% CI: 1.18-1.89) for quintile 4, and 1.58 (95% CI: 1.26-1.99) for quintile 5 (p for trend <0.001).  The resp. multivariate-adjusted relative risks for IFG or Type II diabetes compared with quintile 1 of SUA level were 1.55 (95% CI: 0.95-2.63), 1.62 (95% CI: 0.98-2.67), 1.61 (95% CI: 1.01-2.58), and 1.78 (95% CI: 1.11-2.85) (p for trend = 0.030).  The assocn. between SUA level and risk for hypertension and IFG or Type II diabetes was stronger among men with a body mass index (BMI) <24.2 kg/m2 than among men with a BMI ≥ 24.2 kg/m2, although the abs. risk was greater in more obese men.  These results indicate that SUA level is closely assocd. with an increased risk for hypertension and IFG or Type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cnCE46OuC7Vg90H21EOLACvtfcHk0lieYycnOdyP6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVemsrc%253D&md5=e45bb450308dd110e14f8bc793e3237e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1023%2FA%3A1024600905574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1024600905574%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DN.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DTatara%26aufirst%3DK.%26atitle%3DSerum%2520uric%2520acid%2520and%2520risk%2520for%2520development%2520of%2520hypertension%2520and%2520impaired%2520fasting%2520glucose%2520or%2520Type%2520II%2520diabetes%2520in%2520Japanese%2520male%2520office%2520workers%26jtitle%3DEur.%2520J.%2520Epidemiol.%26date%3D2003%26volume%3D18%26spage%3D523%26epage%3D530%26doi%3D10.1023%2FA%3A1024600905574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sundström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agostino, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kannel, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasan, R. S.</span><span> </span><span class="NLM_article-title">Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000150784.92944.9a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000150784.92944.9a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=28-33&author=J.+Sundstr%C3%B6mauthor=L.+Sullivanauthor=R.+B.+D%E2%80%99Agostinoauthor=D.+Levyauthor=W.+B.+Kannelauthor=R.+S.+Vasan&title=Relations+of+serum+uric+acid+to+longitudinal+blood+pressure+tracking+and+hypertension+incidence&doi=10.1161%2F01.HYP.0000150784.92944.9a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000150784.92944.9a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000150784.92944.9a%26sid%3Dliteratum%253Aachs%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSullivan%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%2BB.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DKannel%26aufirst%3DW.%2BB.%26aulast%3DVasan%26aufirst%3DR.%2BS.%26atitle%3DRelations%2520of%2520serum%2520uric%2520acid%2520to%2520longitudinal%2520blood%2520pressure%2520tracking%2520and%2520hypertension%2520incidence%26jtitle%3DHypertension%26date%3D2005%26volume%3D45%26spage%3D28%26epage%3D33%26doi%3D10.1161%2F01.HYP.0000150784.92944.9a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Alper, A. B.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenson, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, L. L.</span><span> </span><span class="NLM_article-title">Childhood uric acid predicts adult blood pressure. The Bogalusa Heart Study</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000150783.79172.bb</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000150783.79172.bb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=34-38&author=A.+B.+Alperauthor=W.+Chenauthor=L.+Yauauthor=S.+R.+Srinivasanauthor=G.+S.+Berensonauthor=L.+L.+Hamm&title=Childhood+uric+acid+predicts+adult+blood+pressure.+The+Bogalusa+Heart+Study&doi=10.1161%2F01.HYP.0000150783.79172.bb"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000150783.79172.bb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000150783.79172.bb%26sid%3Dliteratum%253Aachs%26aulast%3DAlper%26aufirst%3DA.%2BB.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DYau%26aufirst%3DL.%26aulast%3DSrinivasan%26aufirst%3DS.%2BR.%26aulast%3DBerenson%26aufirst%3DG.%2BS.%26aulast%3DHamm%26aufirst%3DL.%2BL.%26atitle%3DChildhood%2520uric%2520acid%2520predicts%2520adult%2520blood%2520pressure.%2520The%2520Bogalusa%2520Heart%2520Study%26jtitle%3DHypertension%26date%3D2005%26volume%3D45%26spage%3D34%26epage%3D38%26doi%3D10.1161%2F01.HYP.0000150783.79172.bb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Shankar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, B. E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. J.</span><span> </span><span class="NLM_article-title">The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study</span> <span class="citation_source-journal">J. Hum. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1038/sj.jhh.1002095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1038%2Fsj.jhh.1002095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17024135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1akurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=937-945&author=A.+Shankarauthor=R.+Kleinauthor=B.+E.+K.+Kleinauthor=F.+J.+Nieto&title=The+association+between+serum+uric+acid+level+and+long-term+incidence+of+hypertension%3A+population-based+cohort+study&doi=10.1038%2Fsj.jhh.1002095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study</span></div><div class="casAuthors">Shankar, A.; Klein, R.; Klein, B. E. K.; Nieto, F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Human Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">937-945</span>CODEN:
                <span class="NLM_cas:coden">JHHYEN</span>;
        ISSN:<span class="NLM_cas:issn">0950-9240</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increasing exptl. evidence, including recently developed animal models support a causal role for uric acid in the development of hypertension.  However, it is not clear whether serum uric acid levels are independently assocd. with the long-term incidence of hypertension.  We examd. the assocn. between serum uric acid levels and 10-yr incidence of hypertension in a population-based cohort study based in Beaver Dam city and township, Wisconsin, US.  We studied 2520 hypertension-free individuals (56.3% women, age: 43-84 years, 98% Caucasian) at the baseline examn. (1988-1990).  The main outcome of interest was hypertension (systolic blood pressure (BP) of 140 mm Hg or higher, diastolic BP 90 mm Hg or higher, or combination of self-reported high BP diagnosis and use of antihypertensive medications) incidence over 10 years among baseline normotensive individuals.  Nine hundred and fifty-six individuals developed hypertension over a 10-yr follow-up period.  The relative risk (RR) (95% confidence intervals (CI)) of incident hypertension increased in a dose-dependent manner (P-trend<0.05 in all models) with increasing uric acid quartiles.  Multivariable RR (95% CI) comparing the highest quartile of serum uric acid (≥390 μmol/l) to the lowest quartile (≤260 μmol/l) was 1.65 (1.41-1.93).  This assocn. persisted in subgroup analyses by categories of smoking, alc. intake, body mass index, baseline blood pressure and estd. glomerular filtration rate (GFR).  In conclusion, increasing quartiles of serum uric acid was assocd. with 10-yr incidence of hypertension independent of smoking, alc. intake and baseline kidney function suggesting an independent pos. assocn. between serum uric acid levels and hypertension development among community-dwelling older adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZTwJtaXZ-LVg90H21EOLACvtfcHk0lieYycnOdyP6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1akurjF&md5=87ad1385c9c8f2a7dff1007fea892887</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fsj.jhh.1002095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jhh.1002095%26sid%3Dliteratum%253Aachs%26aulast%3DShankar%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKlein%26aufirst%3DB.%2BE.%2BK.%26aulast%3DNieto%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520association%2520between%2520serum%2520uric%2520acid%2520level%2520and%2520long-term%2520incidence%2520of%2520hypertension%253A%2520population-based%2520cohort%2520study%26jtitle%3DJ.%2520Hum.%2520Hypertens.%26date%3D2006%26volume%3D20%26spage%3D937%26epage%3D945%26doi%3D10.1038%2Fsj.jhh.1002095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Mellen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleyer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlinger, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenknecht, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wofford, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrington, D. M.</span><span> </span><span class="NLM_article-title">Serum uric acid predicts incident hypertension in a biethnic cohort. The atherosclerosis risk in communities study</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000249768.26560.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000249768.26560.66" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=1037-1042&author=P.+B.+Mellenauthor=A.+J.+Bleyerauthor=T.+P.+Erlingerauthor=G.+W.+Evansauthor=F.+J.+Nietoauthor=L.+E.+Wagenknechtauthor=M.+R.+Woffordauthor=D.+M.+Herrington&title=Serum+uric+acid+predicts+incident+hypertension+in+a+biethnic+cohort.+The+atherosclerosis+risk+in+communities+study&doi=10.1161%2F01.HYP.0000249768.26560.66"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000249768.26560.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000249768.26560.66%26sid%3Dliteratum%253Aachs%26aulast%3DMellen%26aufirst%3DP.%2BB.%26aulast%3DBleyer%26aufirst%3DA.%2BJ.%26aulast%3DErlinger%26aufirst%3DT.%2BP.%26aulast%3DEvans%26aufirst%3DG.%2BW.%26aulast%3DNieto%26aufirst%3DF.%2BJ.%26aulast%3DWagenknecht%26aufirst%3DL.%2BE.%26aulast%3DWofford%26aufirst%3DM.%2BR.%26aulast%3DHerrington%26aufirst%3DD.%2BM.%26atitle%3DSerum%2520uric%2520acid%2520predicts%2520incident%2520hypertension%2520in%2520a%2520biethnic%2520cohort.%2520The%2520atherosclerosis%2520risk%2520in%2520communities%2520study%26jtitle%3DHypertension%26date%3D2006%26volume%3D48%26spage%3D1037%26epage%3D1042%26doi%3D10.1161%2F01.HYP.0000249768.26560.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Krishnan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwoh, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuller, L.</span><span> </span><span class="NLM_article-title">Hyperuricemia and incidence of hypertension among men without metabolic syndrome</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1161/01.HYP.0000254480.64564.b6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1161%2F01.HYP.0000254480.64564.b6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17190877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivFKrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=298-303&author=E.+Krishnanauthor=C.+K.+Kwohauthor=H.+R.+Schumacherauthor=L.+Kuller&title=Hyperuricemia+and+incidence+of+hypertension+among+men+without+metabolic+syndrome&doi=10.1161%2F01.HYP.0000254480.64564.b6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome</span></div><div class="casAuthors">Krishnan, Eswar; Kwoh, C. Kent; Schumacher, H. Ralph; Kuller, Lewis</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-303</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The aim of this project was to study the risk of developing hypertension over a 6-yr follow-up in normotensive men with baseline hyperuricemia (serum uric acid >7.0 mg/dL) but without diabetes/glucose intolerance or metabolic syndrome.  We analyzed the data on men without metabolic syndrome or hypertension at baseline from the Multiple Risk Factor Intervention Trial.  These men (n=3073; age: 35 to 57 years) were followed for an av. of 6 years by annual examns.  Follow-up blood pressure among those with baseline was consistently higher than among those with normal serum uric acid concn.  We used Cox regression models for adjustment for the effects of serum creatinine, body mass index, age, blood pressure, proteinuria, serum cholesterol and triglycerides, alc. and tobacco use, risk factor interventions, and use of diuretics.  In these models, normotensive men with baseline hyperuricemia had an 80% excess risk for incident hypertension (hazard ratio: 1.81; 95% CI: 1.59 to 2.07) compared with those who did not.  Each unit increase in serum uric acid was assocd. with a 9% increase in the risk for incident hypertension (hazard ratio: 1.09; 95% CI: 1.02 to 1.17).  We conclude that the hyperuricemia-hypertension risk relationship is present among normotensive middle-aged men without diabetes/glucose intolerance or metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsHbjKakq3LVg90H21EOLACvtfcHk0lipH0vQrDCR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivFKrtw%253D%253D&md5=2989f4340bb7396463f0d0ca8dbd7f6b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000254480.64564.b6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000254480.64564.b6%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DE.%26aulast%3DKwoh%26aufirst%3DC.%2BK.%26aulast%3DSchumacher%26aufirst%3DH.%2BR.%26aulast%3DKuller%26aufirst%3DL.%26atitle%3DHyperuricemia%2520and%2520incidence%2520of%2520hypertension%2520among%2520men%2520without%2520metabolic%2520syndrome%26jtitle%3DHypertension%26date%3D2007%26volume%3D49%26spage%3D298%26epage%3D303%26doi%3D10.1161%2F01.HYP.0000254480.64564.b6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Edozien, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udo, U. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrimshaw, N. S.</span><span> </span><span class="NLM_article-title">Effects of high levels of yeast feeding on uric acid metabolism of young men</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="refDoi"> DOI: 10.1038/228180a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1038%2F228180a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=5460023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaE3MXhtV2hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1970&pages=180&author=J.+C.+Edozienauthor=U.+U.+Udoauthor=V.+R.+Youngauthor=N.+S.+Scrimshaw&title=Effects+of+high+levels+of+yeast+feeding+on+uric+acid+metabolism+of+young+men&doi=10.1038%2F228180a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of high levels of yeast feeding on uric acid metabolism of young men</span></div><div class="casAuthors">Edozien, J. C.; Udo, Udo U.; Young, Vernon Robert; Scrimshaw, Nevin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">5267</span>),
    <span class="NLM_cas:pages">180</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The daily feeding of 45 g of yeast contg. 2.9 g of nucleic acid increased the serum uric acid level of a subject to approx. 7 mg/100 ml which is the dividing line between normal persons and those with gout or gallstones.  For 16 days, 4 subjects were fed a controlled, low-purine diet.  Then, for 9-day periods, they received different levels of food yeast (Torula utilis [Torulopsis utilis]).  Total protein intake was maintained at 100 g/day.  Ingestion of more than 2.9 g of nucleic acid/day increased the uric acid excretion to >1000 mg/ day.  Doubling the nucleic acid ingestion to 5.8 g/day likewise doubled the uric acid excretion.  It was suggested that for normal individuals, a dietary level of 2 g of a single-cell protein/ individual/day would seem to involve the least risk of stone formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNEiMFkXXoCrVg90H21EOLACvtfcHk0lipH0vQrDCR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtV2hsg%253D%253D&md5=be49ba424d5e134dd6bf1b195c0596cc</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2F228180a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F228180a0%26sid%3Dliteratum%253Aachs%26aulast%3DEdozien%26aufirst%3DJ.%2BC.%26aulast%3DUdo%26aufirst%3DU.%2BU.%26aulast%3DYoung%26aufirst%3DV.%2BR.%26aulast%3DScrimshaw%26aufirst%3DN.%2BS.%26atitle%3DEffects%2520of%2520high%2520levels%2520of%2520yeast%2520feeding%2520on%2520uric%2520acid%2520metabolism%2520of%2520young%2520men%26jtitle%3DNature%26date%3D1970%26volume%3D228%26spage%3D180%26doi%3D10.1038%2F228180a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Yü, T.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, L.</span><span> </span><span class="NLM_article-title">Impaired renal function in gout; Its association with hypertensive vascular disease and intrinsic renal disease</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/0002-9343(82)90593-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2F0002-9343%2882%2990593-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=7058827" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1982&pages=95-100&author=T.-F.+Y%C3%BCauthor=L.+Berger&title=Impaired+renal+function+in+gout%3B+Its+association+with+hypertensive+vascular+disease+and+intrinsic+renal+disease&doi=10.1016%2F0002-9343%2882%2990593-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0002-9343%2882%2990593-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9343%252882%252990593-9%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25BC%26aufirst%3DT.-F.%26aulast%3DBerger%26aufirst%3DL.%26atitle%3DImpaired%2520renal%2520function%2520in%2520gout%253B%2520Its%2520association%2520with%2520hypertensive%2520vascular%2520disease%2520and%2520intrinsic%2520renal%2520disease%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1982%26volume%3D72%26spage%3D95%26epage%3D100%26doi%3D10.1016%2F0002-9343%2882%2990593-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Ciompi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Caterina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernini, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelassi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L’Abbate, A.</span><span> </span><span class="NLM_article-title">Uric acid levels and platelet function in humans. An in-vivo ex-vivo study</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=6085297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaL3sXlslCks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1983&pages=143-147&author=M.+L.+Ciompiauthor=R.+De+Caterinaauthor=D.+Bertolucciauthor=W.+Berniniauthor=C.+Michelassiauthor=A.+L%E2%80%99Abbate&title=Uric+acid+levels+and+platelet+function+in+humans.+An+in-vivo+ex-vivo+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Uric acid levels and platelet function in humans.  An in-vivo ex-vivo study</span></div><div class="casAuthors">Ciompi, M. L.; De Caterina, R.; Bertolucci, D.; Bernini, W.; Michelassi, C.; L'Abbate, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Rheumatology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-7</span>CODEN:
                <span class="NLM_cas:coden">CERHDP</span>;
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">Platelet function (aggregation by ADP, adrenaline, collagen, and circulating platelet aggregates) before, during, and after dietary induction of hyperuricemia (RNA, 3 g/day) was studied in 5 healthy volunteers to assess the relationship between uric acid  [69-93-2] level and platelet function.  In the same subjects, during a 2nd period of RNA diet, the acute and chronic effects of a hypo-uricemizing agent, allopurinol, were assessed.  No significant correlation was detected between platelet function and uricemia either in the absence or in the presence of pharmacol. treatment with allopurinol.  On the basis of these results, the well known relationship between uric acid levels and ischemic heart disease does not appear to be mediated by an exaggerated platelet function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4oPLgoXUMHbVg90H21EOLACvtfcHk0lgtrCED1BrxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslCks7k%253D&md5=aad3ca5c3ece5d562de3cb3f9817a96d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiompi%26aufirst%3DM.%2BL.%26aulast%3DDe%2BCaterina%26aufirst%3DR.%26aulast%3DBertolucci%26aufirst%3DD.%26aulast%3DBernini%26aufirst%3DW.%26aulast%3DMichelassi%26aufirst%3DC.%26aulast%3DL%25E2%2580%2599Abbate%26aufirst%3DA.%26atitle%3DUric%2520acid%2520levels%2520and%2520platelet%2520function%2520in%2520humans.%2520An%2520in-vivo%2520ex-vivo%2520study%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D1983%26volume%3D1%26spage%3D143%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curhan, G.</span><span> </span><span class="NLM_article-title">Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid. The Third National Health and Nutrition Examination Survey</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1002/art.20761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1002%2Fart.20761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15641075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FitVymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=283-289&author=H.+K.+Choiauthor=S.+Liuauthor=G.+Curhan&title=Intake+of+purine-rich+foods%2C+protein%2C+and+dairy+products+and+relationship+to+serum+levels+of+uric+acid.+The+Third+National+Health+and+Nutrition+Examination+Survey&doi=10.1002%2Fart.20761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey</span></div><div class="casAuthors">Choi Hyon K; Liu Simin; Curhan Gary</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-9</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  Various commonly consumed foods have long been suspected of affecting the serum uric acid level, but few data are available to support or refute this impression.  Our objective was to evaluate the relationship between dietary factors and serum uric acid levels in a nationally representative sample of men and women in the US.  METHODS:  Using data from 14,809 participants (6,932 men and 7,877 women) ages 20 years and older in the Third National Health and Nutrition Examination Survey (for the years 1988-1994), we examined the relationship between the intake of purine-rich foods, protein, and dairy products and serum levels of uric acid.  Diet was assessed with a food-frequency questionnaire.  We used multivariate linear regression to adjust for age, sex, total energy intake, body mass index, use of diuretics, beta-blockers, allopurinol, and uricosuric agents, self-reported hypertension and gout, serum creatinine level, and intake of alcohol.  RESULTS:  The serum uric acid level increased with increasing total meat or seafood intake and decreased with increasing dairy intake.  After adjusting for age, the differences in uric acid levels between the extreme quintiles of intake were 0.48 mg/dl for total meat (95% confidence interval [95% CI] 0.34, 0.61; P < 0.001 for trend), 0.16 mg/dl for seafood (95% CI 0.06, 0.27; P = 0.005 for trend), and -0.21 mg/dl for total dairy intake (95% CI -0.37, -0.04; P = 0.02 for trend).  After adjusting for other covariates, the differences between the extreme quintiles were attenuated but remained significant (P < 0.05 for all comparisons).  The total protein intake was not associated with the serum uric acid level in multivariate analyses (P = 0.74 for trend).  Those who consumed milk 1 or more times per day had a lower serum uric acid level than did those who did not drink milk (multivariate difference -0.25 [95% CI -0.40, -0.09]; P < 0.001 for trend).  Similarly, those who consumed yogurt at least once every other day had a lower serum uric acid level than did those who did not consume yogurt (multivariate difference -0.26 [95% CI -0.41, -0.12]; P < 0.001 for trend).  CONCLUSION:  These findings from a nationally representative sample of adults in the US suggest that higher levels of meat and seafood consumption are associated with higher serum levels of uric acid but that total protein intake is not.  Dairy consumption was inversely associated with the serum uric acid level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQy4oLfwrmagjAEfvC7EH1LfW6udTcc2eaYKlZY0zxq8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FitVymsg%253D%253D&md5=a7c87de81af75a89863eea32ead51440</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fart.20761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.20761%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCurhan%26aufirst%3DG.%26atitle%3DIntake%2520of%2520purine-rich%2520foods%252C%2520protein%252C%2520and%2520dairy%2520products%2520and%2520relationship%2520to%2520serum%2520levels%2520of%2520uric%2520acid.%2520The%2520Third%2520National%2520Health%2520and%2520Nutrition%2520Examination%2520Survey%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D283%26epage%3D289%26doi%3D10.1002%2Fart.20761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlson, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curhan, G.</span><span> </span><span class="NLM_article-title">Purine-rich foods, dairy and protein intake, and the risk of gout in men</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.1056/NEJMoa035700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1056%2FNEJMoa035700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15014182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitV2qur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1093-1103&author=H.+K.+Choiauthor=K.+Atkinsonauthor=E.+W.+Karlsonauthor=W.+Willettauthor=G.+Curhan&title=Purine-rich+foods%2C+dairy+and+protein+intake%2C+and+the+risk+of+gout+in+men&doi=10.1056%2FNEJMoa035700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Purine-rich foods, dairy and protein intake, and the risk of gout in men</span></div><div class="casAuthors">Choi, Hyon K.; Atkinson, Karen; Karlson, Elizabeth W.; Willett, Walter; Curhan, Gary</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1093-1103</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Purine-rich foods and high protein intakes may be risk factors for gout development.  Consumption of dairy products may protect against gout.  We investigated the assocn. of these dietary factors in new cases of gout prospectively over 12-yr period.  The relationship between dietary risk factors and new cases of gout was examd. in 47,150 men who had no history of gout at baseline.  The diet was assessed every 4 yr by food-frequency questionnaire.  During the 12-yr study there were 730 confirmed new cases of gout.  The multivariate relative risk of gout among men in the highest vs. lowest quintile of meat intake was 1.41 (95% CI 1.07-1.86); the corresponding relative risk assocd. with seafood intake was 1.51 (95% CI 1.17-1.95).  The incidence of gout decreased with increasing intakes of dairy products; the multivariate relative risk among men in the highest vs. lowest quintile was 0.56 (95% CI 0.42-0.74).  The level of consumption of purine-rich vegetables and the total protein intake were not assocd. with increased risk of gout.  Thus, higher levels of meat and seafood consumption were assocd. with increased risk of gout, whereas higher levels of dairy products consumption was assocd. with decreased risk.  Moderate intake of purine-rich vegetables or protein was not assocd. with increased risk of gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCuZGM3pHt-LVg90H21EOLACvtfcHk0lgtrCED1BrxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitV2qur4%253D&md5=f3642d563b140796e2b6b1c268f78339</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa035700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa035700%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DKarlson%26aufirst%3DE.%2BW.%26aulast%3DWillett%26aufirst%3DW.%26aulast%3DCurhan%26aufirst%3DG.%26atitle%3DPurine-rich%2520foods%252C%2520dairy%2520and%2520protein%2520intake%252C%2520and%2520the%2520risk%2520of%2520gout%2520in%2520men%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1093%26epage%3D1103%26doi%3D10.1056%2FNEJMoa035700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Stafford, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmerson, B. T.</span><span> </span><span class="NLM_article-title">Effect of purine restriction on serum and urine urate in normal subjects</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">165A</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span><span class="refDoi"> DOI: 10.1007/978-1-4684-4553-4_61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2F978-1-4684-4553-4_61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165A&publication_year=1984&pages=309-316&author=W.+Staffordauthor=B.+T.+Emmerson&title=Effect+of+purine+restriction+on+serum+and+urine+urate+in+normal+subjects&doi=10.1007%2F978-1-4684-4553-4_61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2F978-1-4684-4553-4_61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4684-4553-4_61%26sid%3Dliteratum%253Aachs%26aulast%3DStafford%26aufirst%3DW.%26aulast%3DEmmerson%26aufirst%3DB.%2BT.%26atitle%3DEffect%2520of%2520purine%2520restriction%2520on%2520serum%2520and%2520urine%2520urate%2520in%2520normal%2520subjects%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1984%26volume%3D165A%26spage%3D309%26epage%3D316%26doi%3D10.1007%2F978-1-4684-4553-4_61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Emmerson, B. T.</span><span> </span><span class="NLM_article-title">Identification of the causes of persistent hyperuricaemia</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1463</span><span class="refDoi"> DOI: 10.1016/0140-6736(91)93141-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2F0140-6736%2891%2993141-U" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1991&pages=1461-1463&author=B.+T.+Emmerson&title=Identification+of+the+causes+of+persistent+hyperuricaemia&doi=10.1016%2F0140-6736%2891%2993141-U"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0140-6736%2891%2993141-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0140-6736%252891%252993141-U%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerson%26aufirst%3DB.%2BT.%26atitle%3DIdentification%2520of%2520the%2520causes%2520of%2520persistent%2520hyperuricaemia%26jtitle%3DLancet%26date%3D1991%26volume%3D337%26spage%3D1461%26epage%3D1463%26doi%3D10.1016%2F0140-6736%2891%2993141-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Kong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Mammalian nucleoside transporters</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.2174/1389200043489162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F1389200043489162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=14965251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVCisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=63-84&author=W.+Kongauthor=K.+Engelauthor=J.+Wang&title=Mammalian+nucleoside+transporters&doi=10.2174%2F1389200043489162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian nucleoside transporters</span></div><div class="casAuthors">Kong, Wei; Engel, Karen; Wang, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nucleoside transporters mediate cellular uptake of physiol. nucleosides for nucleic acid synthesis in the salvage pathways in many cell types.  These transporters also play an important role in in vivo disposition and intracellular targeting of many nucleoside analogs used in anticancer and antiviral drug therapy.  In mammalian cells, there are two major nucleoside transporter gene families: the equilibrative nucleoside transporters (ENTs) and the concentrative nucleoside transporters (CNTs).  The ENTs are facilitated carrier proteins and the CNTs are Na+-dependent secondary active transporters.  Recent mol. cloning of a no. of ENT and CNT transporters has greatly advanced our understanding of the mol. and cellular mechanisms by which nucleosides and nucleoside analogs are transported across biol. membranes.  In this manuscript, we review the structure, function, tissue distribution, and cellular localization of various cloned mammalian nucleoside transporters.  Information on transporter interaction with various nucleoside drugs and analogs is presented.  Current knowledge on the regulation of nucleoside transporters in various cell types and tissues is reviewed.  The therapeutic significance of nucleoside transporters is discussed along with emerging data from recent clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZk2rVY91y7Vg90H21EOLACvtfcHk0liFe1Y4s_13PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVCisLg%253D&md5=cf44fb2dfaa5e21027a826508418a893</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F1389200043489162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200043489162%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DW.%26aulast%3DEngel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DMammalian%2520nucleoside%2520transporters%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2004%26volume%3D5%26spage%3D63%26epage%3D84%26doi%3D10.2174%2F1389200043489162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">King, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span> </span><span class="NLM_article-title">Nucleoside transporters: from scavengers to novel therapeutic targets</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1016/j.tips.2006.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.tips.2006.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=16820221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=416-425&author=A.+E.+Kingauthor=M.+A.+Ackleyauthor=C.+E.+Cassauthor=J.+D.+Youngauthor=S.+A.+Baldwin&title=Nucleoside+transporters%3A+from+scavengers+to+novel+therapeutic+targets&doi=10.1016%2Fj.tips.2006.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside transporters: from scavengers to novel therapeutic targets</span></div><div class="casAuthors">King, Anne E.; Ackley, Michael A.; Cass, Carol E.; Young, James D.; Baldwin, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">416-425</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hydrophilic purine and pyrimidine nucleosides rely on specialized carrier proteins for their membrane translocation.  The recent identification of two gene families encoding equilibrative and concentrative nucleoside transporters in mammals and other organisms has provided the essential breakthrough to a more complete understanding of the biol. significance of nucleoside transport.  Although nucleoside salvage is a primary function of these proteins, recent data indicate functions beyond metabolic recycling.  In brain and spinal cord, for example, nucleoside transporters have the potential to regulate synaptic levels of neuroactive purines such as adenosine and, thereby, indirectly modulate physiol. processes through G-protein-coupled purine P1 receptors.  As described in this review, recent research indicates novel putative functions for CNS nucleoside transporters in sleep, arousal, drug and alc. addiction, nociception and analgesia.  The therapeutic use of nucleoside analog drugs and nucleoside transporter inhibitors in viral, neoplastic, cardiovascular and infectious disease is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIDQRtv6l-PrVg90H21EOLACvtfcHk0liFe1Y4s_13PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsro%253D&md5=8046d41e24553ca9add8e5b97873f9b1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BE.%26aulast%3DAckley%26aufirst%3DM.%2BA.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26atitle%3DNucleoside%2520transporters%253A%2520from%2520scavengers%2520to%2520novel%2520therapeutic%2520targets%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D416%26epage%3D425%26doi%3D10.1016%2Fj.tips.2006.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span> </span><span class="NLM_article-title">The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1007/s10555-007-9044-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs10555-007-9044-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=17345146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=85-110&author=J.+Zhangauthor=F.+Visserauthor=K.+M.+Kingauthor=S.+A.+Baldwinauthor=J.+D.+Youngauthor=C.+E.+Cass&title=The+role+of+nucleoside+transporters+in+cancer+chemotherapy+with+nucleoside+drugs&doi=10.1007%2Fs10555-007-9044-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs</span></div><div class="casAuthors">Zhang, Jing; Visser, Frank; King, Karen M.; Baldwin, Stephen A.; Young, James D.; Cass, Carol E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-110</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Nucleoside analogs are important components of treatment regimens for various malignancies.  Nucleoside-specific membrane transporters mediate plasma membrane permeation of physiol. nucleosides and most nucleoside analogs, for which the initial event is cellular conversion of nucleosides to active agents. Understanding of the roles of nucleoside transporters in nucleoside drug toxicity and resistance will provide opportunities for potentiating anticancer efficacy and avoiding resistance.  Because transportability is a possible determinant of toxicity and resistance of many nucleoside analogs, nucleoside transporter abundance might be a prognostic marker to assess drug resistance.  Elucidation of the structural determinants of nucleoside analogs for interaction with transporter proteins as well as the structural features of transporter proteins required for permeant interaction and translocation will lead to "transportability guidelines" for the rational design and therapeutic application of nucleoside analogs as anticancer drugs.  It should eventually be possible to develop clin. assays that predict sensitivity and/or resistance to nucleoside anti-cancer drugs and thus to identify those patient populations that will most likely benefit from optimal nucleoside analog treatments.  This review discusses recent results from structure/function studies of human nucleoside transporters, the role of nucleoside transport processes in the cytotoxicity and resistance of several anticancer nucleoside analogs and strategies to improve the nucleoside transporter-related anticancer effects of nucleoside analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop6_0ME-AYJrVg90H21EOLACvtfcHk0liFe1Y4s_13PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqt7c%253D&md5=a8487b1c6234b64f60dbd41f9c6425b8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9044-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9044-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DVisser%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DK.%2BM.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DCass%26aufirst%3DC.%2BE.%26atitle%3DThe%2520role%2520of%2520nucleoside%2520transporters%2520in%2520cancer%2520chemotherapy%2520with%2520nucleoside%2520drugs%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26spage%3D85%26epage%3D110%26doi%3D10.1007%2Fs10555-007-9044-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Molina-Arcas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor-Anglada, M.</span><span> </span><span class="NLM_article-title">Nucleoside transporter proteins</span> <span class="citation_source-journal">Curr. Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.2174/157016109789043892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F157016109789043892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=19485885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlaltrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=426-434&author=M.+Molina-Arcasauthor=F.+J.+Casadoauthor=M.+Pastor-Anglada&title=Nucleoside+transporter+proteins&doi=10.2174%2F157016109789043892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside transporter proteins</span></div><div class="casAuthors">Molina-Arcas, Miriam; Casado, F. Javier; Pastor-Anglada, Marcal</div><div class="citationInfo"><span class="NLM_cas:title">Current Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">426-434</span>CODEN:
                <span class="NLM_cas:coden">CVPUAY</span>;
        ISSN:<span class="NLM_cas:issn">1570-1611</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Concentrative nucleoside transporters (CNT; SLC28) and equilibrative nucleoside transporters (ENT; SLC29) mediate the uptake of natural nucleosides and a variety of nucleoside-derived drugs, mostly used in anticancer therapy.  SLC28 and SLC29 families consist in three and four members, resp., which differ in their substrate selectivity and their energy requirements.  Tissue distribution of these transporters is not homogeneous among tissues, and their expression can be regulated.  In epithelial, CNT and ENT proteins are mostly localized in the apical and basolateral membranes, resp., which results in nucleoside and nucleoside-derived drugs vectorial flux.  Nucleoside transporters can play physiol. roles other than salvages, such as the modulation of extracellular and intracellular adenosine concns.  Moreover, these transporters also have clin. significance.  ENT proteins are target of dipyridamole and dilazep, used as vasodilatory drugs in the treatment of heart and vascular diseases.  On the other hand, nucleoside transporters are responsible for the cellular uptake of currently used anticancer nucleoside-derived drugs, thus these membrane proteins might play a significant role in nucleoside-based chemotherapy.  Finally, several polymorphisms have been described in CNT and ENT proteins that could affect nucleoside homeostasis, adenosine signaling events or nucleoside-derived drug cytotoxicity or pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6QSfaVZrWuLVg90H21EOLACvtfcHk0lh2m25jYsAerg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlaltrrF&md5=087c19c72d4fcb508444506bf83567c5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F157016109789043892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016109789043892%26sid%3Dliteratum%253Aachs%26aulast%3DMolina-Arcas%26aufirst%3DM.%26aulast%3DCasado%26aufirst%3DF.%2BJ.%26aulast%3DPastor-Anglada%26aufirst%3DM.%26atitle%3DNucleoside%2520transporter%2520proteins%26jtitle%3DCurr.%2520Vasc.%2520Pharmacol.%26date%3D2009%26volume%3D7%26spage%3D426%26epage%3D434%26doi%3D10.2174%2F157016109789043892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Damaraju, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span> </span><span class="NLM_article-title">Human nucleoside transporters: Biomarkers for response to nucleoside drugs</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1080/15257770903044499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1080%2F15257770903044499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=20183595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=450-463&author=V.+L.+Damarajuauthor=M.+B.+Sawyerauthor=J.+R.+Mackeyauthor=J.+D.+Youngauthor=C.+E.+Cass&title=Human+nucleoside+transporters%3A+Biomarkers+for+response+to+nucleoside+drugs&doi=10.1080%2F15257770903044499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Human nucleoside transporters: biomarkers for response to nucleoside drugs</span></div><div class="casAuthors">Damaraju, Vijaya L.; Sawyer, Michael B.; Mackey, John R.; Young, James D.; Cass, Carol E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">450-463</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">This review describes recent advances in developing human nucleoside transporters (hNTs) as biomarkers to predict response to nucleoside analog drugs with clin. activity.  Understanding processes that contribute to drug response or lack thereof will provide strategies to potentiate efficacy or avoid toxicities of nucleoside analog drugs.  HNT abundance, evaluated by immunohistochem. methods, has shown promise as a predictive marker to assess clin. drug response that could be used to identify patients who would most likely benefit from nucleoside analog drug treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7jJpO026jWrVg90H21EOLACvtfcHk0lh2m25jYsAerg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgsb7F&md5=f106473d7e0196be500b07a8942c8005</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F15257770903044499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770903044499%26sid%3Dliteratum%253Aachs%26aulast%3DDamaraju%26aufirst%3DV.%2BL.%26aulast%3DSawyer%26aufirst%3DM.%2BB.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DCass%26aufirst%3DC.%2BE.%26atitle%3DHuman%2520nucleoside%2520transporters%253A%2520Biomarkers%2520for%2520response%2520to%2520nucleoside%2520drugs%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2009%26volume%3D28%26spage%3D450%26epage%3D463%26doi%3D10.1080%2F15257770903044499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Parkinson, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaraju, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">Molecular biology of nucleoside transporters and their distributions and functions in the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span><span class="refDoi"> DOI: 10.2174/156802611795347582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.2174%2F156802611795347582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=21401500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=948-972&author=F.+E.+Parkinsonauthor=V.+L.+Damarajuauthor=K.+Grahamauthor=S.+Y.+M.+Yaoauthor=S.+A.+Baldwinauthor=C.+E.+Cassauthor=J.+D.+Young&title=Molecular+biology+of+nucleoside+transporters+and+their+distributions+and+functions+in+the+brain&doi=10.2174%2F156802611795347582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of nucleoside transporters and their distributions and functions in the brain</span></div><div class="casAuthors">Parkinson, Fiona E.; Damaraju, Vijaya L.; Graham, Kathryn; Yao, Sylvia Y. M.; Baldwin, Stephen A.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">948-972</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Pyrimidine and purine nucleosides and their derivs. have crit. functions and pharmacol. applications in the brain.  Nucleosides and nucleobases are precursors of nucleotides, which serve as the energy-rich currency of intermediary metab. and as precursors of nucleic acids.  Nucleosides (e.g., adenosine) and nucleotides are key signaling mols. that modulate brain function through interaction with cell surface receptors.  Brain pathologies involving nucleosides and their metabolites range from epilepsy to neurodegenerative disorders and psychiatric conditions to cerebrovascular ischemia.  Nucleoside analogs are used clin. in the treatment of brain cancer and viral infections.  Nucleosides are hydrophilic mols., and transportability across cell membranes via specialized nucleoside transporter (NT) proteins is a crit. determinant of their metab. and, for nucleoside drugs, their pharmacol. actions.  In mammals, there are two types of nucleoside transport process: bidirectional equilibrative processes driven by chem. gradients, and unidirectional concentrative processes driven by sodium (and proton) electrochem. gradients.  In mammals, these processes, both of which are present in brain, are mediated by members of two structurally unrelated membrane protein families (ENT and CNT, resp.).  In this Chapter, we review current knowledge of cellular, physiol., pathophysiol. and therapeutic aspects of ENT and CNT distribution and function in the mammalian brain, including studies with NT inhibitors and new research involving NT knockout and transgenic mice.  We also describe recent progress in functional and mol. studies of ENT and CNT proteins, and summarize emerging evidence of other transporter families with demonstrated or potential roles in the transport of nucleosides and their derivs. in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcSfa1v5U49bVg90H21EOLACvtfcHk0lh2m25jYsAerg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLs%253D&md5=3ae60f56621756708a806d64cae57fa7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2174%2F156802611795347582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795347582%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DF.%2BE.%26aulast%3DDamaraju%26aufirst%3DV.%2BL.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520biology%2520of%2520nucleoside%2520transporters%2520and%2520their%2520distributions%2520and%2520functions%2520in%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D948%26epage%3D972%26doi%3D10.2174%2F156802611795347582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Gray, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, K. M.</span><span> </span><span class="NLM_article-title">The concentrative nucleoside transporter family, SLC28</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span><span class="refDoi"> DOI: 10.1007/s00424-003-1107-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs00424-003-1107-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=12856181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVygtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2004&pages=728-734&author=J.+H.+Grayauthor=R.+P.+Owenauthor=K.+M.+Giacomini&title=The+concentrative+nucleoside+transporter+family%2C+SLC28&doi=10.1007%2Fs00424-003-1107-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The concentrative nucleoside transporter family, SLC28</span></div><div class="casAuthors">Gray, Jennifer H.; Owen, Ryan P.; Giacomini, Kathleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">728-734</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The SLC28 family consists of three subtypes of sodium-dependent, concentrative nucleoside transporters, CNT1, CNT2, and CNT3 (SLC28A1, SLC28A2, and SLC28A3, resp.), that transport both naturally occurring nucleosides and synthetic nucleoside analogs used in the treatment of various diseases.  These subtypes differ in their substrate specificities: CNT1 is pyrimidine-nucleoside preferring, CNT2 is purine-nucleoside preferring, and CNT3 transports both pyrimidine and purine nucleosides.  Recent studies have identified key amino acid residues that are determinants of pyrimidine and purine specificity of CNT1 and CNT2.  The tissue distributions of the CNTs vary: CNT1 is localized primarily in epithelia, whereas CNT2 and CNT3 have more generalized distributions.  Nucleoside transporters in the SLC28 and SLC29 families play crit. roles in nucleoside salvage pathways where they mediate the first step of nucleotide biosynthesis.  In addn., these transporters work in concert to terminate adenosine signaling.  SLC28 family members are crucial determinants of response to a variety of anticancer and antiviral nucleoside analogs, as they modulate the entry of these analogs into target tissues.  Further, this family is involved in the absorption and disposition of many nucleoside analogs.  Several CNT single nucleoside polymorphisms (SNPs) have been identified, but have yet to be characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt0s05_IoTLLVg90H21EOLACvtfcHk0libUIAe1_F8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVygtr0%253D&md5=e1ab38f2dccfb8ea978a3263c0d8117b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00424-003-1107-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-003-1107-y%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DJ.%2BH.%26aulast%3DOwen%26aufirst%3DR.%2BP.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DThe%2520concentrative%2520nucleoside%2520transporter%2520family%252C%2520SLC28%26jtitle%3DPfluegers%2520Arch.%26date%3D2004%26volume%3D447%26spage%3D728%26epage%3D734%26doi%3D10.1007%2Fs00424-003-1107-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Smith, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slugoski, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">The broadly selective human Na<sup>+</sup>/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">25436</span><span class="NLM_x">–</span> <span class="NLM_lpage">25449</span><span class="refDoi"> DOI: 10.1074/jbc.M409454200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1074%2Fjbc.M409454200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=15870078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslyltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25436-25449&author=K.+M.+Smithauthor=M.+D.+Slugoskiauthor=S.+K.+Loewenauthor=A.+M.+L.+Ngauthor=S.+Y.+M.+Yaoauthor=X.-Z.+Chenauthor=E.+Karpinskiauthor=C.+E.+Cassauthor=S.+A.+Baldwinauthor=J.+D.+Young&title=The+broadly+selective+human+Na%2B%2Fnucleoside+cotransporter+%28hCNT3%29+exhibits+novel+cation-coupled+nucleoside+transport+characteristics&doi=10.1074%2Fjbc.M409454200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Broadly Selective Human Na+/Nucleoside Cotransporter (hCNT3) Exhibits Novel Cation-coupled Nucleoside Transport Characteristics</span></div><div class="casAuthors">Smith, Kyla M.; Slugoski, Melissa D.; Loewen, Shaun K.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Chen, Xing-Zhen; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">25436-25449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The concentrative nucleoside transporter (CNT) protein family in humans is represented by three members, hCNT1, hCNT2, and hCNT3.  HCNT3, a Na+/nucleoside symporter, transports a broad range of physiol. purine and pyrimidine nucleosides as well as anticancer and antiviral nucleoside drugs, and belongs to a different CNT subfamily than hCNT1/2.  H+-dependent Escherichia coli NupC and Candida albicans CaCNT are also CNT family members.  The present study utilized heterologous expression in Xenopus oocytes to investigate the specificity, mechanism, energetics, and structural basis of hCNT3 cation coupling.  HCNT3 exhibited uniquely broad cation interactions with Na+, H+, and Li+ not shared by Na+-coupled hCNT1/2 or H+-coupled NupC/CaCNT.  Na+ and H+ activated hCNT3 through mechanisms to increase nucleoside apparent binding affinity.  Direct and indirect methods demonstrated cation/nucleoside coupling stoichiometries of 2:1 in the presence of Na+ and both Na+ plus H+, but only 1:1 in the presence of H+ alone, suggesting that hCNT3 possesses two Na+-binding sites, only one of which is shared by H+.  The H+-coupled hCNT3 did not transport guanosine or 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine, demonstrating that Na+- and H+-bound versions of hCNT3 have significantly different conformations of the nucleoside binding pocket and/or translocation channel.  Chimeric studies between hCNT1 and hCNT3 located hCNT3-specific cation interactions to the C-terminal half of hCNT3, setting the stage for site-directed mutagenesis expts. to identify the residues involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4bEqiGSKSFrVg90H21EOLACvtfcHk0libUIAe1_F8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslyltbs%253D&md5=ab23cba0b33a5b48384b4317d1e1fa87</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409454200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409454200%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DSlugoski%26aufirst%3DM.%2BD.%26aulast%3DLoewen%26aufirst%3DS.%2BK.%26aulast%3DNg%26aufirst%3DA.%2BM.%2BL.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DChen%26aufirst%3DX.-Z.%26aulast%3DKarpinski%26aufirst%3DE.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520broadly%2520selective%2520human%2520Na%252B%252Fnucleoside%2520cotransporter%2520%2528hCNT3%2529%2520exhibits%2520novel%2520cation-coupled%2520nucleoside%2520transport%2520characteristics%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25436%26epage%3D25449%26doi%3D10.1074%2Fjbc.M409454200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">The equilibrative nucleoside transporter family, SLC29</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span><span class="refDoi"> DOI: 10.1007/s00424-003-1103-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1007%2Fs00424-003-1103-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=12838422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2004&pages=735-743&author=S.+A.+Baldwinauthor=P.+R.+Bealauthor=S.+Y.+M.+Yaoauthor=A.+E.+Kingauthor=C.+E.+Cassauthor=J.+D.+Young&title=The+equilibrative+nucleoside+transporter+family%2C+SLC29&doi=10.1007%2Fs00424-003-1103-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The equilibrative nucleoside transporter family, SLC29</span></div><div class="casAuthors">Baldwin, Stephen A.; Beal, Paul R.; Yao, Sylvia Y. M.; King, Anne E.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">735-743</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The human SLC29 family of proteins contains four members, designated equilibrative nucleoside transporters (ENTs) because of the properties of the first-characterized family member, hENT1.  They belong to the widely-distributed eukaryotic ENT family of equilibrative and concentrative nucleoside/nucleobase transporters and are distantly related to a lysosomal membrane protein, CLN3, mutations in which cause neuronal ceroid lipofuscinosis.  A predicted topol. of 11 transmembrane helixes with a cytoplasmic N-terminus and an extracellular C-terminus has been exptl. confirmed for hENT1.  The best-characterized members of the family, hENT1 and hENT2, possess similar broad substrate specificities for purine and pyrimidine nucleosides, but hENT2 in addn. efficiently transports nucleobases.  The ENT3 and ENT4 isoforms have more recently also been shown to be genuine nucleoside transporters.  All four isoforms are widely distributed in mammalian tissues, although their relative abundance varies: ENT2 is particularly abundant in skeletal muscle.  In polarized cells ENT1 and ENT2 are found in the basolateral membrane and, in tandem with concentrative transporters of the SLC28 family, may play a role in transepithelial nucleoside transport.  The transporters play key roles in nucleoside and nucleobase uptake for salvage pathways of nucleotide synthesis, and are also responsible for the cellular uptake of nucleoside analogs used in the treatment of cancers and viral diseases.  In addn., by regulating the concn. of adenosine available to cell surface receptors, they influence many physiol. processes ranging from cardiovascular activity to neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotvcZfpp35T7Vg90H21EOLACvtfcHk0libUIAe1_F8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVygsbk%253D&md5=f8fda351e0b312d78e1e2fa21aab850c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00424-003-1103-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-003-1103-2%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DBeal%26aufirst%3DP.%2BR.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DKing%26aufirst%3DA.%2BE.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520equilibrative%2520nucleoside%2520transporter%2520family%252C%2520SLC29%26jtitle%3DPfluegers%2520Arch.%26date%3D2004%26volume%3D447%26spage%3D735%26epage%3D743%26doi%3D10.1007%2Fs00424-003-1103-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hiratochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuramochi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">690</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2012.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.ejphar.2012.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=22709993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=690&publication_year=2012&pages=183-191&author=M.+Hiratochiauthor=K.+Tataniauthor=K.+Shimizuauthor=Y.+Kuramochiauthor=N.+Kikuchiauthor=N.+Kamadaauthor=F.+Itohauthor=M.+Isaji&title=Hypouricemic+effects+of+novel+concentrative+nucleoside+transporter+2+inhibitors+through+suppressing+intestinal+absorption+of+purine+nucleosides&doi=10.1016%2Fj.ejphar.2012.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides</span></div><div class="casAuthors">Hiratochi, Masahiro; Tatani, Kazuya; Shimizu, Kazuo; Kuramochi, Yu; Kikuchi, Norihiko; Kamada, Noboru; Itoh, Fumiaki; Isaji, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">690</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">183-191</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed concentrative nucleoside transporter 2 (CNT2) inhibitors as a novel pharmacol. approach for improving hyperuricemia by inhibiting intestinal absorption of purines.  Dietary purine nucleosides are absorbed in the small intestines by CNTs expressed in the apical membrane.  In humans, the absorbed purine nucleosides are rapidly degraded to their final end product, uric acid, by xanthine oxidase.  Based on the expression profile of human CNTs in digestive tract tissues, we established a working hypothesis that mainly CNT2 contributes to the intestinal absorption of purine nucleosides.  In order to confirm this possibility, we developed CNT2 inhibitors and found that (2R,3R,4S,5R)-2-(6-amino-8-{[3'-(3-aminopropoxy)-biphenyl-4-ylmethyl]-amino}-9H-purin-9-yl)-5-hydroxymethyl-tetrahydrofuran-3,4-diol (KGO-2142) and 1-[3-(5-{[1-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydrofuran-2-yl)-1H-benzimidazol-2-ylamino]-methyl}-2-ethoxyphenoxy)-propyl]-piperidine-4-carboxylic acid amide (KGO-2173) were inhibitory.  These CNT2 inhibitors had potent inhibitory activity against inosine uptake via human CNT2, but they did not potently interfere with nucleoside uptake via human CNT1, CNT3 or equilibrative nucleoside transporters (ENTs) in vitro.  After oral administration of KGO-2173 along with [14C]-inosine, KGO-2173 significantly decreased the urinary excretion of radioactivity at 6 and 24 h in rats.  Since dietary purine nucleosides are not utilized in the body and are excreted into the urine rapidly, this decrease in radioactivity in the urine represented the inhibitory activity of KGO-2173 toward the absorption of [14C]-inosine in the small intestines.  KGO-2142 almost completely inhibited dietary RNA-induced hyperuricemia and the increase in urinary excretion of uric acid in cebus monkeys.  These novel CNT2 inhibitors, KGO-2142 and KGO-2173, could be useful therapeutic options for the treatment of hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_du09fjQTgrVg90H21EOLACvtfcHk0lhhNGAwWYUcpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgu77K&md5=638d64359fef790478e2abcfb42e3964</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DHiratochi%26aufirst%3DM.%26aulast%3DTatani%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DKuramochi%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DN.%26aulast%3DKamada%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DHypouricemic%2520effects%2520of%2520novel%2520concentrative%2520nucleoside%2520transporter%25202%2520inhibitors%2520through%2520suppressing%2520intestinal%2520absorption%2520of%2520purine%2520nucleosides%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D690%26spage%3D183%26epage%3D191%26doi%3D10.1016%2Fj.ejphar.2012.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Tatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, S.</span><span> </span><span class="NLM_article-title">Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1021/ml500343r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500343r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=244-248&author=K.+Tataniauthor=M.+Hiratochiauthor=Y.+Nonakaauthor=M.+Isajiauthor=S.+Shuto&title=Identification+of+8-aminoadenosine+derivatives+as+a+new+class+of+human+concentrative+nucleoside+transporter+2+inhibitors&doi=10.1021%2Fml500343r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fml500343r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500343r%26sid%3Dliteratum%253Aachs%26aulast%3DTatani%26aufirst%3DK.%26aulast%3DHiratochi%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIsaji%26aufirst%3DM.%26aulast%3DShuto%26aufirst%3DS.%26atitle%3DIdentification%2520of%25208-aminoadenosine%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520human%2520concentrative%2520nucleoside%2520transporter%25202%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D244%26epage%3D248%26doi%3D10.1021%2Fml500343r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giltay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Functional expression of human intestinal Na<sup>+</sup>-dependent and Na<sup>+</sup>-independent nucleoside transporters in Xenopus laevis oocytes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span><span class="refDoi"> DOI: 10.1016/S0006-2952(97)00170-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2FS0006-2952%2897%2900170-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=1909-1918&author=G.+Chandrasenaauthor=R.+Giltayauthor=S.+D.+Patilauthor=A.+Bakkenauthor=J.+D.+Unadkat&title=Functional+expression+of+human+intestinal+Na%2B-dependent+and+Na%2B-independent+nucleoside+transporters+in+Xenopus+laevis+oocytes&doi=10.1016%2FS0006-2952%2897%2900170-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900170-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900170-6%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DGiltay%26aufirst%3DR.%26aulast%3DPatil%26aufirst%3DS.%2BD.%26aulast%3DBakken%26aufirst%3DA.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DFunctional%2520expression%2520of%2520human%2520intestinal%2520Na%252B-dependent%2520and%2520Na%252B-independent%2520nucleoside%2520transporters%2520in%2520Xenopus%2520laevis%2520oocytes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D53%26spage%3D1909%26epage%3D1918%26doi%3D10.1016%2FS0006-2952%2897%2900170-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Ngo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Ontogenic and longitudinal activity of Na<sup>+</sup>-nucleoside transporters in the human intestine</span> <span class="citation_source-journal">Am. J. Physiol.: Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">G475</span><span class="NLM_x">–</span> <span class="NLM_lpage">G481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2001&pages=G475-G481&author=L.+Y.+Ngoauthor=S.+D.+Patilauthor=J.+D.+Unadkat&title=Ontogenic+and+longitudinal+activity+of+Na%2B-nucleoside+transporters+in+the+human+intestine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DL.%2BY.%26aulast%3DPatil%26aufirst%3DS.%2BD.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DOntogenic%2520and%2520longitudinal%2520activity%2520of%2520Na%252B-nucleoside%2520transporters%2520in%2520the%2520human%2520intestine%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2001%26volume%3D280%26spage%3DG475%26epage%3DG481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Govindarajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakken, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor-Anglada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">In situ hydridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta</span> <span class="citation_source-journal">Am. J. Physiol. Regul. Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">R1809</span><span class="NLM_x">–</span> <span class="NLM_lpage">R1822</span><span class="refDoi"> DOI: 10.1152/ajpregu.00293.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1152%2Fajpregu.00293.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2007&pages=R1809-R1822&author=R.+Govindarajanauthor=A.+H.+Bakkenauthor=K.+L.+Hudkinsauthor=Y.+Laiauthor=F.+J.+Casadoauthor=M.+Pastor-Angladaauthor=C.-M.+Tseauthor=J.+Hayashiauthor=J.+D.+Unadkat&title=In+situ+hydridization+and+immunolocalization+of+concentrative+and+equilibrative+nucleoside+transporters+in+the+human+intestine%2C+liver%2C+kidneys%2C+and+placenta&doi=10.1152%2Fajpregu.00293.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00293.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00293.2007%26sid%3Dliteratum%253Aachs%26aulast%3DGovindarajan%26aufirst%3DR.%26aulast%3DBakken%26aufirst%3DA.%2BH.%26aulast%3DHudkins%26aufirst%3DK.%2BL.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DCasado%26aufirst%3DF.%2BJ.%26aulast%3DPastor-Anglada%26aufirst%3DM.%26aulast%3DTse%26aufirst%3DC.-M.%26aulast%3DHayashi%26aufirst%3DJ.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DIn%2520situ%2520hydridization%2520and%2520immunolocalization%2520of%2520concentrative%2520and%2520equilibrative%2520nucleoside%2520transporters%2520in%2520the%2520human%2520intestine%252C%2520liver%252C%2520kidneys%252C%2520and%2520placenta%26jtitle%3DAm.%2520J.%2520Physiol.%2520Regul.%2520Integr.%2520Comp.%2520Physiol.%26date%3D2007%26volume%3D293%26spage%3DR1809%26epage%3DR1822%26doi%3D10.1152%2Fajpregu.00293.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit59"><span> <span class="citation_source-book">The Japanese Pharmacopoeia</span>, <span class="NLM_edition">16</span>th ed.; Ministerial Notification No. 65; <span class="NLM_publisher-name">The Ministry of Health, Labour and Welfare</span>, March 24,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>pp 267, 292 (English version on the website <a href="http://jpdb.nihs.go.jp/jp16e/" class="extLink">http://jpdb.nihs.go.jp/jp16e/</a>). “JP2” is a 1:1 mixture of phosphate buffer solution (pH 6.8) and distilled water. The phosphate buffer solution could be prepared by dissolving 3.40 g of potassium dihydrogen phosphate and 3.55 g of disodium hydrogen phosphate in enough water to make 1000 mL.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Japanese+Pharmacopoeia%2C+16th+ed.%3B+Ministerial+Notification+No.+65%3B+The+Ministry+of+Health%2C+Labour+and+Welfare%2C+March+24%2C+2011%2C+pp+267%2C+292+%28English+version+on+the+website+http%3A%2F%2Fjpdb.nihs.go.jp%2Fjp16e%2F%29.+%E2%80%9CJP2%E2%80%9D+is+a+1%3A1+mixture+of+phosphate+buffer+solution+%28pH+6.8%29+and+distilled+water.+The+phosphate+buffer+solution+could+be+prepared+by+dissolving+3.40+g+of+potassium+dihydrogen+phosphate+and+3.55+g+of+disodium+hydrogen+phosphate+in+enough+water+to+make+1000+mL."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DThe%2520Japanese%2520Pharmacopoeia%26pub%3DThe%2520Ministry%2520of%2520Health%252C%2520Labour%2520and%2520Welfare%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Kasuga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonehara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyachi, H.</span><span> </span><span class="NLM_article-title">Improvement of water-solubility of biarylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ-selective partial agonists by disruption of molecular planarity/symmetry</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7164</span><span class="NLM_x">–</span> <span class="NLM_lpage">7173</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2Fj.bmc.2010.08.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7164-7173&author=J.+Kasugaauthor=M.+Ishikawaauthor=M.+Yoneharaauthor=M.+Makishimaauthor=Y.+Hashimotoauthor=H.+Miyachi&title=Improvement+of+water-solubility+of+biarylcarboxylic+acid+peroxisome+proliferator-activated+receptor+%28PPAR%29+%CE%B4-selective+partial+agonists+by+disruption+of+molecular+planarity%2Fsymmetry&doi=10.1016%2Fj.bmc.2010.08.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DKasuga%26aufirst%3DJ.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DYonehara%26aufirst%3DM.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DImprovement%2520of%2520water-solubility%2520of%2520biarylcarboxylic%2520acid%2520peroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529%2520%25CE%25B4-selective%2520partial%2520agonists%2520by%2520disruption%2520of%2520molecular%2520planarity%252Fsymmetry%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7164%26epage%3D7173%26doi%3D10.1016%2Fj.bmc.2010.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span><span class="refDoi"> DOI: 10.1021/jm101356p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry&doi=10.1021%2Fjm101356p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0li05Hgb8CTxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554%26doi%3D10.1021%2Fjm101356p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Ritzel, M. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na<sup>+</sup>/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine</span> <span class="citation_source-journal">Mol. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.3109/09687689709044322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.3109%2F09687689709044322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10087507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK1MXhsl2ksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=203-211&author=M.+W.+L.+Ritzelauthor=S.+Y.+M.+Yaoauthor=A.+M.+L.+Ngauthor=J.+R.+Mackeyauthor=C.+E.+Cassauthor=J.+D.+Young&title=Molecular+cloning%2C+functional+expression+and+chromosomal+localization+of+a+cDNA+encoding+a+human+Na%2B%2Fnucleoside+cotransporter+%28hCNT2%29+selective+for+purine+nucleosides+and+uridine&doi=10.3109%2F09687689709044322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine</span></div><div class="casAuthors">Ritzel, Mabel W. L.; Yao, Sylvia Y. M.; Ng, Amy M. L.; Mackey, John R.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Membrane Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-211</span>CODEN:
                <span class="NLM_cas:coden">MMEBE7</span>;
        ISSN:<span class="NLM_cas:issn">0968-7688</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Two Na+-dependent nucleoside transporters implicated in adenosine and uridine transport in mammalian cells are distinguished functionally on the basis of substrate specificity: CNT1 is selective for pyrimidine nucleosides but also transports adenosine; CNT2 (also termed SPNT) is selective for purine nucleosides but also transports uridine.  Both proteins belong to a gene family that includes the NupC proton/nucleoside symporter of E. coli.  CDNAs encoding members of the CNT family have been isolated from rat tissues (jejunum, brain, liver; rCNT1 and rCNT2/SPNT) and, most recently, human kidney (hCNT1 and hSPNT1).  Here, the mol. cloning and functional characterization of a CNT2/SPNT-type transporter from human small intestine are described.  The encoded 658-residue protein (hCNT2 in the nomenclature) had the same predicted amino acid sequence as human kidney hSPNT1, except for a polymorphism at residue 75 (Arg substituted by Ser), and was 83 and 72% identical to rCNT2 and hCNT1, resp.  Sequence differences between hCNT2 and rCNT2 were greatest at the N-terminus.  In Xenopus oocytes, recombinant hCNT2 exhibited the functional characteristics of a Na+-dependent nucleoside transporter with selectivity for adenosine, other purine nucleosides and uridine (adenosine and uridine Kmapp values 8 and 40 μM, resp.).  HCNT2 transcripts were found in kidney and small intestine but, unlike rCNT2, were not detected in liver.  Deoxyadenosine, which undergoes net renal secretion in humans, was less readily transported than adenosine.  HCNT2 also mediated small, but significant, fluxes of the antiviral purine nucleoside analog 2',3'-dideoxyinosine.  HCNT2 is, therefore potentially involved in both the intestinal absorption and renal handling of purine nucleosides (including adenosine), uridine and purine nucleoside drugs.  The gene encoding hCNT2 was mapped to chromosome 15q15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSi0_9TUksJ7Vg90H21EOLACvtfcHk0li05Hgb8CTxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsl2ksrk%253D&md5=9babfea6eee96c71978a5b9c542107de</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3109%2F09687689709044322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F09687689709044322%26sid%3Dliteratum%253Aachs%26aulast%3DRitzel%26aufirst%3DM.%2BW.%2BL.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DNg%26aufirst%3DA.%2BM.%2BL.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520cloning%252C%2520functional%2520expression%2520and%2520chromosomal%2520localization%2520of%2520a%2520cDNA%2520encoding%2520a%2520human%2520Na%252B%252Fnucleoside%2520cotransporter%2520%2528hCNT2%2529%2520selective%2520for%2520purine%2520nucleosides%2520and%2520uridine%26jtitle%3DMol.%2520Membr.%2520Biol.%26date%3D1998%26volume%3D15%26spage%3D203%26epage%3D211%26doi%3D10.3109%2F09687689709044322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Ritzel, M. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritzel, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowles, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpinski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span> </span><span class="NLM_article-title">Molecular identification and characterization of novel human and mouse concentrative Na<sup>+</sup>-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system <i>cib</i>)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">2914</span><span class="NLM_x">–</span> <span class="NLM_lpage">2927</span><span class="refDoi"> DOI: 10.1074/jbc.M007746200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1074%2Fjbc.M007746200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=11032837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVGjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=2914-2927&author=M.+W.+L.+Ritzelauthor=A.+M.+L.+Ngauthor=S.+Y.+M.+Yaoauthor=K.+Grahamauthor=S.+K.+Loewenauthor=K.+M.+Smithauthor=R.+G.+Ritzelauthor=D.+A.+Mowlesauthor=P.+Carpenterauthor=X.-Z.+Chenauthor=E.+Karpinskiauthor=R.+J.+Hydeauthor=S.+A.+Baldwinauthor=C.+E.+Cassauthor=J.+D.+Young&title=Molecular+identification+and+characterization+of+novel+human+and+mouse+concentrative+Na%2B-nucleoside+cotransporter+proteins+%28hCNT3+and+mCNT3%29+broadly+selective+for+purine+and+pyrimidine+nucleosides+%28system+cib%29&doi=10.1074%2Fjbc.M007746200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)</span></div><div class="casAuthors">Ritzel, Mabel W. L.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Graham, Kathryn; Loewen, Shaun K.; Smith, Kyla M.; Ritzel, R. Gary; Mowles, Delores A.; Carpenter, Pat; Chen, Xing-Zhen; Karpinski, Edward; Hyde, Ralph J.; Baldwin, Stephen A.; Cass, Carol E.; Young, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2914-2927</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The human concentrative (Na+-linked) plasma membrane transport proteins hCNT1 and hCNT2 are selective for pyrimidine nucleosides (system cit) and purine nucleosides (system cif), resp.  Both have homologs in other mammalian species and belong to a gene family (CNT) that also includes hfCNT, a newly identified broad specificity pyrimidine and purine Na+-nucleoside symporter (system cib) from the ancient marine vertebrate, the Pacific hagfish (Eptatretus stouti).  The authors now report the cDNA cloning and characterization of cib homologs of hfCNT from human mammary gland, differentiated human myeloid HL-60 cells, and mouse liver.  The 691- and 703-residue human and mouse proteins, designated hCNT3 and mCNT3, resp., were 79% identical in amino acid sequence and contained 13 putative transmembrane helixes.  HCNT3 was 48, 47, and 57% identical to hCNT1, hCNT2, and hfCNT, resp.  When produced in Xenopus oocytes, both proteins exhibited Na+-dependent cib-type functional activities.  HCNT3 was electrogenic, and a sigmoidal dependence of uridine influx on Na+ concn. indicated a Na+:uridine coupling ratio of at least 2:1 for both hCNT3 and mCNT3 (cf 1:1 for hCNT1/2).  Phorbol myristate acetate-induced differentiation of HL-60 cells led to the parallel appearance of cib-type activity and hCNT3 mRNA.  Tissues contg. hCNT3 transcripts included pancreas, bone marrow, trachea, mammary gland, liver, prostate, and regions of intestine, brain, and heart.  The hCNT3 gene mapped to chromosome 9q22.2 and included an upstream phorbol myristate acetate response element.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQsjUSC-yYHbVg90H21EOLACvtfcHk0liSHGYzPymiKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVGjtbg%253D&md5=39ece99c697f93b9c84118f6c1c3d933</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M007746200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M007746200%26sid%3Dliteratum%253Aachs%26aulast%3DRitzel%26aufirst%3DM.%2BW.%2BL.%26aulast%3DNg%26aufirst%3DA.%2BM.%2BL.%26aulast%3DYao%26aufirst%3DS.%2BY.%2BM.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DLoewen%26aufirst%3DS.%2BK.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DRitzel%26aufirst%3DR.%2BG.%26aulast%3DMowles%26aufirst%3DD.%2BA.%26aulast%3DCarpenter%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.-Z.%26aulast%3DKarpinski%26aufirst%3DE.%26aulast%3DHyde%26aufirst%3DR.%2BJ.%26aulast%3DBaldwin%26aufirst%3DS.%2BA.%26aulast%3DCass%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520identification%2520and%2520characterization%2520of%2520novel%2520human%2520and%2520mouse%2520concentrative%2520Na%252B-nucleoside%2520cotransporter%2520proteins%2520%2528hCNT3%2520and%2520mCNT3%2529%2520broadly%2520selective%2520for%2520purine%2520and%2520pyrimidine%2520nucleosides%2520%2528system%2520cib%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D2914%26epage%3D2927%26doi%3D10.1074%2Fjbc.M007746200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Osada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoriya, K.</span><span> </span><span class="NLM_article-title">Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1016/0014-2999(93)90201-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2F0014-2999%2893%2990201-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=8243554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1993&pages=183-188&author=Y.+Osadaauthor=M.+Tsuchimotoauthor=H.+Fukushimaauthor=K.+Takahashiauthor=S.+Kondoauthor=M.+Hasegawaauthor=K.+Komoriya&title=Hypouricemic+effect+of+the+novel+xanthine+oxidase+inhibitor%2C+TEI-6720%2C+in+rodents&doi=10.1016%2F0014-2999%2893%2990201-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents</span></div><div class="casAuthors">Osada, Yoshio; Tsuchimoto, Masahiro; Fukushima, Hisashi; Takahashi, Katsushi; Kondo, Shiro; Hasegawa, Masaichi; Komoriya, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">183-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The authors studied the xanthine oxidase/xanthine dehydrogenase inhibitory activity and hypouricemic effect of a newly synthesized xanthine oxidase/xanthine dehydrogenase inhibitor, TEI-6720, 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, and compared its effects with those of allopurinol in rodents.  TEI-6720 was found to inhibit bovine milk xanthine oxidase, and mouse liver and rat liver xanthine oxidase/xanthine dehydrogenase with IC50 values of 1.4, 1.8 and 2.2 nM, resp.  On bovine milk xanthine oxidase, TEI-6720 exhibited mixed-type inhibition and the Ki value was 0.7 nM.  TEI-6720 displayed prolonged urate-lowering activity in normal mice and rats.  The authors evaluated the hypouricemic effect of TEI-6720 on hyperuricemia induced by the uricase inhibitor, K oxonate (250 mg/kg s.c., 1 h before the test drugs), and measured the total molarity of both serum allantoin and urate in rats.  Oral TEI-6720 and allopurinol had a hypouricemic effect 2 h after their administration to oxonate-pretreated rats with ED50 values of 1.5 and 5.0 mg/kg, resp.  Both compds. also reduced the combined molarity of uric acid and allantoin in rats.  The ED50 values of TEI-6720 and allopurinol were 2.1 and 6.9 mg/kg p.o., resp.  Thus, TEI-6720 appears to be useful for the treatment of hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX2Q3y8qGVDLVg90H21EOLACvtfcHk0liSHGYzPymiKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWitbk%253D&md5=53668fde3cc79e44162913118a737807</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990201-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990201-R%26sid%3Dliteratum%253Aachs%26aulast%3DOsada%26aufirst%3DY.%26aulast%3DTsuchimoto%26aufirst%3DM.%26aulast%3DFukushima%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DKomoriya%26aufirst%3DK.%26atitle%3DHypouricemic%2520effect%2520of%2520the%2520novel%2520xanthine%2520oxidase%2520inhibitor%252C%2520TEI-6720%252C%2520in%2520rodents%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D241%26spage%3D183%26epage%3D188%26doi%3D10.1016%2F0014-2999%2893%2990201-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Lang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cass, C. E.</span><span> </span><span class="NLM_article-title">Acquisition of human concentrative nucleoside transporter 2 (hCNT2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1143-1152&author=T.+T.+Langauthor=M.+Selnerauthor=J.+D.+Youngauthor=C.+E.+Cass&title=Acquisition+of+human+concentrative+nucleoside+transporter+2+%28hCNT2%29+activity+by+gene+transfer+confers+sensitivity+to+fluoropyrimidine+nucleosides+in+drug-resistant+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DT.%2BT.%26aulast%3DSelner%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DJ.%2BD.%26aulast%3DCass%26aufirst%3DC.%2BE.%26atitle%3DAcquisition%2520of%2520human%2520concentrative%2520nucleoside%2520transporter%25202%2520%2528hCNT2%2529%2520activity%2520by%2520gene%2520transfer%2520confers%2520sensitivity%2520to%2520fluoropyrimidine%2520nucleosides%2520in%2520drug-resistant%2520leukemia%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1143%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Shin, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landowski, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drach, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span> </span><span class="NLM_article-title">Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.1016/S0006-291X(03)01259-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1016%2FS0006-291X%2803%2901259-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=696-703&author=H.-C.+Shinauthor=C.+P.+Landowskiauthor=D.+Sunauthor=B.+S.+Vigauthor=I.+Kimauthor=S.+Mittalauthor=M.+Laneauthor=G.+Rosaniaauthor=J.+C.+Drachauthor=G.+L.+Amidon&title=Functional+expression+and+characterization+of+a+sodium-dependent+nucleoside+transporter+hCNT2+cloned+from+human+duodenum&doi=10.1016%2FS0006-291X%2803%2901259-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901259-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901259-2%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DH.-C.%26aulast%3DLandowski%26aufirst%3DC.%2BP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DVig%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DMittal%26aufirst%3DS.%26aulast%3DLane%26aufirst%3DM.%26aulast%3DRosania%26aufirst%3DG.%26aulast%3DDrach%26aufirst%3DJ.%2BC.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26atitle%3DFunctional%2520expression%2520and%2520characterization%2520of%2520a%2520sodium-dependent%2520nucleoside%2520transporter%2520hCNT2%2520cloned%2520from%2520human%2520duodenum%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D307%26spage%3D696%26epage%3D703%26doi%3D10.1016%2FS0006-291X%2803%2901259-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unadkat, J. D.</span><span> </span><span class="NLM_article-title">Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1124/mol.65.3.558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10.1124%2Fmol.65.3.558" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=558-570&author=C.+Changauthor=P.+W.+Swaanauthor=L.+Y.+Ngoauthor=P.+Y.+Lumauthor=S.+D.+Patilauthor=J.+D.+Unadkat&title=Molecular+requirements+of+the+human+nucleoside+transporters+hCNT1%2C+hCNT2%2C+and+hENT1&doi=10.1124%2Fmol.65.3.558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.3.558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.3.558%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DNgo%26aufirst%3DL.%2BY.%26aulast%3DLum%26aufirst%3DP.%2BY.%26aulast%3DPatil%26aufirst%3DS.%2BD.%26aulast%3DUnadkat%26aufirst%3DJ.%2BD.%26atitle%3DMolecular%2520requirements%2520of%2520the%2520human%2520nucleoside%2520transporters%2520hCNT1%252C%2520hCNT2%252C%2520and%2520hENT1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D558%26epage%3D570%26doi%3D10.1124%2Fmol.65.3.558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">66</a></strong><div class="note"><p class="first last">Preliminary studies have suggested the following characteristics of compound <b>22</b>: (a) Compound <b>22</b> is a highly selective inhibitor of hCNT2 rather than hCNT1. (b) Compound <b>22</b> is not a substrate for hCNT2. (c) Compound <b>22</b> is a competitive inhibitor of hCNT2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Halbfinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span> </span><span class="NLM_article-title">Molecular recognition of modified adenine nucleotides by the P2Y<sub>1</sub>-receptor. 1. A synthetic, biochemical, and NMR approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5325</span><span class="NLM_x">–</span> <span class="NLM_lpage">5337</span><span class="refDoi"> DOI: 10.1021/jm990156d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990156d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5325-5337&author=E.+Halbfingerauthor=D.+T.+Majorauthor=M.+Ritzmannauthor=J.+Ublauthor=G.+Reiserauthor=J.+L.+Boyerauthor=K.+T.+Hardenauthor=B.+Fischer&title=Molecular+recognition+of+modified+adenine+nucleotides+by+the+P2Y1-receptor.+1.+A+synthetic%2C+biochemical%2C+and+NMR+approach&doi=10.1021%2Fjm990156d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm990156d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990156d%26sid%3Dliteratum%253Aachs%26aulast%3DHalbfinger%26aufirst%3DE.%26aulast%3DMajor%26aufirst%3DD.%2BT.%26aulast%3DRitzmann%26aufirst%3DM.%26aulast%3DUbl%26aufirst%3DJ.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DHarden%26aufirst%3DK.%2BT.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DMolecular%2520recognition%2520of%2520modified%2520adenine%2520nucleotides%2520by%2520the%2520P2Y1-receptor.%25201.%2520A%2520synthetic%252C%2520biochemical%252C%2520and%2520NMR%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5325%26epage%3D5337%26doi%3D10.1021%2Fjm990156d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Gottlieb, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span><span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lhmpoCr5TddbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Schaner, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, K. M.</span><span> </span><span class="NLM_article-title">Functional characterization of a human purine-selective, Na<sup>+</sup>-dependent nucleoside transporter (hSPNT1) in a mammalian expression system</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1487</span><span class="NLM_x">–</span> <span class="NLM_lpage">1491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=10336543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1487-1491&author=M.+E.+Schanerauthor=J.+Wangauthor=L.+Zhangauthor=S.-F.+Suauthor=K.+M.+Gerstinauthor=K.+M.+Giacomini&title=Functional+characterization+of+a+human+purine-selective%2C+Na%2B-dependent+nucleoside+transporter+%28hSPNT1%29+in+a+mammalian+expression+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system</span></div><div class="casAuthors">Schaner, Marci E.; Wang, Juan; Zhang, Lei; Su, Sheng-Fang; Gerstin, Karin M.; Giacomini, Kathleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1487-1491</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nucleosides and nucleoside analogs are actively transported in the human kidney.  With the recent cloning of a purine-selective, Na+-dependent, nucleoside transporter (hSPNT1, also termed hCNT2) from human kidney, it is now possible to study the interaction of nucleosides and nucleoside analogs with this transport protein and gain a more detailed knowledge of the underlying mechanisms of nucleoside transport in the human kidney.  In this study we examd. the substrate selectivity of hSPNT1 for nucleosides and nucleoside analogs.  We detd. that the naturally occurring nucleosides adenosine, inosine, and uridine are substrates for this carrier, whereas thymidine is not.  The nucleoside analogs (0.5 mM) 2',3'-dideoxyadenosine; 2',3'-dideoxyinosine; and 2-chloro-2'-deoxyadenosine (2CdA), significantly inhibited the uptake of [3H]inosine in HeLa cells transiently transfected with hSPNT1.  However, there was no significant Na+-dependent uptake of [3H]2',3'-dideoxyinosine or [3H]2CdA in the transfected cells, suggesting that these nucleoside analogs are not permeants of hSPNT1.  Interestingly, 2CdA was considerably less potent in inhibiting [3H]inosine uptake in HeLa cells expressing hSPNT1 than in cells expressing the rat homolog rSPNT (IC50 = 371 μM vs. 13.8 μM), suggesting that there may be notable species differences in the kinetic interactions of some nucleoside analogs with purine-selective nucleoside transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraE4hTuLH30rVg90H21EOLACvtfcHk0lhmpoCr5TddbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGnsbo%253D&md5=d6522563b973d6300f20b3e0ec1925e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchaner%26aufirst%3DM.%2BE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DS.-F.%26aulast%3DGerstin%26aufirst%3DK.%2BM.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DFunctional%2520characterization%2520of%2520a%2520human%2520purine-selective%252C%2520Na%252B-dependent%2520nucleoside%2520transporter%2520%2528hSPNT1%2529%2520in%2520a%2520mammalian%2520expression%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D1487%26epage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01884">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_06318"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01884">10.1021/acs.jmedchem.5b01884</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_003.xlsx">XLSX</a>)</p></li><li><p class="inline">Synthetic procedures and characterization data for all intermediates, HPLC analysis data for all tested compounds, experimental procedures for conformational analysis, and determination of solubility in JP2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_002.pdf">jm5b01884_si_002.pdf (200.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01884/suppl_file/jm5b01884_si_003.xlsx">jm5b01884_si_003.xlsx (10.17 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01884&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01884%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-8%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01884" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                926KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998b0c9f0a3ca0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
